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1. INTRODUCTION 
1.1. Electrophiles and inflammation 
There are many bioactive natural products with different structures that affect their targets by 
their electrophilic nature. These electrophilic natural products convey diverse biological 
activities, such as antifungal, antimitotic, or antitumor activity. Many others play important 
roles in fighting inflammation. Michael acceptor systems such as ,-unsaturated aldehydes, 
ketones, amides, -lactones and -lactones (Figure 1), as well as ring strained cyclic 
molecules such as epoxides, aziridines, -lactones and -lactames are some examples.1 
 
Figure 1: Some natural ,-unsaturated compounds.1 
The activity of the ,-unsaturated carbonyl compounds is mostly based on their Michael 
acceptor activity, i.e. adding nucleophiles to the electrophilic -position of their enone 
system.
2
 Through this activity, ,-unsaturated carbonyl compounds trigger the activation or 
inhibition of anti- and proinflammatory pathways, where reactive sulfhydryl groups of 
cysteine residues in proteins play a major role in transforming chemical reactivity into a 
biological activity.
3
 Depending on their structures, ,-unsaturated carbonyl systems may 
have other types of reactivity like radical scavenging, double bond isomerization or reductive 
potential which are often referred to as antioxidative behavior (Figure 2).
2
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Figure 2: Important reactivities of ,-unsaturated compounds.2 
The activation of the Nrf2-Keap1 pathway and the inhibition of the NF-B pathway are 
examples of cellular defense strategies against inflammation where the thiol-mediated 
processes play a key role leading to induction of phase 2 enzymes. Nrf2 (nuclear factor-
erythroid-2-related factor 2) is a transcription factor which is tightly regulated by a cytosolic 
repressor protein called Kelch-like ECH-associated protein1 (Keap1). Keap1, in combination 
with an adaptor component Cul3 (Cullin 3)-based ubiquitin E3 ligase complex, promotes Nrf2 
ubiquitination and proteosomal degradation in basal conditions.
4
 As shown in Figure 3, Keap1 
can be activated either by oxidation (leading to the formation of disulfide) or by a Michael 
addition reaction with an electrophile such as an ,-unsaturated compound. This leads to 
liberation of the transcriptional factor Nrf2 which then translocates into the nucleus and binds 
to antioxidant response elements (ARE) leading to expression of anti-inflammatory proteins 
like heme oxygenese-1 (HO-1).
5
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Figure 3: Mechanism of Nrf2-Keap1 activation pathway, (CuI3: Cullin 3; Keap1: Kelch-like ECH-associated 
protein1; Nrf2: nuclear factor-erythroid-2-related factor 2; ,: ,-unsaturated compound; ARE: Antioxidant 
response element; HO-1: heme oxygenese-1).  
On the other hand, the transcriptional factor nuclear factor-kappa B (NF-B) is a heterodimer 
of p65 and p50 proteins. In unstimulated cells, NF-B is sequestered in the cytoplasm by 
binding to inhibitor proteins (IBs) which are themselves controlled by protein kinases 
(IKKs). Following cell stimulation, IKK activates IB by phosphorylation of its serine 
residues. The activation of IB leads to its ubiquitination and then degradation which 
liberates the NF-B. The free NF-B translocates into the nucleus and binds to target DNA 
sites resulting in transcription of many proinflammatory genes.
6
 Therefore, the deactivation of 
NF-B, where an alkylation of reactive cysteines at p50 and p65 DNA binding sites or at the 
regulatory kinase IKK is crucial, is of great importance. It leads to downregulation of 
proinflammatory factors like tumor necrosis factor (TNF, formerly named TNF-) and 
enzymes such as cyclooxygenase-2 (COX-2) or inducible NO synthase (iNOS) (Figure 4).
7
  
The mechanisms of these two pathways above emphasize the eligibility of ,-unsaturated 
compounds for triggering the thiol-mediated gene expression in the cell, which makes them 
attractive to be used as anti-inflammatory agents. 
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Figure 4: Mechanism of NF-B inhibition pathway, (NF-B: nuclear factor-kappa B; a heterodimer of p50 and 
p65 proteins; IKK: IB kinase; IB: inhibitor of kappa B,  Ub-Ub-Ub: ubiquitination; ,: ,-unsaturated 
compound; iNOS: inducible NO synthase; COX-2: cyclooxygenase-2; TNF: tumor necrosis factor). 
1.2. Chalcones  
Chalcones are natural ,-unsaturated carbonyl compounds from the class of plant 
polyphenols, which have the structure of 1,3-diphenylprop-2-en-1-ones. They belong to the 
largest class of plant secondary metabolites and considered to be the biosynthetic precursors 
of cyclic flavonoids.
8
 Figure 5 shows some plants which are sources of chalcones
9
 and some 
natural chalcones 2-5 are shown in Figure 6. 
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Figure 5: Some sources of chalcones. 
 
 
Figure 6: Chalcone (1) and some examples of natural chalcones (2-5). 
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The numbering system of chalcones is shown on the structure of chalcone (1) (Figure 6). The 
C=C in the ,-unsaturated moiety of chalcones can adopt a Z (cis) or an E (trans) 
configuration. Thermodynamically, the E-isomer is more stable and all the isolated chalcones 
are in this form.
10
 The / photoisomerization of chalcones is known and different isomers 
may have different biological activity.
11
 Orientation of the C=O and the C=C around the 
single bond is also important in chalcones. They adopt either the s-cis or the s-trans 
conformation (Figure 7A). The X-ray crystal structures of many -unsubstituted chalcones 
clearly show the preference for the s-cis conformer (as in Figure 6), while some -substituted 
chalcones have been reported to adopt the s-trans conformation,
12
 such as the -Me12 and -
F
13
 chalcones (Figure 7B). 
 
Figure 7: A) s-cis and s-trans Conformations of chalcones, B) Examples of s-trans chalcones. (Examples of      
s-cis chalcones are shown in Figure 6). 
1.2.1. Biological activity of chalcones 
Chalcones are found in fruits, vegetables, spices and tea. As chemoprotective and 
chemopreventive agents, chalcones have been reported to possess many biological activities 
such as anti-inflammatory, antioxidative, antimitotic, antibacterial, antifungal, antimalarial 
and antileishmanial.
8-10,14-17
 Cytotoxic and antiviral properties were also found.
8,10,15
 As 
electrophiles, the activity of chalcones is mostly based on the Michael acceptor activity of 
their ,-unsaturated carbonyl system as well as their radical scavenging or reductive 
potential (antioxidative behavior).
2
  
1.2.2. Fine tuning the Michael acceptor activity of chalcones 
Despite the ability of Michael acceptors to address certain cysteine residues, they are a 
neglected class of compounds in drug development.
8
 This is due to possible unspecific 
reactions of the very strong electrophiles with less reactive thiol groups. Additionally, such 
electrophiles can be trapped by the cellular glutathione (GSH), whose cysteine residue has 
only moderate reactivity, and thus leads to reduced activity of potent electrophiles. 
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Consequently, fine tuning of the Michael acceptor activity of ,-unsaturated compounds is 
highly needed to improve specificity.  
Some reported studies to assess the reactivity of ,-unsaturated systems 
The assessment of the reactivity of compounds would be a very helpful tool to potentially 
predict their biological activity. Different approaches have been reported to compare similar 
natural products and synthetic molecules in order to correlate their biological activity with the 
reactivity of their ,-unsaturated carbonyl system, such as NMR spectroscopic analyses and 
in silico methods. The 
13
C NMR shift of the -carbons in a series of drug-like molecules 
(Figure 8) was used for example to estimate their electrophilicity, then to correlate it with 
their Michael acceptor activity, reduction potential and photoisomerization.
18
  
 
Figure 8: Scaffolds of the drug-like compounds that were used to correlate their electrophilicity (which was 
estimated using 
13
C NMR shifts of the -carbons) with their biological activity.18 
A study on prostaglandins (Figure 9) showed that the calculated LUMO coefficients and net 
atom charges are in agreement with the proposed 1,4-addition reactivities depicted by their 
13
C NMR studies.
19
  
 
Figure 9: An example of prostaglandins. 
Reduction ability of the C=O of the chalcones can also be used as an indicator for the 
electrophilicity of the -position because of the delocalization of electrons along the ,-
unsaturated moiety.
10
 Dimmock and coworkers for example found a good correlation between 
the reduction potential of the C=O functionality and the cytotoxicity of the some chalcones 
(Figure 10). The higher the reduction potential the more toxic was the compound.
20
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Figure 10: Examples for chalcones investigated by Dimmock.
20 
Zoete published an interesting study on 30 plant phenylpropenoids and synthetic analogues 
(Figure 11) that showed a correlation between their EHOMO values and their biological activity 
as inducers for NAD(P)H:quinone oxidoreductase-1 (NQO1). It was demonstrated that the 
lower absolute EHOMO value of a compound i.e. the lower its reduction potential, the stronger 
is its electron-donating nature and the greater is its inducer potency.
21
 
 
Figure 11: Classes of the plant phenylpropenoids and synthetic analogues that were investigated by Zoete.
21
 
The EHOMO and ELUMO energies were also correlated with reduction potential and radical 
scavenging activity of some synthetic chalcones (Figure 12). The study showed that the 
INTRODUCTION 
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higher EHOMO values, the smaller is the reduction potential. In addition, high EHOMO and 
ELUMO values lead to high radical scavenging activity.
22
 
 
Figure 12: Synthetic chalcones that were investigated for the relationship between their EHOMO and ELUMO 
energies and their reduction potential and radical scavenging activity.
22
  
Assays to determine the reactivity of ,-unsaturated compounds toward thiols 
Since the biological activity of Michael acceptors depends on their reaction with cysteine 
residues of proteins during the thiol-mediated processes, the assessment of their 
electrophilicity towards thiols in particular is of great interest.  
Recently an NMR-based assay was developed and used to group different ,-unsaturated 
natural products (e.g. curcumin and (R)-carvone) as reversible and irreversible thiol sinks.
23
 
The 
1
H NMR spectra (in DMSO-d6) were obtained for the compounds in presence of a thiol to 
identify the thiol-trapping agents among the tested compounds at first, then the reversibility of 
the reactions was investigated upon dilution of the DMSO-samples with CDCl3. This assay is 
valuable and helps to get important structural information especially when more than one 
reactive site had reacted in one molecule. But it is not a quantitative assay that can be used to 
compare a library of compounds with small structural differences like chalcones. 
Dinkova-Kostova and Talalay
24
 determined the rate of the reaction of some ,-unsaturated 
compounds with thiols in a 1:1 mixture of MeCN and 100 mM TRIS-HCl pH 7.4 at 25 °C. A 
good correlation was found between the reactivity of the tested compounds and their ability to 
elevate cellular Glutathione (GSH). 
A facile spectrophotometric kinetic assay was developed during this PhD work to assess the 
reactivity of the synthesized chalcones toward thiols especially that the conditions of 
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Dinkova-Kostova and Talalay were not suitable for the stability and the wide range of 
reactivity of the synthesized chalcones as will be shown later. Additionally the developed 
assay is based on 96-well plate format which enables fast and simple testing. 
Modulating the reactivity of chalcones 
The fine tuning of the reactivity of compounds is a promising approach to optimize potent 
compounds for a specific biological target. A recent example where electrophilicity tuning 
strategy was successful is the modulation of the reactivity of the CN group in a series of aryl 
nitriles by variation of the aryl moiety (Figure 13). A good correlation was found between the 
calculated electrophilicity and the inhibitory activity of the synthesized compounds toward a 
cysteine protease, i.e. higher electrophilicity led to more inhibition. Additionally, it was found 
that the reduced electrophilicity resulted in reduced cytotoxicity.
25
 
 
Figure 13: Examples of aryl nitriles whose electrophilicity was correlated with their inhibitory activity towards a 
cysteine protease.
25
 
In order to modulate the reactivity of chalcones, the strategy of changing the substitution 
pattern of the aromatic rings of chalcones has been widely used. An example is the 10 fold 
increase in reactivity of chalcone (1, Figure 6) towards sulfur ylids by introducing electron-
withdrawing substituents in the B-ring.
26
 Another strategy which is not that common in 
literature is to modify the -position of the ,-unsaturated carbonyl system. This is a 
promising concept since it should have a direct and straightforward influence on the 
reactivity. In 1978 Yamamura investigated the reaction of several -X-chalcone derivatives 
(Figure 14) with benzene and acetic acid in the presence of palladium(II)-acetate. He found 
that when X is a bulky and powerfully electron-withdrawing group, such as COPh, NO2, 
COOEt and COOH, the addition of benzene to the carbon-carbon double bond occurs.
27
 This 
means that electron-withdrawing groups lead to an enhancement of the electrophilicity of 
chalcones and therefore the Michael addition takes place easily. This example of the influence 
of -substitution on chemical reactivity shows that a great difference in reactivity of 
chalcones can be achieved by only a single modification. 
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Figure 14: -X-Chalcones investigated by Yamamura.27 
Examples of the influence of -modification on biological activity are also present. Lawrence 
et al. described the effect of different -X-substituents (X = F, CN, COOEt) and different 
substitution patterns on the B-ring of a series of chalcones on their biological activity (Figure 
15A) exhibiting antimitotic properties caused by inhibition of tubulin polymerization. The 
most potent compound in their series was the one with X = F and with 3-hydroxy-4-methoxy 
B-ring.
13
 In a review of antimitotic chalcones and related compounds as inhibitors of tubulin 
assembly, Ducki pointed out that the enhanced bioactivity of some -substituted chalcones as 
antimitotics is attributed to their s-trans conformation which increases their affinity for 
tubulin.
28
 In another example, the effect of -X-substituents (X = CN, COOH, COOMe, OH, 
OMe, Cl, Br) in oleanane (Figure 15B) and ursane triterpenoids was shown on inhibition of 
NO production in mouse macrophages and found that the CN substituent gave the best 
activity. No correlation was found in this case between the Taft’s * values  of the -X-
substituents and the biological activity which means that the activity does not depend on the 
strength of the electron-withdrawing effect of the substituents in this case.
29
 
 
Figure 15: Literature examples of -X-enones to modulate biological activity: A) chalcones as antimitotic 
agents,
13
 B) oleanane triterpenoids as inhibitors of NO production.
29
 
1.2.3. Chalcones as warhead groups  an outlook 
‘Warhead group’ is an expression termed for a reactive group that binds covalently to its 
target. It is the major element of an activity-based probe (ABP) which consists of three 
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elements (Figure 16): 1) a warhead group, 2) a tag that allows detection of the covalent 
enzyme-probe complex and 3) a linker (spacer) that joins the two previous elements 
together.
30
 ABPs are used to profile the functional state of enzymes in complex proteomes in 
a strategy which is called activity-based protein profiling (ABPP). This strategy is also a 
powerful tool to characterize the selectivity of enzyme inhibitor on a global scale.
31
 
 
Figure 16: Schematic representation of an activity-based probe (ABP). 
As reactive electrophiles, Michael acceptors including chalcones may be utilized as warhead 
groups due to their ability to bind covalently to cysteine residues of proteins. Chalcones may 
serve a useful extension of the toolbox of ABPs to be used in labeling studies to identify 
reactive cysteines of the proteins for example. This would be invaluable, since there are many 
families of enzymes that use cysteine-dependent chemical transformation such as proteases.
32
 
Recently, a proteome-wide study applied an ABP that has an electrophilic iodoacetamide 
probe ended with an alkyne (Figure 17). This ABP was used to label cysteine residues in 
proteins then click-chemistry strategy was used to add a tag to the ABP. After digestion, the 
released probe-labeled peptides were analyzed by LC-MS/MS to identify the modified 
cysteines. This approach was also used to distinguish between cysteines of heightened 
reactivity and less reactive cysteines and thus indicating the importance of hyper-reactive 
cysteines. Additionally, it was envisioned that by a variation of the electrophile reactivity one 
will be able to target different subsets of cysteines.
32
 Since the electrophilic activity of 
chalcones can be modulated, they may be utilized in the same manner, especially that there is 
a strong need for tailored electrophiles to trigger the thiol-mediated gene expression and to 
develop new warhead groups.
30
 In another study, chalcones proved to block active-site 
cysteines in cysteine proteases such as cathepsin B and L or topoisomerase I, and by that 
display anticancer properties.
33
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Figure 17: The approach of labeling cysteine residues of proteins using ABP and click chemistry. 
Consequently, fine-tuning the electrophilicity of chalcones could potentially lead to more 
potent irreversible covalent inhibitors that can attach to recognition motifs with high 
selectivity. If so, this can unfold the positive effects of covalent irreversible drugs such as a 
high degree/complete inactivation of the target, potentially reduced dosing, a higher 
efficiency, or circumvention of some resistance pathways.
31
 
1.2.4. Synthetic methods for the preparation of chalcones 
1.2.4.1. -Unsubstituted chalcones 
Many methods have been described for the preparation of chalcones. Nevertheless, the most 
common strategy to synthesize them is the base-mediated Claisen-Schmidt condensation of an 
aldehyde and a ketone in a polar solvent such as MeOH.
10
 Variable bases were used to 
achieve this condensation such as NaOH and KOH. Scheme 1 below shows the mechanism of 
this reaction. The acetophenone in presence of a base forms the enolate that can attack the 
aldehyde; once the alkoxide is formed the dehydration occurs to furnish the chalcone. 
Bukhari
34
 reported recently in a mini review some known methods and various catalysts used 
for the synthesis of chalcones, among these catalysts are LiOH
.
H2O, anhydrous Na2CO3, 
BiCl3 and NaOH-Al2O3. 
 
INTRODUCTION 
14 
 
Scheme 1: Base-mediated Claisen-Schmidt condensation mechanism. 
Synthesis of chalcones by Suzuki coupling between benzoyl chlorides and phenylvinyl-
boronic acids as in Scheme 2 is another reported method to get the chalcones.
35
 
 
Scheme 2: Chalcone synthesis via Suzuki coupling.
35 
 
Heck coupling reaction between aryl vinyl ketones and aryl iodides (Scheme 3) was also 
reported as a method for the synthesis of chalcones in good to excellent yields.
36
  
 
Scheme 3: Chalcone synthesis via Heck coupling.
36
  
To reduce reaction time and facilitate work-up, ultrasound
37
 and microwave irradiation
38-39
 
were also investigated for the synthesis of chalcones. 
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1.2.4.2. -Substituted chalcones 
Substitutions on the -position of the ,-unsaturated carbonyl unit have been achieved in 
synthetic triterpenoids (Figure 15B),
29
 mimetics of those (Figure 18A),
40
 chalcones (Figure 
14, 15A)
13,27
 and the 3(2H)-furanones (Figure 18B)
41
 which were synthesized by Simon 
Lindner in our group.  
 
Figure 18: Examples of -substituted enones.  
Some reported methods for the synthesis of -X-chalcones are discussed below. 
-Halogenated chalcones (-F/Cl/Br/I-chalcones) 
Huang
42
 reported a one-pot stereoselective method for the preparation of (E)--F-chalcones 
by Witting reaction via the corresponding -F-substituted ylids (Scheme 4). Ylid 6 was 
allowed to react with equimolar amounts of N-fluorodiphenylsulfonamide (7) to form salt 8, 
and then a strong base (lithium diisopropylamine, LDA) was added to form ylid 9 smoothly. 
The -F-ylid 9 can then react in situ with an aldehyde 10 to give (E)--F-chalcones 11.  
 
Scheme 4: Synthesis of (E)--F-chalcones by Witting reaction.42  
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A series of (Z)--F-chalcones 14 were prepared by Lawrence and co-workers13 by aldol 
condensation between the -F-acetophenone 13, that was synthesized from the corresponding 
-Br-acetophenone 12, and an aldehyde 10 using piperidine as a base (Scheme 5). They 
claimed that they used a catalytic amount of piperidine, but 3-5 drops of piperidine is not a 
catalytic amount with respect to 0.5 mmol of the ketone and equimolar amounts of the 
aldehyde they used. Their compounds showed potent cytotoxic and tubulin inhibitory 
properties.  
 
Scheme 5: Synthesis of (Z)--F-chalcones by Lawrence.13 
As antimitotic agents, Edwards et al.
43
 prepared some (Z)--Cl-chalcones (Figure 19) by 
chlorination of the -H-chalcones using sulfuryl chloride (SO2Cl2) but with low yields. 
 
Figure 19: (Z)--Cl-Chalcones prepared by Edwards.43 
Mioskowski group
44
 showed that the chlorination of ,-unsaturated ketones can be achieved 
by Et4NCl3, suggesting that it may occur via vicinal ,-dichloroketones which undergo 
spontaneous dehydrohalogenation (Scheme 6).  
 
Scheme 6: Synthesis of -Cl-chalcone using Et4NCl3.
44
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In 2002, Concellόn45 reported the preparation of (Z)--chloro-,-unsaturated ketones by 
reacting -chloro--hydroxyketones with acetic anhydride, pyridine and 4-dimethyl-
aminopyridine (DMAP) in high yields. An example is shown in Scheme 7. The -Cl-
acetophenone 15 was treated with LDA or potassium hexamethyldisilazide (KHMDS) to get 
the enolate that was reacted with benzaldehyde 16 to get the -chloro--hydroxyketone 17. 
Elimination of water from 17 gave -Cl-chalcone 18. 
 
Scheme 7: The synthesis of (Z)--Cl-chalcone (18) by Concellόn.45 
The classical bromination method of chalcones with Br2 affording ,-dibromochalcones 
which can undergo dehydrobromintaion in presence of a base (e.g. Et3N) to get the -
bromochalcones is widely used in literature.
46-48
 Akamanchi et al.
49
 in 2002 published a novel 
one-step procedure for the preparation of -bromo-,-unsaturated carbonyl compounds from 
the corresponding ,-unsaturated carbonyl compounds utilizing Et4NBr as a brominating 
agent in presence of Dess-Martin periodinane (DMP 19, Scheme 8). When they applied their 
method on chalcone (1) they got a mixture of a (Z/E)--bromo-chalcone but Z was the major 
isomer. Scheme 8 shows the mechanism of bromination by their method. Two acetate ligands 
of DMP (19) firstly transfer to Et4NBr forming tetraethylammonium[di(acyloxy)bromate (I)] 
(20) which then adds to the double bond of chalcone (1) to form bromoacetoxylated 
intermediate 21. The acetate ion formed in the reaction acts as a base and abstracts the -H 
furnishing the -Br-chalcone 22.  
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Scheme 8: Mechanism of -bromination of chalcones using Et4NBr in presence of DMP (19).
49
 
As an example for the synthesis of -I-chalcone, Rossi50 published in 1993 a Pd-catalyzed 
method that involves a reaction between 1-alkynyl ketone 23 and Bu3SnH followed by 
iododestannylation of 24 to afford a Z/E mixture of -I-chalcone 25 (Scheme 9). 
 
Scheme 9: Pd-Catalyzed synthesis of -I-chalcone 25 by Rossi.50 
-Aryl-chalcones 
Regarding the -aryl-chalcones (e.g. 27), they can be prepared by Suzuki coupling the way 
Ducki and coworkers
48
 did it for example (Scheme 10A). They started with the -Br-
chalcones (e.g. 26) and could get moderate to good overall yields (26–84%) with high 
selectivity for the E-isomer in all of their -aryl-chalcones prepared by this method. In the 
same article, Ducki showed another method to prepare -aryl-chalcones (Scheme 10B) by 
aldol condensations of a range of substituted benzaldehydes (e.g. 29) with ketones (e.g. 28) 
catalyzed by piperidine as a base in good to excellent yields (58–97%). The products from 
these reactions were isolated as E/Z mixtures. Ducki et al. evaluated their -aryl-chalcones 
for their ability to inhibit tubulin assembly. 
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Scheme 10: Methods used by Ducki
48
 for the synthesis of -aryl-chalcones, A) by Suzuki coupling, B) by aldol 
condensation.  
Flynn et al.
51
 used a one-pot Pd-mediated hydrostannylation/cross coupling protocol to get the 
-aryl-chalcones (e.g. 33) as shown in the following example in Scheme 11. 
Hydrostannylation of alkyne 30 gives compound 31 that upon Cu-catalyzed cross coupling 
with an organic halide 32 furnishes the -aryl-chalcone 33. They got initially the Z-isomer, 
but they reported its isomerization to the thermodynamic mixture of E- and Z- isomers. 
 
Scheme 11: Pd-Mediated hydrostannylation/cross coupling protocol to get -aryl-chalcones.51 
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-Me/COOEt/COOH/CN chalcones 
As antimitotic agents, Edwards
43
 prepared (E)--Me-chalcones by the piperidinium acetate 
mediated aldol condensation of propiophenones and benzaldehydes using EtOH as a solvent. 
In 2008, Bolm
52
 prepared the (E)--Me-chalcone 35 (Scheme 12) by condensation of 
propiophenone 34 with benzaldehyde (16) using aq. KOH as a base in EtOH. 
 
Scheme 12: Preparation of (E)--Me-chalcone 35 by Bolm.52 
Batey et al.
53
 prepared (E)--Me-chalcones and (E)-COOEt-chalcones using Edwards 
reagents (piperidine and glacial AcOH)
43
 but benzene was used as a solvent instead of EtOH 
and it was heated to reflux using a Dean Stark apparatus (route 1, Scheme 13). For the 
synthesis of (E)--Me-chalcones where the A-ring is a substituted aromatic ring (not just a 
phenyl) a three-step aldol protocol was used (route 2, Scheme 13). The TiCl4-mediated aldol 
reaction between the aldehyde and an appropriately substituted propiophenone afforded syn-
-hydroxy ketones that were then immediately converted to the corresponding mesylates, 
which underwent elimination giving the (E)--Me-chalcones. 
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Scheme 13: Synthesis of (E)--Me-chalcones and (E)-COOEt-chalcones by Batey.53 
The Knoevenagel condensation reaction of ethyl 3-(2-hydroxyphenyl)-3-oxopropanoate (36) 
and benzaldehyde (16) was investigated by Zhu et al. in 2009 (Scheme 14).
54
 They found that 
a catalytic amount of L-proline was enough to catalyze the reaction giving the desired product 
(-COOEt-chalcone 37) in 90% yield under very mild reaction conditions. But, when they 
performed the reaction in the presence of molecular sieves 4 Å (MS 4 Å) or with piperidine or 
pyrrolidine as a catalyst, only the trans cyclized product (flavanone) 38 was obtained. 
Moreover, they found that the -COOEt-2’-OH-chalcone 37 could be easily converted to the 
cyclized isomer 38 under basic conditions.  
 
Scheme 14: Synthesis of (E)--COOEt-chalcone 37 by Zhu.54 
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Wang et al.
55
 synthesized some -COOH-chalcones as potential aldose reductase inhibitors. 
They firstly prepared the corresponding -COOEt-chalcones via Knoevenagel condensation 
of a series of ethyl benzoylacetates with a range of benzaldehydes in the presence of acetic 
acid in toluene and using 6-aminohexanoic acid as a catalyst. The produced -COOEt-
chalcones were hydrolyzed with 6 N NaOH in EtOH and subsequently acidified with 6 N HCl 
to afford the (Z)--COOH-chalcones (Scheme 15). They claimed to have the Z-isomer for 
both their -COOEt- and -COOH-chalcones, but it was not mentioned how the 
configuration of the compounds was determined. On the other hand, Batey et al.
53
 determined 
the stereochemistry of their -COOEt-chalcones (Scheme 13) by the chemical shift of the 
vinylic protons, saying that the vinylic protons of the (E)--COOEt-chalcones resonate 
further downfield ( = 8.2-7.8 ppm) compared to the corresponding (Z)-isomers ( = 7.2-6.8 
ppm). Appling this rule on Wang compounds indicates that their assignment of the 
configuration might not be correct, since the shift of the -H for their -COOH-chalcones is 
7.59-7.85 ppm.  
  
Scheme 15: Synthesis of -COOH-chalcones by Wang with assignment of configuration as shown.55 
Based on the 
3
JC-H coupling constants of Cketone-H and Cester-H, the correct stereochemistry of 
-COOEt-chalcones can be determined unambiguously. This method was used by Deng56 
based on Kingsbury article
57
 in assigning the E-configuration for his -COOEt-chalcones 
which have 
3
JC-H of 9.8-9.9 Hz for their Cketone-H and 7.6-7.7 Hz for their Cester-H. Kingsbury 
reported that in the Z-isomer the 
3
JC-H of the Cester-H is larger than that of the Cketone-H, while 
the vice versa is true for the E-isomer as indicated in Figure 20. 
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Figure 20: 
3
JC-H Coupling constants of Cketone-H and Cester-H of (E)--COOEt- and (Z)--COOEt-,-
unsaturated carbonyl compounds found by Kingsbury.
57
 
Lawrence
13
 reported the synthesis of -COOEt and -CN-chalcones by Knoevenagel 
condensation of benzaldehydes with the -ketoesters or -ketonitriles, respectively. Piperidine 
was used as a base and the reactions were conducted in EtOH just in the same way the -F-
chalcones was prepared (Scheme 5). 
-NO2-chalcones 
Concerning the -NO2-chalcones, in 1955 Dornow
58
 prepared -NO2-chalcone 41 (Scheme 
16) by reacting 1.0 eq. of -NO2-acetophenone 39 with equimolar amount of the Schiff base 
40 that was generated from benzaldehyde (16) before. The reaction was done in Et2O in 
presence of 1.1 eq. acetic anhydride (Ac2O). 
  
Scheme 16: Synthesis of -NO2-chalcone 41 by Dornow.
58
  
In 2002 Sagitullina
59
 prepared the same -NO2-chalcone 41 by reacting 1.0 eq. of -NO2-
acetophenone 39 with 1.6 eq. benzaldehyde (16) in presence of 0.084 eq. -alanine and       
2.8 eq. glacial acetic acid (Scheme 17). The reaction was done in benzene that was heated at 
reflux using a Dean Stark apparatus. 
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Scheme 17: Synthesis of -NO2-chalcone 41 by Sagitullina.
59
 
A regio- and stereoselective nitration method of chalcone derivatives was published in 2006 
by Wu et al.
60
 The method is based on using nitric oxide to get (E)--NO2-chalcones 
exclusively in good yields (Scheme 18A).  
  
Scheme 18: A) Synthesis of -NO2-chalcones by Wu, B) Mechanism of nitration of -H-chalcones with NO.
60
  
The authors claimed that first a trace of oxygen oxidizes NO to NO2, and then electrophilic 
addition of NO2 to the -position of the -H-chalcone 42 gives a carbon-centered radical 43. 
Coupling of NO with the -carbon of 43 affords the nitroso compound 44 that upon addition 
of another 2 eq. of NO gives N-nitroso-N-nitrite 45. Rearrangement of 45 furnishes a 
diazonium nitrate 46 which undergoes anti-elimination affording the -NO2-chalcone 47 as 
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an E-isomer which is much more stable than the Z-isomer (Scheme 18B). Only a trace amount 
of O2 is needed at the beginning to form NO2 that initiates the reaction, any further needed 
NO2 is produced from the reaction of NO with the eliminated HNO3. It was found that an 
excess of NO2 leads to many side reactions.
60
 
-CF3-chalcones 
As an -CF3-chalcone, the only reported example which is not substituted on the -position 
was published in 2013 by Cahard
61
 who prepared (E)--CF3-chalcone 50 by Wittig 
olefination of 48 with ylid 49 as shown in Scheme 19.  
 
Scheme 19: Synthesis of (E)--CF3-chalcone 50 by Cahard.
61
 
1.3. Determination of the anti-inflammatory activity 
As a prerequisite for other biological tests, the determination of cell viability or cytotoxicity in 
presence of the tested compounds is normally performed so that the subsequent biological 
tests can be done at a suitable concentration. These assays are also used to study the effect of 
the tested compounds on cell viability or to show direct cytotoxic effects that lead to cell 
death, which is very important in drug development. Hence the MTT cell viability assay was 
performed for most of the synthesized chalcones in this study. Then the influence of these 
chalcones on the production of NO was measured by the Griess assay as an indication for 
their potential anti-inflammatory activity. A description of the theory behind these two 
biological assays is given below.  
1.3.1. Cell viability 
There are a variety of assay methods that can be used to determine the cell viability. These 
assays can be divided into two main categories: assays that measure cell death and assays that 
quantify biochemical processes which are considered as viability markers. Some known 
methods to assess the viability are presented here.
62
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1- Vital dyes: Vital dyes are fluorescent or colored molecules that can be used to discriminate 
between living and dead cells. Some of them work by marking the dead ones and the others 
by marking the living ones. Cytofluorometry (Figure 21) or fluorescence microscopy is then 
used to count the cells. 
  
Figure 21: The principle of cytofluorometry. 
2- Extracellular release of proteins: Measuring the release of intracellular proteins into cell 
culture supernatants is a way to quantify the rupture of the plasma membrane of cells. 
Flourometric or colorimetric measurement of lactate dehydrogenase (LDH) is an example. 
3- Cellular metabolism: Many biomarkers of cells can be used to measure their viability. ATP 
which is essential for cellular life is an example. Quantification of the amount of intracellular 
ATP can be used as an indication of cell viability, since it is produced in living cells. The 
well-known MTT test is another example of this category. It depends on the ability of cellular 
mitochondrial reductases to convert MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide) into a violet-colored compound (Scheme 20) that can be easily 
quantified spectrophotometrically. 
4- Cell attachment: Normally, the viable cells tend to adhere to the culture substrate while the 
injured cells round up and detach with time, which is concurrent with cell death. Hence, the 
degree of the attachment of the cells can be used to reflect their viability. 
MTT assay 
The MTT assay is a sensitive and quantitative colorimetric assay that is used to measure the 
viability of the cells. In this assay, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide) which is dissolved in a physiologically balanced solution is added to 
cells in culture and incubated for a specific time. During the incubation time the viable cells 
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reduce the yellow water-soluble MTT using mitochondrial dehydrogenase enzymes to a 
formazan dye which is a purple and water-insoluble compound (Scheme 20). The formazan is 
solubilized using SDS (sodium dodecyl sulfate), for example, then the intensity of its purple 
color is determined spectrophotometrically. Since only viable cells have active metabolism, 
the amount of formazan produced is directly proportional to the number of viable cells.
63
  
 
Scheme 20: Conversion of the yellow MTT to a violet formazan dye during the MTT assay. 
1.3.2. The anti-inflammatory activity through inhibition of iNOS (NO assay) 
Nitric oxide (NO) is an important physiological messenger and regulator molecule in diverse 
biological systems. It has important roles in neurotransmission in central nervous system and 
in peripheral nerves for example. Additionally, high levels of NO are produced in response to 
inflammation and mediate proinflammatory and destructive effects. NO has many biological 
effects depending on its concentration and place of production. Some of these effects are 
direct which are mediated by NO itself. The other effects are indirect and they are mediated 
by reactive nitrogen species that are produced by the reaction of NO with superoxide anion 
(O2ˉ) or with oxygen (O2) (Figure 22). So the molecular mechanism mediating the biological 
activities of NO can be classified into three groups: 1) NO reacts readily with transition 
metals (e.g. Fe, Cu, Zn) which are present in the catalytic sites of enzymes, and by that 
reaction NO regulates the activity of many enzymes, 2) the NO
+
 which is produced upon 
reaction of NO with O2 is able to induce S-nitrosylation of cysteine residues of proteins and 
thus leads to modification of the activity of those proteins and 3) the peroxynitrite (ONOOˉ) 
that is produced when NO reacts with superoxide anion (O2ˉ) is a nitrating agent and a strong 
oxidizing agent which is able to modify proteins, lipids and nucleic acids. 
64
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Figure 22: Molecular mechanisms that mediate the biological activities of NO.  
NO synthesis is catalyzed by nitric oxide synthase (NOS) enzymes. Three different isoforms 
of these enzymes have been characterized, the neuronal NOS (nNOS), endothelial NOS 
(eNOS) and the inducible NOS (iNOS). The first two are found in resting cells and are 
activated by high intracellular calcium concentration. In contrast, iNOS is not found in resting 
cells and is produced in many inflammatory and tissue cells only as a result of stimulation. In 
humans, iNOS is produced upon inhibition of the NF-B pathway (Figure 4). 
Proinflammatory cytokines such as tumor necrosis factor (TNF) and microbial products such 
as lipopolysaccharide (LPS) are examples of stimulants of iNOS gene expression. High levels 
of NO are produced as a result of inflammatory stimuli and mediate proinflammatory and 
destructive effects.
64
 Therefore, the inhibition of NO production is a way to demonstrate anti-
inflammatory activity and the quantification of the amount of NO produced by the 
proinflammatory protein iNOS is a valuable tool to study the anti-inflammatory activity of 
compounds. 
Generally, NO can be quantified by many methods such as Griess assay, chemiluminescence, 
and electrochemistry. Using chemiluminescence, the detection of NO involves its reaction 
with ozone forming activated NO2 (NO2
*
) that upon relaxation to NO2 emits a photon which 
can be detected by a photomultiplier tube. The analytical signal is proportional to the 
instantaneous concentration of NO, hence the NO is measured in a direct way.
65
 The detection 
of NO electrochemically can be achieved either by reduction of NO to N2O2
2-
 or by its 
oxidation to NO3ˉ. To determine the NO concentration, the current is measured and compared 
to a calibration curve.
65
 The most widely used method to measure NO is the Griess assay due 
to its low cost, simple execution and easy data analysis. In the Griess assay, the NO is 
determined indirectly by measuring the nitrite (NO2ˉ) which is a product of NO’s 
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autooxidation.
65
 This assay depends on a diazotization reaction (Scheme 21) that was 
originally described by Griess. In acidic medium, the NO2ˉ
 
is reacting with sulfanilamide (51) 
to form a diazonium salt 52 that gives a pink azo dye 54 upon reacting with N-1-
naphthylethylenediamine dihydrochloride (53). So, upon treating a sample that contains NO2ˉ 
with the Griess reagent, nitrite is detected and analyzed by formation of a pink color that can 
be monitored spectrophotometrically. The absorbance of the measured sample is then 
compared to the absorbance of similarly treated NO2ˉ
 
standards via a calibration curve. The 
measured NO2ˉ concentration is proportional to the concentration of NO released.
65
  
 
Scheme 21: Chemical reactions involved in the measurement of NO2
ˉ
 using the Griess assay. 
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2. AIM OF THE PRESENT WORK 
This work aims to fine tune the chemical reactivity and biological activity of chalcones. Since 
the electrophilic nature of chalcones is essential for their biological activity which often 
depends on thiol-mediated regulation processes, the first objective of this work is to develop a 
facile screening assay to assess the electrophilicity of chalcones in thia-Michael additions. 
This would be very valuable, since there is no known simple and efficient quantitative method 
to compare the electrophilicity of different chalcones and other ,-unsaturated carbonyl 
compounds. Understanding the Michael acceptor activity of the ,-unsaturated carbonyl 
group would help in the rational design of potential drugs.  
The second and major aim of this work is to prepare a library of -modified chalcones and to 
study the influence of the -substitution of the ,-unsaturated carbonyl system on both the 
chemical reactivity against thiols (thia-Michael addition) and the biological activity 
concerning the inflammation proteins HO-1 and iNOS. 
Finally, to study the effect of a substituent in the -position of the ,-unsaturated carbonyl 
unit of chalcones in presence of a 2’-hydroxy group, the last aim is to synthesize a series of  
-X-2’-hydroxychalcones and compare their biological activity with the -X-2’-OMe 
analogues. 
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3. RESULTS AND DISCUSSION 
The wide range of biological activities of chalcones and the possibility to modulate their 
reactivity make them attractive targets for research. Aiming to fine-tune the reactivity of 
chalcones, three different sets of chalcones were synthesized and their activity as potential 
anti-inflammatory agents was investigated. These are -H-chalcones with different 
substitution patterns, -substituted-tetramethoxychalcones and -substituted-2’-hydroxy-
trimethoxychalcones. The synthetic details are presented first followed by the assessment of 
chemical reactivity of the synthesized chalcones and finally their anti-inflammatory activity is 
discussed. 
3.1. Synthesis of the chalcones 
3.1.1. Synthesis of -H-chalcones 
Four known -H-chalcones 3, 60-62 were synthesized applying the classical Claisen-Schmidt 
condensation of acetophenones 55-58 with benzaldehydes 59, 29 and 16 using Ba(OH)2 
. 
8 
H2O as a base and MeOH as a solvent (Scheme 22).
66
  
 
Scheme 22: Synthesis of -H-chalcones. 
All of the synthesized -H-chalcones adopt the E-configuration. This is proven by the JH-H 
coupling in their 
1
H NMR spectra
*
 which is in the range reported for the E-chalcones (15-16 
Hz).
12
 The X-ray structures of 2’,3,4,4’-tetramethoxychalcone (-H-TMC, 60)67 and its       
2’-hydroxy analogue (-H-HC, 61) (Figure 23) showed clearly the E-configuration and the   
                                                 
*
 The two doublets can also appear as a pseudo singlet (higher order signal). 
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s-cis conformation of these two chalcones. Remarkably, the 2’-OH in chalcone 61 leads to a 
smaller dihedral angle between the two aromatic rings (11.38°) compared to that of chalcone 
60 (26.88°), which implies more conjugation in the system in the case of 61. This effect of the 
OH at the 2’-position can be rationalized by its intramolecular H-bonding with the carbonyl 
functionality forming a 6-membered ring. 
 
Figure 23: X-Ray structure of 2’-hydroxy-3,4,4’-trimethoxychalcone (-H-HC, 61). 
3.1.2. Synthesis of -X-2’,3,4,4’-tertramethoxychalcones (-X-TMCs) 
To fine-tune the reactivity of chalcones, the natural-product-like 2’,3,4,4’-tetramethoxy-
chalcone (-H-TMC, 60) was chosen as a scaffold to introduce X-substituents in its              
-position. In order to get a potentially broad range of activity, X-substituents with diverse 
electronic properties were chosen. So, thirteen -X-derivatives of 60 were prepared, some 
with electron-withdrawing X-groups like CN, NO2, CF3 and halogens which are supposed to 
enhance the Michael acceptor activity and some others with electron-donating X-substituents 
such as Me and Ph which are expected to lead to less electrophilicity compared to the parent 
chalcone 60. 
In order to introduce the -X-substituent, two synthetic strategies were followed. The first 
one was to introduce X to acetophenone 56 to get -X-acetophenones 63-67, then Claisen-
Schmidt condensation with aldehyde 29 was performed (route 1, Scheme 23). Chalcones -F-
TMC (68), -CN-TMC (69), -Me-TMC (70), -NO2-TMC (71) and -COOEt-TMC (72) 
were prepared from their corresponding acetophenones 63-67 following this route. The 
second approach which was applied to get -Br-TMC (73), -Cl-TMC (74) and -I-TMC 
(75) was to introduce X directly in -H-TMC (60) (route 2, Scheme 23). The -CF3-TMC 
(77) and the -aryl-TMCs (78-80) were prepared from -Br-TMC (73). While -COOH-
TMC (76) was prepared from the ester derivative 72. Synthetic and structural details are given 
below. 
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Scheme 23: The general routes to get the -X-TMCs. 
Synthesis of -F/CN/Me/NO2/COOEt-TMCs (68-72) 
Chalcones 68-72 were prepared according to route 1 (Scheme 23), so their precursors          
i.e. -X-acetophenones (X = F, CN, Me, NO2, COOEt) were prepared beforehand. The 
synthesis of these acetophenones is discussed below followed by the synthesis of the targeted 
chalcones. 
Synthesis of-X-acetophenones (X = F (63), CN (64), Me (65), NO2 (66), COOEt (67)): 
The -F-acetophenone 63 was prepared in a yield of 63 % by nucleophilic substitution 
reaction from the corresponding -Br-acetophenone 81 using KF and 18-crown-6 ether in dry 
MeCN (Scheme 24).
13
 KF has to be died very well before the reaction, and the crown ether 
should be water-free. The crown ether enhances the reaction by complexation with K
+
 that 
leads to activation of the Fˉ. To insure momobromination, the -Br-acetophenone 81 was 
prepared utilizing a high dilution method which was established in our group by Paul 
Baumeister.
68
 Thus, the bromination of acetophenone 56 which was dissolved in 
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EtOAc/CHCl3 (1:1) solvent mixture in a concentration of 4.8 mM was accomplished by 
portion-wise addition of 2.2 eq. of CuBr2. The reaction mixture was heated at reflux for 7 h, 
increasing the reaction time led to dibromination. 
  
Scheme 24: Synthesis of -F-acetophenone 63. 
To get the -CN-acetophenone 64 (Scheme 25), -Br-acetophenone 81 was stirred in brine 
affording the 90% of -Cl-acetophenone 8269 which was transformed into the -CN analogue 
64 using KCN in EtOH/H2O (1:1) in a 68% yield.
70
 In order to get a higher yield of 64, this 
two-step procedure was preferred over the direct conversion of the Br-acetophenone 81 into 
the CN derivative 64. 
  
Scheme 25: Synthesis of -CN-acetophenone 64. 
Methylation of the commercially available 1-(2,4-dihydroxyphenyl)propan-1-one (83) using 
CH3I and K2CO3 in acetone afforded the -Me-acetophenone 65 with a yield of 55% (Scheme 
26).
71
 
  
Scheme 26: Synthesis of -Me-acetophenone 65. 
RESULTS AND DISCUSSION 
35 
In order to get -NO2-acetophenone 66, my Bachelor student Franziska Naporra
72
 tried to 
apply Ballini’s one-pot solventless reaction73 shown in Scheme 27. This includes a nitroaldol 
reaction of CH3NO2 and benzaldehyde 84 on activated alumina for 2 h at 0 °C followed by 20 
h at rt, then in situ addition (0 °C) of wet-alumina supported CrO3 and standing for additional 
20 h at rt before the extraction of the product using Et2O. Firstly she did the reaction using 
Al2O3-90 active but could not observe any conversion. Upon using Al2O3-super 1, she did not 
get the desired product but 47 % of compound 85 that could be formed by elimination of H2O 
from the formed nitroalcohol. Her attempts to oxidize 85 to get the targeted acetophenone 66 
using t-BuOOH and BuLi
74
 were not successful, which can be attributed to the presence of the 
electron-donating OMe group in the ortho and para positions. 
 
Scheme 27: Attempts to prepare -NO2-acetophenone 66 according to Ballini.
73
 
Another two-step procedure was followed then in order to prepare the -NO2-acetophenone 
66 (Scheme 28A).
75
 The first step was the synthesis of nitroalcohol 86 by a Henry reaction of 
aldehyde 84 with CH3NO2 using NaOAc as illustrated in Scheme 28B. Attempts to purify the 
nitroalcohol 85 failed which might be rationalized by its instability. Therefore the produced 
nitroalcohol 86 was subsequently used without further purification in the next step which is 
oxidation with pyridinium chloroformate (PCC) to give the targeted acetophenone 66 in a 
55% yield over the two steps.  
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Scheme 28: A) Synthesis of -NO2-acetophenone 66, B) Mechanism of Henry reaction between benzaldehyde 
84 and CH3NO2. 
As in the case of -F- 63 and -CN-acetophenones 64, the initial precursor for the 1,3-
dicarbonyl compound, -COOEt-acetophenone 67 was acetophenone 56. Acetophenone 67 
was obtained with a 84% yield by condensation of diethylcarbonate with acetophenone 56 in 
presence of NaH as shown in Scheme 29.
76
 
  
Scheme 29: Synthesis of -COOEt-acetophenone 67. 
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Synthesis of -F/CN/Me/NO2/COOEt-TMCs (68-72):
The synthetic conditions for the titled chalcones, which were synthesized from their 
corresponding acetophenones, are summarized in Table 1 (with the -H-TMC (60)) and the 
details are given afterwards.  
Table 1: Reaction conditions for the synthesis of -X-TMCs 60, 68-72 by route 1 in Scheme 23. 
 
 
X 
Reagents,    
Solvent 
Temp. 
Reaction 
Time 
Yield 
(%) 
Product,  
(configuration) 
H Ba(OH)2 
.
 8 H2O, 
MeOH 
60 °C 24 h 74 -H-TMC (60), (E) 
F Ba(OH)2 
.
 8 H2O, 
MeOH 
60 °C 24 h 39 -F-TMC (68),           
(Z/E 92:8) 
CN piperidine, EtOH rt 24 h 73 -CN-TMC (69), (E) 
Me Ba(OH)2 
.
 8 H2O, 
MeOH 
reflux 5 d 41 -Me-TMC (70), (E) 
NO2 -alanine/AcOH, 
benzene 
reflux 24 h 84 -NO2-TMC (71), (E) 
COOEt piperidine/AcOH, 
benzene, 4 Å MS 
reflux 2 d 71 -COOEt-TMC (72), 
(E) 
To get the -F-TMC (68), the plan was to use the Claisen-Schmidt condensation of -F-
acetophenone 63 with benzaldehyde 29 in presence of a base. Many bases have been screened 
by my Bachelor student Frauke Antoni (Table 2).
77
 Firstly piperidine
13
 was tried, but no 
reaction was observed even at 50 °C. LDA gave also no reaction, while the use of NaH 
resulted in a low yield. KOH and Ba(OH)2 
. 
8 H2O were the best, therefore -F-TMC (68) was 
prepared under the same conditions used to synthesize the -H-chalcones (Scheme 22) to give 
a 39% yield as a mixture of Z/E isomers (92:8). 
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Table 2: Methods tried to synthesize -F-TMC (68).* 
 
 
Entry Reaction conditions Results/Yield of 68
§
 
1 piperidine, EtOH, 50 °C, 3 d No conversion 
2 LDA, THF, rt to 50 °C, 40 h No conversion 
3 NaH, THF, rt, 18 h 25%  
4 KOH, EtOH/H2O, 50 °C, 3 d 53%
 
5 Ba(OH)2 
.
 8 H2O, MeOH, 50 °C, 24 h 62%
 
* Test reactions were performed by the Bachelor student Frauke Antoni.
77
 The reactions were 
stopped when the starting material was gone as indicated on TLC, or when no more conversion was 
observed. 
§ 
calculated using 
1
H NMR. 
 
It was possible to get crystals suitable for X-ray analysis upon recrystallization of α-F-TMC 
(68) from EtOAc/petroleum ether using the solvent diffusion method. The X-ray structure 
(Figure 24) proved its Z-configuration and s-trans conformation with 54.33° between the two 
aromatic rings.  
 
Figure 24: X-Ray structure of -F-TMC (68).  
The -CN-TMC (69) was prepared from -CN-acetophenone 64 and benzaldehyde 29 in 
presence of piperidine
13
 as a base (Table 1). Recrystallization of the product from a mixture of 
EtOAc/petroleum ether afforded yellow crystals of the pure E-isomer of -CN-TMC (69) 
with a yield of 58%. The X-ray structure is depicted in Figure 25 showing E-configuration 
and the s-cis conformation of 69. A prior structural assignment of an -CN chalcone as         
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s-trans conformer based on NOE experiments was published by Lawrence.
13
 But here using 
the X-ray analysis, the s-cis conformation of an -CN-chalcone was proven for the first time 
with a dihedral angle of 73.81° between the two aromatic rings. This angle is considerably 
larger than the published value of 26.88° for the s-cis conformer of -H-TMC (60).67 The     
s-cis conformation of -CN-TMC (69) could be rationalized by the relative slim CN 
substituent compared to the halogens (Cl, Br and I, shown later in Figure 27) or a methyl 
group. 
 
Figure 25: X-Ray structure of -CN-TMC (69). 
Like -F-TMC (68), -Me-TMC (70) was also prepared from its corresponding acetophenone 
65 and benzaldehyde 29 using Ba(OH)2 
.
 8 H2O in MeOH but at reflux. The reaction gave 
41% of the pure targeted chalcone 70. the E-Configuration was assigned to -Me-TMC (70) 
based on the chemical shift of the -H in the 1H NMR spectrum compared with similar 
chalcones prepared by Ducki.
78
 Ducki’s -Me-chalcones have a chemical shift in the range of 
7.08-7.11 ppm for their -H and were reported to adopt the E-configuration and s-trans 
conformation based on an X-ray structure
12
of one of them. Since the shift of the -Hof        
-Me-TMC (70) is 7.11 ppm, then it was assumed to have the same configuration as that for 
Ducki’s -Me-chalcones. 
To prepare the -NO2-chalcone 71, the nitration method (Scheme 18) of the -H-TMC (60) 
using nitric oxide
60
 was tried at first but unfortunately no conversion was observed at all. So 
the other option was to prepare the -NO2-acetophenone 66 then to react it with benzaldehyde 
29. This reaction was performed in presence of piperidine/AcOH in benzene
59
 at reflux to 
afford 84% of the pure E-isomer of -NO2-TMC (71, Figure 26A). The stereochemistry of   
-NO2-TMC (71) was assigned as the E-isomer based on literature.
79
 Kinugasa et al. assigned 
the E-configuration for the -NO2-chalcone they prepared according to Dornow’s method 
(Scheme 16) based on IR and UV spectra. They claimed that the synthesis of the -NO2-
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chalcone is similar to the Knoevenagel condensation of benzaldehyde (16) with primary 
nitroalkanes which is known to give trans--nitrostyrenes preferentially (Figure 26B).79  
 
Figure 26: A) (E)--NO2-TMC (71), B) trans--Nitrostyrenes formed by Knoevenagel condensation of 
benzaldehyde (16) with primary nitroalkanes.
79
 
The -COOEt-TMC (72) was obtained with a 71% yield by Knoevenagel condensation of   
-COOEt-acetophenone 67 with benzaldehyde 29 in presence of piperidine/AcOH in benzene 
that was heated at reflux over molecular sieves (4 Å).
53
 The stereochemistry of chalcone72 
was assigned as the E-isomer based on the 
3
JC-H coupling constants of Cketone-H and Cester-H
56
 
as indicated in the introduction (Figure 20).
Synthesis of -COOH-TMC (76) 
By saponification of -COOEt-TMC (72) with aqueous NaOH at ambient temperature the 
acid derivative 76 was obtained in a 75% yield (Scheme 30).
55
 The same double bond 
configuration (E) as for the ester 72 was assumed. It was tried to measure the 
3
JC-H coupling 
constants of Cketone-H and Cacid-H but the peaks of the NMR spectrum were not narrow 
enough to permit this measurement. 
  
Scheme 30: Synthesis of -COOH-TMC (76). 
RESULTS AND DISCUSSION 
41 
Synthesis of -Br/Cl/I-TMCs (73-75) 
To synthesize the -halogenated chalcones (73-75), it is not possible to follow route 2 
(Scheme 23) that was used to prepare the -F-TMC (68). This is because Cl, Br and I 
substituents are considered as good to very good leaving groups. Hence, 73-75 were prepared 
following route 2 (Scheme 23) from the -H-TMC (60). At the beginning it was tried to 
brominate the -position using the classical bromination method, i.e. Br2/base, but 
unfortunately this led to bromination on the aromatic rings in addition to the -position. This 
could be rationalized by the highly electron-rich aromatic rings bearing the OMe substituents. 
On the other hand, bromination with Et4NBr in presence of DMP (19, Scheme 8)
49
 gave the 
desired product 73 in a good yield. This method gave a mixture of Z and E isomers (as 
reported in literature)
49
 in about 89% yield, but by recrystallization it was possible to get 58% 
of the pure Z-isomer of compound-Br-TMC (73) (Table 3).  
Table 3: Reaction conditions for the synthesis of -X-TMCs 73-75. 
 
X Reagents Time 
Yield (%) 
before 
rec.
a 
Yield (%) 
after rec. 
Product, 
(configuration       
after rec.) 
Br
49
 DMP (1.2 eq.), 
Et4NBr (1.2 eq.) 
24 h 89 58 -Br-TMC (73),           
(Z) 
Cl 
DMP (2.0 eq.), 
Et4NCl (2.0 eq.) 
5 d 29 20 -Cl-TMC (74),           
(Z) 
I DMP (2.0 eq.), 
Et4NI (2.0 eq.) 
5 d nd 29 -I-TMC (75),           
(Z/E 93:7) 
a 
rec: recrystallization 
 
To chlorinate -H-TMC (60) affording the -Cl analogue 74, SO2Cl2 was first tried according 
to Edwards.
43
 The LC-MS analysis of the crude reaction mixture after work-up showed the 
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presence of the desired product, but the reaction gave a multi-component mixture which made 
it difficult to get the desired product in a pure form. The idea was then to apply the known 
procedure used to prepare -Br TMC (73)49 to synthesize the -Cl and -I compounds 74 and 
75 respectively (Table 3) from their corresponding Et4NX salts. This method gave the desired 
products (74 and 75) although not with high yields. 
Recrystallization of chalcones 73 and 74 from EtOAc/petroleum ether gave crystals that were 
analyzed by X-ray. Solvent-diffusion method was used to get chalcone 75 crystallized. The   
X-ray structures of chalcones 73-75 (Figure 27) show that they adopt the Z-configuration and 
the s-trans conformation. The structural influence of the X group can be found in the dihedral 
angles between the two aromatic rings of these chalcones. Since the Cl and Br atoms are 
bigger than the F atom, the dihedral angles between A-ring and B-ring in the case of -Cl-
TMC (74) and -Br-TMC (73) were bigger than that of -F-TMC (68) (54.33°, Figure 24). 
The bulky I-substituent forces the carbonyl functionality and the A-ring more out of the plane 
leading to a significantly greater dihedral angle of 78.63° for -I-TMC (75). 

 
Figure 27: X-Ray structures of -Br/Cl/I-TMCs (73-75). The given angles are the dihedral angles between the 
two aromatic rings. 
Synthesis of-CF3-TMC (77) 
At the time the synthesis of -CF3-TMC (77) was performed there was no published 
procedure for a similar chalcone. The first idea to prepare it was by following route 2 
(Scheme 23), which implies the synthesis of -CF3-acetophenone 91 then its condensation 
with benzaldehyde 29. To prepare acetophenone 91, the method of trifluoromethylation of 
enolates (Scheme 31)
80
 was tried. Firstly acetophenone 56 was allowed to with KH to form 
potassium enolate 87 and then boronic compound 88 was added to act as a Lewis acid that 
makes a complex 89 with the enolate and thus increasing its nucleophilicity. Finally the 
commercially available CF3
+
 source 90 was added to react with the boron complex 89 giving 
-Br-TMC (73)                                 -Cl-TMC (74)                                -I-TMC (75)  
       61.37°                                                61.26°                                               78.63° 
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the acetophenone 91. Unfortunately no considerable conversion was observed for this reaction 
sequence. 
  
Scheme 31: The reaction sequence tried to synthesize-CF3-acetophenone 91 by trifluoromethylation of the 
enolate
80
 form of 56. 
On the other hand, the three-step literature procedure shown in Scheme 32 which was applied 
to synthesize -CF3-acetophenone 91 gave the desired acetophenone in a good yield (43%). 
Benzaldehyde 84 was initially converted to hydrazone 92 in a quantitative yield,
81
 then 
hydrazone 92 was treated with trifluoroacetic anhydride ((CF3O)2O) to give compound 93. 
The last step was the hydrolysis of 93 to the -CF3-acetophenone 91 under acidic conditions 
but at rt. No mechanism was given in the reference for the second step.
82
  
  
Scheme 32: Synthesis of -CF3-acetophenone 91 through the hydrazone 92.
81-82
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Having -CF3-acetophenone 91 in hand, it was tried to perform its condensation with 
benzaldehyde 29 using Ba(OH)2 
.
 8 H2O as base. The GC-MS measurement showed that the 
benzaldehyde 29 was not consumed while the CF3-acetophenone 91 was converted to a 
compound with a mass of 180 ([M+H]
+
) which cannot be identified. In addition, condensation 
using piperidine/AcOH in benzene at reflux gave only traces of the desired -CF3-chalcone 
(77) that was detectable by only LC-MS analysis. After these unsuccessful trials to get the -
CF3-chalcone (77) following route 2 (Scheme 23), it was thought that route 1 may help to get 
the desired product.  
By searching for a method to trifluoromethylate the -position of an ,-unsaturated system, 
it was found that this was achieved in steroidal molecules utilizing methyl 
fluorosulfonyldifluoroacetate (MFSDA) in presence of CuI and starting with -Br steroidal 
compound as shown in Scheme 33A.
83
 The proposed mechanism of this trifluoromethylation 
(Scheme 33B) starts with the formation of Cu-carboxylate with elimination of MeI. The 
carboxylate salt readily decarboxylates and loses SO2 affording difluorocarbene (:CF3) and Fˉ 
which are in equilibrium with CF3ˉ. The equilibrium is readily shifted to the right in presence 
of CuI to form the nucleophilic species [CuCF3Iˉ] that reacts with the -Br-steroidal alkenyl 
compound (RBr) affording the - CF3 analouge.
83
 
 
Scheme 33: A) Synthesis of -CF3-steroids done by Chen, B) The proposed mechanism for triflouromethylation 
of -Br-steroidal compounds.83 
Applying this trifluoromethylation method on -Br-TMC (73) gave -CF3-TCM (77) in a 
62% yield (Scheme 34).  
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Scheme 34: Synthesis of -CF3-TMC (77). 
The stereochemistry of chalcone 77 was assigned as the E-isomer based on its 
19
F NMR shift 
(-62.1 ppm) according to Robins who reported that the 
19
F NMR shift
*
 of (E)--CF3-,-
unsaturated compounds (Figure 28) is -65 ± 2 ppm and that of their Z-analogues is -58 ± 2 
ppm.
84
 In consistent with this fact is the 
19
F NMR shift reported for the (E)--CF3 chalcone 
prepared by Cahard (Scheme 19) which is -63.1 ppm.
61
 
 
Figure 28: The -CF3 compounds prepared by Robinson with their configuration and 
19
F NMR shifts.
84
 
Synthesis of-aryl-TMCs 78-80 
Starting with -Br-TMC (73), it was possible to prepare -aryl-TMCs 78-80 by Suzuki 
coupling reaction with corresponding boronic acids (Scheme 35).
48
 Three different aryl 
groups were chosen: Ph, the electron-withdrawing p-NO2-C6H4 and the electron-donating     
p-OMe-C6H4 group. 
                                                 
*
 Some literature references reverse the sign convention (i.e. negative shifts are reported as positive). Reporting 
that 
19
F NMR chemical shifts are upfield from CCl3F (the reference) indicates that the values are negative.  
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Scheme 35: Synthesis of -aryl-TMCs 78-80.  
The E-pure isomers were separated using preparative TLC plates, but it was found that these 
compounds have a high tendency to isomerize upon handling and analysis in solution to E/Z 
mixtures. The configuration of the double bond was assigned based on literature data
48
 to be 
the same as for the starting chalcone 73, i.e. the B-ring and the X group are on the same side 
of the double bond in both cases. 
3.1.3.Synthesis of-X-2’-hydroxy-3,4,4’-trimethoxychalcones (-X-HCs) 
Due to the enhancement of electrophilicity that can be gained by the presence of an OH group 
at the 2’-position of chalcones, the aim here is to study the effect of -substitution in presence 
of a 2’-OH group. Therefore, a series of --X-2’-hydroxychalcones (-X-HCs, X= H (61), F 
(94), CN (95), Me (96), Br (97), Cl (98), CF3 (99), p-NO2-C6H4 (100)) was prepared. Two 
different strategies were followed to get the -X-HCs. The first one is by using the isopropyl 
group to protect the 2’-OH in the acetophenones that were used to prepare the 2’-isopropoxy-
-X-chalcones. After that the deprotection of the OH group afforded the targeted -X-HCs. 
The second route is the deprotection of the 2’-OH of the TMCs selectively. Here are the 
details. 
Synthesis of -F/CN-HCs (94 and 95) 
In order to prepare -F-HC (94) and -CN-HC (95), the corresponding 2’-protected 
acetophenones (F 102 and CN 103) were first synthesized from the Br-acetophenone 101. 
These acetophenones were prepared applying the same methods used to synthesize the 2,4-
dimethoxy analogues (63 and 64) as depicted in Scheme 36 below. 
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Scheme 36: Synthesis of -F- and -CN-acetophenones 102 and 103 respectively. 
Subsequently, the Claisen-Schmidt condensation was carried out with benzaldehyde 29 
affording the 2’-protected chalcones (-X-pHC, X = F (104) and CN (105)) (Scheme 37). 
Again, Ba(OH)2 
.
 8 H2O was used as a base when X = F and piperidine was used in the case 
of X = CN to give 70% of -F-pHC (104) and 75% of -CN-pHC (105). The deprotection of 
the OH functionality using the standard aromatic isopropyl ether-deprotection reagent BCl3 in 
CH2Cl2 afforded -F-HC (94) in a 95% yield and -CN-HC (95) in almost a quantitative 
yield. 
  
Scheme 37: Synthesis of -F- and -CN-HCs (94 and 95 respectively). 
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Figure 29 shows the X-ray structure of -F-pHC (104) with a dihedral angle of 64.46° 
between the two aromatic rings. This angle is larger than that of the F-TMC analogue 68 
(54.33°) which indicates the steric effect of the isopropoxy group in deviating the two 
aromatic rings more from planarity, hence leading to less conjugation within the  system.  
 
Figure 29: X-Ray structure of α-F-pHC (104). 
Synthesis of -Me-HC (96) 
The synthesis of -Me derivative 96 was accomplished by Claisen-Schmidt condensation of 
its corresponding acetophenone 106 with benzaldehyde 29, no protection was needed here for 
the 2’-OH group. Selective methylation of the p-OH of the commercially available 2,4-
dihydroxyacetophenone 83 was firstly performed to get -Me acetophenone 106 in a 
quantitative yield.
71
 After that, acetophenone 106 was allowed to react with benzaldehyde 29 
in presence of piperidine/AcOH in benzene at reflux
53
 furnishing -Me-HC (96) (Scheme 38). 
  
Scheme 38: Synthesis of -Me-HC (96). 
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The X-ray structure of chalcone 96 is given in Figure 30. As expected, chalcone 15 adopt the 
E-configuration and the s-trans conformation. The dihedral angle between the two aromatic 
rings is 63.61°. What is noteworthy is the 6-membered ring formed upon H-bonding between 
the 2’-OH and the carbonyl group.  
 
Figure 30: X-Ray structure of α-Me-HC (96). 
Synthesis of -Br/Cl/CF3/p-NO2-C6H4-HCs (97-100) 
The synthesis of the titled -X-HCs was accomplished via the selective deprotection of the 
oxygen at the 2’-position of their -X-TMCs analogues (Scheme 39). This strategy is based 
on the fact that the 2’-hydroxy methyl ether is more labile to the BCl3 than the other methyl 
ethers which are normally stable in presence of BCl3. This was found by Veronika Forster 
while she was trying to deprotect another substituted methoxy-isopropoxychalcone in our 
group.
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 Appling this method on -X-TMCs (X = Br (73), Cl (74), CF3 (77), p-NO2-C6H4 
(78)) afforded the corresponding -X-HCs (X= Br (97), Cl (98), CF3 (99), p-NO2-C6H4 (100) 
respectively). It was assumed that the -X-HCs have the same configuration as their TMCs 
precursors. 
 
Scheme 39: Synthesis of -X-HCs from their corresponding -X-TMCs. 
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3.2. Assessment of the Michael acceptor activity of chalcones by a kinetic thiol assay 
Chalcones are ,-unsaturated carbonyl compounds which are considered to be good Michael 
acceptors. This means that their biological activity is based on their ability to react with 
cysteine residues of the signal-transducing proteins beside their antioxidant properties.
2
 
Therefore, assessment of their reactivity in thia-Michael addition reactions (Scheme 40) will 
be very helpful in predicting and understanding their biological activity. A facile 
spectrophotometric screening assay to determine the second-order rate constants (k2) of 
chalcones in thia-Michael additions was developed by Nafisah Al-Rifai and Sabine 
Amslinger. This was desirable since there is no reported easy and efficient quantitative 
method to assess the electrophilicity of different chalcones and other ,-unsaturated 
carbonyl compounds.  
 
Scheme 41: Thia-Michael addition to chalcones. 
3.2.1. Development of the kinetic thiol assay 
The developed assay is based on the use of 96-well microtiter plate which allows for a quick 
and easy handling together with small amounts of material needed to determine the k2 values. 
Since it is expected to have great differences in the reactivity of the tested chalcones, the 
developed kinetic assay should be able to measure a wide range of reaction rates. In order to 
develop such an assay, many parameters have to be optimized, such as the solvent system, the 
pH and the mixing procedure. Screening of solvents (Table 4) showed that some are not good 
for the solubility and/or for the stability of the tested chalcones and some are volatile so they 
evaporate during the measurement time. MeCN for example was used by Dinkova-Kostova 
and Talalay in a 1:1 mixture with 100 mM TRIS-HCl buffer of pH 7.4 (TRIS = 
tris(hydroxymethyl)aminomethane) to determine the reactivity of several ,-unsaturated 
compounds with thiols.
24
 But when it was tried here, the tested chalcones did not show 
stability in such a solvent, in addition to its great volatility that makes it inappropriate for 
long-time measurements. To solve the evaporation problem it was thought that a high boiling 
solvent is required. DMSO was the first option since it was used by Mayr
26
 in his kinetic 
assay to determine the reactivity of some enones towards sulfur ylids and by Appendino
23
 in 
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his NMR experiments of Michael acceptors with thiols. However, when it was tried, the 
reaction of the tested chalcones with thiols was very slow under these conditions. Other high 
boiling solvents like diglyme and triglyme were also inappropriate due to their reaction with 
the plastic of the microplate at high solvent content. The best choice was ethylene glycol 
which has a high boiling point and where all of the tested compounds have good solubility 
and stability.  
Another way to reduce the evaporation, which is problematic especially for long time 
measurements, is to cover the 96-well plates with an optical clear PCR foil. The screened 
solvents were used in combination with 100 mM TRIS-HCl buffer
24
 of a physiological to 
slightly basic pH. Different pH’s were tried (7.4, 7.6, 7.8, 8.0) and it was found that 
increasing the pH leads to higher reaction rate, but 7.4 (physiological conditions) was 
suitable. 
Consequently, a solvent system composed of 100 mM TRIS-HCl, pH 7.4, 2 mM EDTA 
buffer/ethylene glycol in a ratio of 20:80 was the best for the assay. EDTA (ethylenediamine-
tetraacetic acid) was used in order to complex with heavy metals that may be present in the 
solvent and lead to thiol oxidation.
86
 
 Table 4: Solvents screened for the kinetic thiol assay. 
Solvent 
Boiling 
point (°C) 
Observations 
EtOH  78 Evaporation ↑, solubility ↓ 
MeOH  65 Stability (chalcone) ↓, evaporation ↑, solubility ↓ 
MeCN  82 Stability (chalcone) ↓, evaporation ↑, solubility ↓ 
DMSO 189 Very slow reaction with thiol 
Diglyme 162 Microplate was damaged at high solvent content 
Triglyme 216 Microplate was damaged at high solvent content 
NMP 203 Microplate was damaged at high solvent content 
Ethylene glycol 197 Stability (chalcone) ↑, evaporation↓, solubility ↑ 
       
 Screened ratios: buffer/organic solvent from 95:5 to 5:95 with 5% steps. 
Initially, many thiols (Figure 31) were screened in different buffer and solvent mixtures 
including cysteamine (107), cysteine (108), 1,4-butanedithiol (109), dithiothreitol (DTT, 110), 
2-mercaptoethanol (111) and glutathione (GSH, 112).  
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Figure 31: Thiols screened in the kinetic thiol assay. 
They displayed diverse reactivities upon reaction with the same chalcone. -CN-TMC (69) 
for example showed a fast reaction with cysteamine (107) and a slow one with                       
2-mercaptoethanol (111) and glutathione (112), while the rate of the reaction with 1,4-
Butanedithiol (109) and dithiothreitol (DTT, 110) was intermediate (Figure 32).  
 
Figure 32: UV-Vis spectra of -CN-TMC (69) without and with different thiols (60 fold) in 100 mM TRIS-HCl    
pH 7.4, 2 mM EDTA/ethylene glycol (20:80) at 25 °C (in plastic microtiter plate with a PCR foil). The 
measurement was performed directly after mixing. The measurement was done by Sabine Amslinger. 
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Cysteine (108) was ruled out as a yellow color arose upon its reaction with some of the tested 
chalcones, such as -Br-TMC (73) that gave the Michael adduct without HBr (114) that was 
formed after elimination of HBr from the Michael adduct 113 and a seven-membered 
intramolecular condensation product (115) (Scheme 41) as was proven by LC-MS analysis. 
This color made it difficult to find the appropriate wavelength for the kinetic measurement for 
the chalcones which are also yellow. The high reactivity of cysteamine (107) makes it an ideal 
model thiol for reactivity screening specially that its reactivity is in the same range of many 
surface thiols of proteins as indicated by its pKa value (8.3). Cysteamine (107) has also proven 
to be a good nucleophile in thia-Michael additions,
23
 while the less reactivity of the other 
thiols (109-112) indicates that they have lower nucleophilicity which might partially
87
 refer to 
their high pKa values (1,4-butanedithiol: 10.0; DTT: 9.2; 2-mercaptoethanol: 9.6; glutathione 
9.3) and thus lower thiolate concentrations. For all of these reasons, cysteamine (107) was 
picked to assess the Michael acceptor activity of the tested chalcones as will be shown later. 
 
Scheme 42: Reaction of -Br-TMC (73) with cysteine (108) (12 fold) in 100 mM TRIS-HCl pH 7.4, 2 mM 
EDTA/ethylene glycol (20:80) at 25 °C, products were proven by LC-MS measurements. 
To test a certain chalcone by the developed kinetic assay, firstly UV-Vis scans with 60 fold of 
cysteamine (107) were performed (Figure 33 as an example) in order to estimate the reactivity 
range of this chalcone. These scans were used to pick the suitable wavelengths and the 
appropriate thiol concentrations for the subsequent kinetic measurements. Depending on the 
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reactivity and the structure of the tested chalcone five thiol concentrations ranging from 12 to 
500 fold of the chalcone concentration were chosen for each chalcone/thiol pair. Here are 
some examples: -CN-TMC (69) was very reactive so the chosen thiol concentrations were 
12, 24, 36, 48, 60 fold, -I-TMC (75) showed less reactivity with cysteamine so 60, 72, 84, 
96,108 fold thiol were chosen. It was found that when free phenolic hydroxyl groups were 
present in the tested chalcone, the picked thiol concentrations should be high enough to avoid 
the interference of the deprotonation of these groups. Calythropsin 116 for example is a 
reactive chalcone, but 100-300 fold cysteamine concentrations were used to perform the 
kinetic measurements in order to gain a first-order exponential decay. The use of lower thiol 
amounts resulted in a second-order exponential decay which can be rationalized by the 
deprotonation of the hydroxyl groups of 116 interfering with its reaction with thiol 107. 
 
Figure 33: UV-Vis spectra of -H-TMC (60) without and with 60 fold cysteamine (107) in 100 mM TRIS-HCl       
pH 7.4, 2 mM EDTA/ethylene glycol (20:80) at 25 °C (in plastic microtiter plate with a PCR foil).  
To be sure that the picked wavelength for each compound was the best, LC-MS 
measurements of the reaction mixtures were performed. At the appropriate wavelength of 
each compound, only the decay of the UV-band of the tested compound should occur without 
an interference with product formation. LC-MS studies were also used to prove the Michael 
adduct formation, since the isolation of the products was not easy, which could be due to a 
possible reversibility of the reaction during work-up and purification. Figure 34 shows the 
LC-MS study for the reaction of -H-TMC (60) with cysteamine (107). The LC-MS here 
proved the existence of chalcone 60 with the Michael adduct 117 that has a mass of 405.1610. 
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The UV scans of chalcone 60 showed that  nm is a good wavelength for the kinetic 
measurement and UV spectra obtained from the LC-MS measurement (Figure 34-right side) 
showed that the product 117 is not absorbing at all at this wavelength which implies that this 
wavelength is a proper wavelength for the kinetic assay.  
 
Figure 34: LC-MS analysis of the reaction of -H-TMC (60) with thiol 107 (60 fold) in 100 mM TRIS-HCl 
buffer pH 7.4, 2 mM EDTA/ethylene glycol (20:80). The top graph shows the HPLC chromatogram with DAD 
detection (relative quantification). For particular retention times (peaks) the UV scans are displayed with arrows 
at 360 nm (right side) and the ESI (+ mode) MS spectrum (left side). 
Some NMR experiments were also performed to prove the Michael adduct formation 
independently. 
1
H NMR was measured for a solution of -H-TMC (60) in DMSO-d6 without 
and with 12 fold of cysteamine (107) (Figure 35). The H and H in the 
1
H NMR spectrum of 
60 without cysteamine (107) (Figure 35A) are located in the region of aromatic hydrogens 
and show an AB coupling which is typical for the enone hydrogens of the chalcones. In 
presence of thiol 107, the AB coupling disappeared and another two new peaks appeared in 
the aliphatic region (Figure 35B) which means that the addition of cysteamine 107 to the 
enone system occurred and gave the Michael adduct 117. 
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Figure 35: 
1
H NMR spectra of -H-TMC (60) in DMSO-d6. A) without thiol, B) with 12 fold cysteamine (107) 
after 5 min.  
The results of the aforementioned experiments that were done by Nafisah Al-Rifai and Sabine 
Amslinger to optimize the conditions of a kinetic thiol assay and to prove the thiol adduct 
formation are summarized in Figure 36. 
 
Figure 36: The results of the optimization of the kinetic thiol assay. 
3.2.2. The protocol of the developed kinetic thiol assay 
Since the kinetic assay was developed, the electrophilicity of chalcones were assessed upon 
their reaction with thiol 107. The protocol of this assay starts with the preparation of the 
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chalcone solution (80 or 160 ) and the suitable thiol dilutions in the buffer/ethylene glycol 
(20:80). Then they are pipetted in the 96-well microplate in pre-measurement wells: one row 
for the chalcone solution and another one for the thiol dilutions. Afterwards, the plate is 
incubated for 10 min at 25 °C inside the spectrophotometer. Using a multichannel 
micropipette, equivalent volumes of chalcone solutions and thiol solutions are combined and 
mixed thoroughly in a deep-well microplate covered with a foil. This way of mixing was 
chosen since the shaking inside the spectrophotometer was not efficient. After mixing, the 
reaction mixture is pipetted in the measuring 96-well plate which is then covered with a PCR 
foil. Lastly the measurement is started to get the decay of absorbance of the chalcone versus 
time. Measurements are done in duplicates and for each compound 3-7 independent 
experiments are performed.  
For very fast reactions stopped-flow technique (Figure 37) was conducted since this technique 
is based on a rapid mixing of the two-reactant solutions. The measurements were performed at 
25 °C in the same solvent system used in the microtiter plate assay (100 mM TRIS-HCl buffer 
pH 7.4 with 2 mM EDTA/ethylene glycol (20:80)).  
 
Figure 37: Stopped-flow instrument.  
3.2.3. Determination of the second-order rate constant for reaction of a chalcone with a 
thiol 
The idea of the developed assay is to measure the second-order rate constant (k2) for the 
reaction of a certain chalcone with a thiol such as cysteamine (107) (Scheme 42). To achieve 
this, the measurements were conducted in presence of an excess of the thiol so that the 
pseudo-first-order kinetics can be applied as shown below. 
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Scheme 43: Reaction of chalcones with cysteamine (107) relevant to the kinetic assay. 
The reaction rate equation for the two reactants ( and Thiol) in Scheme 42 is: 
      
     
  
                                                                                     
Since the thiol is in excess, its concentration can be absorbed within the rate constant (k2), 
obtaining a pseudo-first-order constant (kobs) that depends on the concentration of thiol only 
(Equations 2-4). 
                                    
                                               
So                                                                                                               
                             
    
        
                                                    
In order to calculate the second-order rate constant k2 values, firstly the obtained raw data are 
corrected versus the blank to give individual curves (At vs. time) for each measurement. Then 
the kobs values are gained from the time-dependent decay of the absorbance (At) of the αβ 
(chalcone) with Thiol by fitting the data of individual experiments to the first-order 
exponential equation (5):  
      
                                                                                  
with the software OriginPro 8. Finally the k2 values are obtained by linear regression of the 
kobs values versus their corresponding thiol concentrations. Figure 38 shows how the k2 value 
was determined for the reaction of -H-TMC (60) with cysteamine (107) as an example.  
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Entry 
Fold 
cysteamine 
Cysteamine 
[M] 
Individual 
kobs [s
-1
] 
kobs [s
-1
] 
Mean of duplicates 
Abs3 
60 0.00240 
9.12 x 10
-4
 
9.19 x 10
-4
 
Abs4 9.26 x 10
-4
 
Abs5 
72 0.00288 
1.02 x 10
-3
 
1.02 x 10
-3
 
Abs6 1.02 x 10
-3
 
Abs7 
84 0.00336 
1.12 x 10
-3
 
1.12 x 10
-3
 
Abs8 1.13 x 10
-3
 
Abs9 
96 0.00384 
1.25 x 10
-3
 
1.23 x 10
-3
 
Abs10 1.21 x 10
-3
 
Abs11 
108 0.00432 
1.31 x 10
-3
 
1.30 x 10
-3
 
Abs12 1.29 x 10
-3
 
k2 = 0.202 M
-1
 s
-1
 
Figure 38: Left graph: Exponential decay curve for the reaction of 40 M of -H-TMC (60) with 60 fold 
cysteamine (107) at 360 nm in 100 mM TRIS-HCl pH 7.4, 2 mM EDTA/ethylene glycol (20:80) which 
represents the first entry in the table below. Right graph: k2 determination for the reaction of -H-TMC (60) with 
cysteamine (60-108 fold). The table shows the kobs values obtained at each thiol concentration as duplicates, then 
the mean of duplicates and finally the k2 value. 
In the case of stopped-flow measurements, the kobs values are given directly by the software of 
the instrument. So one has only to do the linear fits to get the k2 values. 
3.2.4. Assessment of the reactivity of -H-chalcones 
First of all, the reactivity of some -H-chalcones was assessed by the developed kinetic assay 
since almost all natural product chalcones are -unsubstituted  -OH-chalcones are the only 
exception.
88
 In order to establish structure-activity relationships, 2’,3,4,4’-tetrasubstituted 
chalcones were mainly chosen, such as the natural chalcones butein (2) and calythropsin 
(116). Chalcone (1), flavokawain A (3), isoliquiritigenin (4) and xanthohumol (5) (Figure 6) 
were also tested. Table 5 shows the parameters used in the kinetic measurements of the tested 
-H-chalcones, i.e. wavelengths, fold cysteamine (107) and time intervals (t) and the results 
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of the kinetic studies are given afterwards in Table 6. Representative k2 value determinations 
for the tested -H-chalcones are given in the Appendix. 
Table 5: Wavelengths, fold thiol and time intervals (t) used in the kinetic thiol assay of -H-chalcones. 
# Name 
Wavelength  
[nm] 
Fold 
cysteamine
a
 
t [s] 
1  Chalcone 320 12-60 11 
62 2’-Hydroxychalcone 295 100-500 Stopped-flow 
2  Butein 390 60-108 15 
3  Flavokawain A 375 60-108 11 
4  Isoliquiritigenin 390 60-108 17 
5  Xanthohumol 390 60-108 50 
60 2’,3,4,4’-Tetramethoxy-
chalcone 
360 60-108 25 
61 2’-Hydroxy-3,4,4’-trimethoxy- 
chalcone 
390 60-108 11 
116  Calythropsin 390 100-300 11 
118 4-Methoxy-2’,3,4’-trimethoxy-
chalcone 
390 60-108 18 
119 2’,4’-Dihydroxy-3,4-
dimethoxy-chalcone 
390 60-108 15 
120 2’,3,4,4’-Tetraisopropoxy-
chalcone 
365 60-108 35 
121 4’-Methoxy-2’,3,4-
triisopropoxychalcone 
365 60-108 32 
122 2’,4,4’-Triisopropoxychalcone 360 60-108 35 
123 4-Methoxy-2’,3,4’-
triisopropoxychalcone 
360 36-84 40 
124 2’, 4’-Diisopropoxy-3,4-
dimethoxychalcone 
365 60-108 40 
a
 12-60: 12, 18, 24, 36, 48, 60; 36-84: 36, 48, 60, 72, 84; 60-108: 60, 72, 84, 96, 108; 100-300: 100, 150, 200, 
250, 300; 100-500:100, 200, 300, 400, 500. 
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Table 6: k2 Values of -H-chalcones with cysteamine (107) at 25 °C.* 
 
# 2’ 3’ 4’ 6’ 3 4 k2
a
 [M
-1
 s
-1
] 
1  H H H H H H 3.04 ± 0.10 
62 OH H H H H H 5.08 ± 0.043b 
2  OH H OH H OH OH 0.271 ± 0.027 
3  OH H OMe OMe H OMe 0.649 ± 0.0090 
4  OH H OH H H OH 0.258 ± 0.010 
5  OH prenyl OMe H H OH 0.124 ± 0.0054 
60 OMe H OMe H OMe OMe 0.193 ± 0.019 
61 OH H OMe H OMe OMe 0.717 ± 0.041 
116  OH H OMe H OH OH 0.325 ± 0.011 
118 OH H OH H OH OMe 0.417 ± 0.0079 
119 OH H OH H OMe OMe 0.464 ± 0.039 
120 OiPr H OiPr H OiPr OiPr 0.135 ± 0.0047 
121 OiPr H OMe H OiPr OiPr 0.148 ± 0.0083 
122 OiPr H OiPr H H OiPr 0.108 ± 0.0056 
123 OiPr H OiPr H OiPr OMe 0.118 ± 0.0069 
124 OiPr H OiPr H OMe OMe 0.103 ± 0.0082 
a 
Reactions were carried out in 100 mM TRIS-HCl pH 7.4, 2 mM EDTA/ethylene glycol (20:80) under 
pseudo-first order conditions at a concentration of 40 µM for chalcones and 12 to 500 fold cysteamine (107).  
b
 Done by stopped-flow technique. * The measurements and data analysis were done by Nafisah Al-Rifai, 
Sabine Amslinger and Katrin Winter. 
A good structure-activity relationship can be derived from the k2 values in Table 6. The main 
points are indicated in Figure 39 and the details are discussed afterwards. 
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Figure 39: The structure-activity relationship deduced from the k2 values of -H-chalcones in Table 6. 
1. The 2’-OH enhances the reactivity significantly which is consistent with the    
literature.
89-90
 Upon reaction with cysteamine (107), 2’-hydroxychalcone (62) has a k2 
value of 5.08 M
-1
s
-1
 being the most active compound in the series. It is more reactive than 
its parent compound chalcone (1, k2: 3.04 M
-1
s
-1
) by about 1.7 fold. The influence of the     
2’-OH can also be seen when the 2’-OH chalcone 61 (k2: 0.717 M
-1
s
-1
) is compared with 
its 2’-OMe analogue 60 (k2: 0.193 M
-1
s
-1
). The 2’-OH affects the reactivity of the 
chalcones by activating their carbonyl group through the intramolecular H-bonding and 
by stabilizing the conjugation leading to less distortion from planarity. This is indicated 
by the smaller dihedral angle between the two rings in -H-HC (61, Figure 23) compared 
to -H-TMC (60)67 as mentioned before.  
2. The least reactive compound in the 2’-OH chalcone series is xanthohumol (5) with a k2 
value of 0.124 M
-1
s
-1
. This is due to its very electron-rich and sterically demanding        
A-ring. 
3. The OH substituent is considered to be more electron-donating than the OMe group due 
to its negatively charged state upon deprotonation. Therefore replacing the OH 
substituent with an OMe increased the reactivity. It was noticed that such a replacement 
in the B-ring enhanced the reactivity more than a similar one in the A-ring, since the 
substituents on the B-ring are closer to the double bond of the enone moiety and thus 
have more resonance and inductive effects on the conjugation of the  system. This point 
was deduced from the comparison of k2 values of chalcone 2 with chalcones 116 and 118. 
Chalcone 116 (k2: 0.325 M
-1
s
-1
) with a 4’-OMe showed more reactivity than its 
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tetrahydroxy analogue 2 (k2: 0.271 M
-1
s
-1
) and chalcone 118 (k2: 0.417 M
-1
s
-1
) which is a 
4-OMe analogue is even much more reactive than chalcone 116. 
4. Butein (2) and its 3-dehydroxy analogue isoliquiritigenin (4) have unexpectedly nearly 
the same k2 values which indicates a particularly big influence of the substituents in the  
4-position. 
5. There is only a small difference in reactivity between the two regioisomers flavokawain 
A (3) (k2: 0.649 M
-1
s
-1
) and -H-HC (61) (k2: 0.717 M
-1
s
-1
) which both have three OMe 
groups. This could be a result of the steric hindrance of the 6’-OMe in 3 that leads to less 
conjugation and thus less reactivity compared to chalcone 61. 
6. The reactivity of the isopropoxy compounds 120-124 is somewhat similar to their 
tetramethoxychalcone analogue 60. This is not surprising since they are all tetraalkoxy 
compounds. The slight variation in their reactivity might be due to steric factors which 
affect the dihedral angle between the two aromatic rings thus affecting the conjugation of 
the  system. 
Overall, the reactivity of the chalcones is affected by the electronic nature of the substituents 
on the aromatic rings. Simultaneously the steric effects of these substituents play an essential 
role. 
The formation of the expected thiol adduct A (Figure 40) in the kinetic assay of the 
compounds in Table 5 was proven in all cases by LC-MS analysis of the assay samples. The 
chromatograms of LC-MS analyses of the tested -H-chalcones are shown in the Appendix.* 
In some cases, a seven membered 1,4-thiazepine intramolecular condensation product B was 
found in addition to product A. The cyclized product B which is formed by the nucleophilic 
attack of the NH2 residue on the carbonyl group was found only when a 2’-OH was present  
with the exception of butein (2) and flavokawain A (3). Such a reaction was reported recently 
for ,-unsaturated aldehydes.23  
 
                                                 
*
 The LC-MS results of the chalcones that were tested by Katrin Winter are not included in the Appendix. 
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Figure 40: Products of the reaction of -H-chalcones with cysteamine (107) in 100 mM TRIS-HCl pH 7.4, 2 
mM EDTA/ethylene glycol (20:80) at 25 °C (found by LC-MS analysis). 
It was tried to determine the k2 value for phenylvinylketone (Figure 41) which is an ,-
unsaturated compound with only one aromatic ring, but the attempts were unsuccessful 
because its absorption maximum is less than 300 nm and the developed UV-Vis detection-
based assay cannot be used in such a case. This can be considered as a limitation of the assay 
developed. 
 
Figure 41: Structure of phenylvinylketone. 
3.2.5. Assessment of the reactivity of -X-TMCs 
The chemical reactivity of the synthesized -X-TMCs towards thiols was determined using 
the developed spectrophotometric kinetic assay. This allows for a deeper insight into their 
potential biological activities that is based on the Michael addition of thiols to their enone unit 
as will be shown afterwards. 
The UV-Vis spectra of -X-TMCs (Figure 42) which were obtained prior to their reactivity 
assessment indicate the influence of the different X substituents on the conjugated  system. 
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Figure 42: UV-Vis spectra of the -X-TMCs in 100 mM TRIS-HCl pH 7.4, 2 mM EDTA/ethylene glycol 
(20:80) at 25 °C. All compounds were at 40 M, only chalcones 71 and 77 were at 80 M. 
As in the case of -H-chalcones, cysteamine (107) was used as the S-nucleophile to compare 
the -X-TMCs and the applied reaction media is again 100 mM TRIS-HCl buffer pH 7.4, 2 
mM EDTA/ethylene glycol (20:80). In the setting of the microtiter plate reader, this mixture 
enabled the kinetic measurements of -X-TMCs within two to 63 h. Stopped-flow 
measurements were performed in the case of very fast reactions using the same solvent 
system in a similar way. Assay conditions with wavelengths, thiol concentrations and time 
intervals for   -X-TMCs are given in Table 7 and the results of the kinetic measurements are 
shown in Table 8. Representative k2 value determinations for all tested -X-TMCs-thiol pairs 
are given in the Appendix. 
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Table 7: Wavelengths, fold thiol and time intervals (t) used in the kinetic assay of -X-TMCs. 
# X 
Wavelength 
[nm] 
Chalcone 
[µM] 
Fold thiol
a
 t [s] 
69 CN 380 40 12-60 Stopped-flow 
71 NO2 390 80 60-108 Stopped-flow 
77 CF3
 355 80 60-108 Stopped-flow
* 
73 Br 360 40 100-500 Stopped-flow 
74 Cl 335 40 12-60 18 
78 p-NO2-C6H4 375 40 60-108 25 
75 I 345 40 60-108 18 
72 COOEt 320 40 60-108 25 
68 F 350 40 100-500 90 
80 p-OMe-C6H4 350 40 60-108 600 
70 Me 330 40 200-500 180 
79 Ph 350 40 200-500 180 
76 COOH 310 40 200-400 7 min 
69 CN 380 40 60-108
b
 Stopped-flow 
71 NO2 390 80 60-108
b
 Stopped-flow 
77 CF3 355 80 20-40
b
 11
*
 
73 Br 360 40 60-108
b
 80 
73 Br 360 40 60-108
c
 80 
73 Br 360 40 12-24
d,e
 10 min 
 
Fold thiol: 12-24: 12, 15, 18, 21, 24; 12-60: 12, 18, 24, 36, 48, 60; 20-40: 20, 25, 30, 35, 40; 60-108: 60, 72, 84, 
96, 108; 100-500: 100, 200, 300, 400, 500; 200-500: 200, 300, 400, 450, 500; 200-400: 200, 250, 300, 350, 400. 
a 
Cysteamine, 
b -mercaptoethanol, c 1,4-butanedithiol, d glutathione, e higher amounts than 27 fold of GSH gave 
decreasing instead of increasing kobs values for the corresponding higher GSH concentrations. This could be 
because thiol oxidation may take place to get GSSG. 
*
 The data was fit to a single exponential + slope function 
to determine kobs. 
The great influence of a simple exchange of only one substituent on reactivity is revealed by 
the second-order-rate constants k2. The -CN-TMC (69) has a k2 value of 5750 M
-1
 s
-1 
 which 
is about 1.6 million fold the k2 value of -COOH-TMC (76) (0.00371 M
-1
 s
-1
). The CN 
substituent is a powerful electron-withdrawing group, which explains the highest reactivity of 
chalcone 69. The NO2 substituent has even a stronger electron-withdrawing ability, but 
unexpectedly a smaller k2 value (749 M
-1
 s
-1
) was determined for chalcone 71. The structural 
differences between 69 and 71 (Figure 43) may account for the difference in their reactivity. 
The steric effects of the NO2 group in chalcone 71 prefers the configuration where the NO2 
and the B-ring are not in the same side, whereas the slim size of the CN functionality of 
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chalcone 69 allows the CN group to be in the same side of the B-ring as shown in the X-ray 
structure of 69 (Figure 25). Hence, as indicated from both structures, the nucleophilic attack 
to the -position of -CN-TMC (69) is easier than that in the case of chalcone 71 with the 
steric demand of the NO2 functionality.  
Table 8: Results of kinetic measurements of -X-TMCs at 25 °C.* 
 
# X Thiol k2
a 
/ M
-1
s
-1
 Rel. rate
b
 
69 CN 107 5750 ± 130
c
 1,600,000 
71 NO2 107 749 ± 9.0
c
 200,000 
77 CF3 107 17.1 ± 1.8
c
 4,600 
73 Br 107 2.89 ± 0.080
c
 780 
74 Cl 107 1.65 ± 0.021 450 
78 p-NO2-C6H4 107 0.293 ± 0.025 79 
75 I 107 0.282 ± 0.015 76 
72 COOEt 107 0.281 ± 0.029 76 
60 H 107 0.193 ± 0.019 52 
68 F 107 0.0168 ± 0.00035 4.5 
80 p-OMe-C6H4 107 0.00856 ± 0.0013 2.3 
70 Me 107 0.00750 ± 0.00039 2.0 
79 Ph 107 0.00669 ± 0.00029 1.8 
76 COOH 107 0.00371 ± 0.000060 1.0 
69 CN 111 368 ± 19
c
 1/16
d
 
71 NO2 111 33.6 ± 0.34
c
 1/22
e
 
77 CF3 111 1.49 ± 0.11 1/11
f
 
73 Br 111 0.135 ± 0.011 1/21
g
 
73 Br 109 0.151 ± 0.0086 1/19
g 
73 Br 112 0.0399 ± 0.00050 1/72
g
 
a
 Reactions were carried out in 100 mM TRIS-HCl pH 7.4, 2 mM EDTA/ethylene glycol (20:80) under pseudo-
first-order conditions at concentrations of 40 M for all chalcones except chalcones 71 and 77 which were tested 
at 80 M. for chalcones 71, 77 together with 12 to 500 fold cysteamine (107) or thiols 109, 111 or 112; b k2 (X, 
107) relative to k2 (COOH, 107); 
c
 done by stopped-flow technique; 
d
 k2 (CN, 111) relative to k2 (CN, 107); 
e
 k2 
(NO2, 111) relative to k2 (NO2, 107); 
f
 k2 (CF3, 111) relative to k2 (CF3, 107); 
g
 k2 (Br, 111), k2 (Br, 109) or k2 (Br, 
112) relative to k2 (Br, 107). * The measurements and data analysis were done by Nafisah Al-Rifai and Sabine 
Amslinger. 
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This ability of the CF3 to withdraw electrons is still high but much less than the CN and NO2, 
which is consistent with the order of reactivity of chalcone 77 after the CN 90 and NO2 95 
chalcones with a k2 value of 17.1 M
-1
 s
-1
.  
 
Figure 43: Comparison of the structures, Hemmett p values and reactivities of the four most reactive chalcones 
in the -X-TMCs series. 
The halogens come next in the order of both reactivity and electron-withdrawing property. 
The -Br-TMC (73) displayed the highest reactivity among the halogen derivatives with a    
k2 value of 2.89 M
-1
 s
-1
. Upon comparing the CN chalcone (69) with the Br analogue (73) 
where both the -X-substituent and the -H are on opposite sides of the C=C, a good 
correlation can be found between the Hammett p values (which indicate the inductive and 
resonance effects)
91
 and the k2 values, i.e. the higher the p value, the more reactive is the 
chalcone (Figure 43). This is also true when comparing the two chalcones that have the -X-
substituent and the -H on the same side of the C=C, namely the more reactive NO2 chalcone 
(71) with a p value of 0.78 compared to the less reactive CF3 chalcone (77) with a p value 
of 0.23. 
The Cl chalcone 74 showed a little bit less reactivity (k2: 1.65 M
-1
 s
-1
) than the Br one 73 
which refers to the lower resonance effect of the Br substituent caused by the longer C-Br 
bond (1.905 Å) compared to the C-Cl bond (1.736 Å). The C-I bond (2.099 Å) in -I-TMC 
(75) is even longer and should lead to more activation, but the steric effect caused by the 
bulky size of the I atom (see X-ray structures in Figure 27) plays a significat role in 
decreasing the conjugation of the enone sytem and thus leads to less reactivity with a k2 of 
0.282 M
-1
 s
-1
 for the -I-TMC (75). The lowest reactivity of the F anlogue 68 is explained by 
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the high resonance effect of the small F atom which overrules its negative inductive effect 
making the F substituent the most deactivating halogen substituent (k2: 0.0168 M
-1
 s
-1
). The 
differences in the dihedral angles and C-X bond lengths indicated by the X-ray structures 
(Figures 24 and 27) of these four -halogen-TMCs that adopt the s-trans conformation reveal 
that both electronic and steric effects have a great influence on the conjugation of the  
system and thus on the reactivity, particularly in the case of -I-TMC (75). This is of course 
taking into consideration that the preferred structure in solution (such as buffer/ethylene 
glycol mixture or in culture medium with serum proteins) might be different, but the relative 
spatial demand of the substituents which affects the conjugation of the  system should be 
comparable. 
Regarding the -carbon derivatives, the -ester chalcone 72 showed higher reactivity         
(k2: 0.281 M
-1
 s
-1
) than the -unsubstituted analogue 60 (k2: 0.193 M
-1
 s
-1
) which is attributed 
to the electron-withdrawing ability of the COOEt in 72. On the other hand, the electron-
donating property of the -Me group is accounted for the very low reactivity of chalcone 70 
(k2: 0.00750 M
-1
 s
-1
) compared to -H-TMC (60). These electronic effects are also shown 
when comparing the -Ph-TMC (79) with the -aryl chalcone bearing the p-NO2 
functionality 78. As expected, the activation of the electron-withdrawing NO2 group is shown 
by the higher reactivity of chalcone 78 (k2: 0.293 M
-1
 s
-1
) compared to chalcone 79 (k2: 
0.00669 M
-1
 s
-1
). The k2 value of the p-OMe analogue 80 is 0.00856 M
-1
 s
-1
 which is lower 
than the p-NO2 compound as it should be, but unexpectedly it is a little bit higher than that of 
the -Ph-TMC (79). Differences in the E/Z equilibrium ratios or in the conformation may 
explain this behavior of the -p-OMe chalcone 80. The UV-Vis scans of the -aromatic 
chalcones depicted in Figure 42 shows that -p-OMe-C6H4-TMC (80) has a lower absorption 
than the two other -aryl derivatives (78 and 79), which may give a sign regarding its distinct 
behavior.  
The COOH group is the most deactivating substituent not only within the -carbon series 
only but within the whole -X-TMCs. The very low reactivity of chalcone 76 with a k2 value 
of 0.00371 M
-1
 s
-1
 can be explained by deprotonation of the acid functionality at pH 7.4 
producing the carboxylate where a negative charge is distributed between the two oxygen 
atoms and the carbon atom which is directly bonded with the -position. 
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The UV-Vis scans of -CN-TMC (69) with different thiols (Figure 32) showed that this 
chalcone can differentiate between thiols of different reactivities. To have more proof for such 
a differentiation which is important in biological systems especially for potential selectivity, 
kinetic measurements were performed with other thiols than cysteamine (107). 1,4-
Butanedithiol (109), -mercaptoethanol (111) and glutathione (GSH, 112) were chosen for 
this aim. The four most reactive -X-TMCs (X = CN (69), NO2 (71), CF3 (77), Br (73)) were 
tested with -mercaptoethanol (111) which is less reactive than cysteamine (107) and 
interestingly the order of reactivity was the same as that obtained upon reaction with 107 as 
indicated by the k2 values of 368 M
-1
 s
-1
 for -CN-TMC (69), 33.6 M-1 s-1 for -NO2-TMC 
(71), 1.49 M
-1
 s
-1 
for -CF3-TMC (77) and 0.135 M
-1
 s
-1 
for -Br-TMC (73). Chalcone 73 was 
also tested with thiol 109 and 112 to give k2 value of 0.151 M
-1
 s
-1
 and 0.0399 M
-1
 s
-1
,
 
respectively. The lower reactivity of thiols 109, 111, 112 with the Br chalcone 73 compared to 
cysteamine (107) indicates again their lower nucleophilicity as shown before in the case of the 
CN chalcone 69 (Figure 32).  
The LC-MS analyses on the crude reaction mixtures of -X-TMCs with cysteamine proved 
the formation of the expected Michael addition products (117 and 125-135, Scheme 43) in all 
cases except for the I- and COOH-chalcones 75 and 76, respectively. Here only downstream 
products were detected. More specifically, -COOH-TMC (76) gives compound 117 upon 
decarboxylation of its Michael adduct followed by a retro-Michael addition to form chalcone 
60 which was also produced in the case of chalcone 75 by the loss of the thiolate and iodine 
atom through formation of an iodonium ion. 
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Scheme 43: The initial step of the reaction cysteamine (107) with -X-TMCs in 100 mM TRIS-HCl pH 7.4,      
2 mM EDTA/ethylene glycol (20:80) and the subsequent reactions of the initial thia-Michael products. The 
products were confirmed by (LC-MS) analysis. The major products are marked by an underlined substituent X. 
EG = ethylene glycol.  
A similar decarboxylation was reported by Yamamura from his -COOH benzene adduct of 
-acid chalcone (Scheme 44) although under different conditions.27  
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Scheme 44: The decarboxylation of -COOH benzene adduct reported by Yamamura.27 
For -Br-TMC (73) and -Cl-TMC (74), the expected thia-Michael adducts 130 and 131 
respectively were detected but just in trace amounts and just when the measurements were 
done directly after mixing the chalcone solution with the thiol 107 solution. However, the 
formation of subsequent products was again observed. Firstly compound 136 was formed due 
to leaving ability of Cl and Br substituents. Then addition of the solvent (i.e. ethylene glycol) 
to the -position of 136 gave compound 137. The seven-membered intramolecular 
condensation product, i.e. thiazepine 138 found in the case of Br- and Cl-TMCs (73 and 74 
respectively) was formed by the nucleophilic attack of the NH2 residue of compound 136 on 
its carbonyl group. 
Overall, the downstream products for in the case of Br, Cl and COOH chalcones 73, 74, 76 
respectively prove the leaving group quality of these substituents, as Brˉ, Clˉ and CO2. The 
iodine atom in chalcone 75 is leaving as I
+
 in a retro electrophilic addition to the double bond 
of the enone system. The chromatograms of LC-MS analyses of all the tested -X-TMCs are 
shown in the Appendix. 
In the case of -CN-TMC (69), the LC-MS measurements showed only trace amounts of the 
expected Michael adduct in addition to the starting chalcone 69. This could be rationalized by 
the elevated temperature used for the HPLC separation which is 40 °C. It was reported that 
the Michael addition to -CN compounds is reversible at high temperatures (50 °C).92 To 
prove this explanation, the LC-MS experiment was repeated at 25 °C. There, the normal 
addition product was observed as the major product. This result was also confirmed by 
1
H 
NMR measurements of chalcone 69 in presence of cysteamine (107) at 25 °C, 50 °C and then 
again at 25 °C (Figure 44). The spectra (Figure 44e and b-d) shows a mixture of E/Z isomers 
of the enol form of the thia-Michael adduct 139 with OH signals at  = 11.39 and 11.17 ppm 
and singlets for the hydrogens of the -carbon (H'
/
'') at  = 5.37 and 4.24 ppm (Figures 44e 
and b-d). Figure 44c shows the partial reversibility of the Michael addition at 50 °C, which is 
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consistent with finding just trace amounts of the addition adduct in the case of the CN 
chalcone 69 during the LC-MS measurement. 
  
Figure 44: 
1
H NMR spectra of -CN-TMC (69) with cysteamine (107) in DMSO-d6. 
3.2.6. Analysis of reactivity of -X-HCs 
It was firstly tried to determine the k2 of the reaction of -CN-HC (95) with cysteamine (107) 
by the developed UV-Vis based kinetic thiol assay, but it was not possible to get clean 
kinetics. In addition it was noticed that upon dissolving in the solvent mixture of the kinetic 
assay the yellow color of chalcone 95 suddenly disappeared. This behavior could be explained 
by the cyclization of the yellow chalcone 95 to the corresponding colorless flavanone. The 
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cyclization of the 2’-OH chalcones to flavanones (Scheme 45) is a common phenomenon. It 
has been reported to occur mainly in protic solvents and it is affected by pH, temperature, -
substituents and substitution pattern on the chalcone rings.
93-100
 In 2013, this isomerization 
was also investigated under cell culture conditions.
101
  
 
Scheme 45: The isomerization between the chalcone and the flavanone. 
To prove these explanations and to study the tendency of the prepared -X-HCs to isomerize 
giving the cyclized form (flavanone) especially since most of them adopt the s-trans 
conformation, LC-MS analysis was performed. The LC-MS samples were prepared under the 
kinetic assay conditions, i.e. 40 M chalcone in 100 mM TRIS-HCl buffer pH 7.4, 2 mM 
EDTA/ethylene glycol (20:80) without and with cysteamine (107). Based on the DAD 
chromatograms a relative quantification was done (Table 9) just to have an idea on what is 
going on.  
The flavanone structures were identified by their UV-Vis spectra obtained in the LC-MS 
measurements, since both the chalcone form and its cyclized form have the same MS. Three 
points should be taken into account to assign the peaks of the obtained chromatograms 
correctly:  
1. The max of the HCs which is reported to be in the range of 350-450 nm.
93
 The max of the 
synthesized -X-HCs is in 340-380 nm range for X= H (61), F (94), CN (95), Cl (98), p-NO2-
C6H4 (100) and in 290-300 nm for X= Br (97) and CF3 (99).  
2. The retention time of the peaks, since it has been reported that the chalcones have higher 
retention time than the corresponding flavanones.
102
  
3. The MS-fragment that formed upon elimination of HX which should be more intense in the 
flavanone case since such elimination is easy from the flavanone to form the corresponding 
flavones. 
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Table 9: Results of LC-MS studies of -X-HCs without and with 60 fold cysteamine (107).a 
 
   compounds detected by LC-MS 
# X 
Eq
b 
107 
-X-HC 140 141 142 143 144 Other
c
 
61 H 0 > 95% trace - - - - - 
61 H 60 + - +++ - + - - 
94 F 0 > 95% trace - - - - - 
94 F 60 +++ trace ++ - trace - - 
95 CN
d,e
 0 ++ +++ - - - - - 
95 CN 60 - - ++ - - - ++ 
96 Me 0 > 95% trace - - - - - 
96 Me 60 95% trace trace - - - - 
97 Br 0 + +++ - - - - + 
97 Br 60 trace + - trace - ++ + 
98 Cl 0 ++ +++ - - - - - 
98 Cl 60 trace + - + - +++ +
f
 
99 CF3
d
 0 + ++ - - - - + 
99 CF3
d
 60 + ++ - - - - - 
100 p-NO2-C6H4 0 + +++ - - - - - 
100 p-NO2-C6H4 60 + +++ + - - - - 
a
 Reactions were carried out in 100 mM TRIS-HCl pH 7.4, 2 mM EDTA/ethylene glycol (20:80 B/EG) with 40 
µM of -X-HCs. The incubation time prior injection was 1-2 h and the HPLC analysis performed at 40 °C;                    
b
 equivalents used of cysteamine (107); 
c
 see chromatograms in the Appendix; 
d
 measured directly after mixing 
in B:EG; 
e
 measured at 25 °C HPLC column temperature; 
f
 see Figure 46. Molecular ratios were estimated by 
UV measurements and relative amounts were assigned as follows: +++: < 95-60%; ++: < 60-30%; +: < 30-5;      
trace: < 5%. 
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As indicated in Table 9, in the absence of cysteamine (107) only trace amounts of the cyclized 
form 140 were detected in the case of -H-HC (61), -F-HC (94) and -Me-HC (95). On the 
other hand, the flavanone was the predominant component in all the other -X-HCs (X = CN 
(95), Br (97), Cl (98), CF3 (99) and p-NO2-C6H4 (100)), which indicates the activation of the 
-position caused by these -substituents. As an example, Figure 45 shows the results of LC-
MS analysis of -Cl-HC (98) without thiol 107 after about 1:45 h incubation prior to the LC-
MS measurements. The graphs of all the other -X-HCs without and with cysteamine are 
given in the Appendix.  
 
Figure 45: LC-MS analysis of -Cl-HC (98) dissolved in 100 mM TRIS-HCl buffer pH 7.4,                                 
2 mM EDTA/ethylene glycol (20:80); the incubation time was about 1:45 h. The top graph shows the HPLC 
chromatogram with DAD detection (relative quantification). For particular retention times (peaks) the UV scans 
are displayed (right side) and the ESI (+ mode) MS spectrum (left side). * Fragment by HCl elimination. 
* 
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The top graph in Figure 45 shows the HPLC chromatogram of -Cl-HC (98) with DAD 
detection. Despite the fact that the pure Z-isomer of 98 was initially used, two isomers were 
detected in the chalcone form of 98 at 3.0 and 3.1 min. Additionally, two other isomers were 
found but with lower retention times (2.7 and 2.8 min) for the cyclized form of -Cl-HC (98). 
This indicates that there is an equilibrium between the two forms. The first two UV spectra 
which correspond to the flavanone form indicate the absence of the chalcone absorption 
maximum at about 360 nm, which confirms that they are not the yellow chalcone anymore 
although they have the same exact mass. What is noteworthy is the ‘minus HCl’-fragment 
with [M-HCl+H]
+
 of 313.1072 which is more intense in the cases of flavanone than in the 
chalcone. These findings prove that the assignment of peaks at lower retention time is correct. 
Upon reaction of -Cl-HC (98) with 60 fold cysteamine (107), no normal addition product 
141 was found (Figure 46).
*
 Instead, four other products were detected, most are similar to 
those produced by the Cl-TMC analogue 98 (Scheme 43). These products are: two isomers of 
2,3-dihydro-1,4-thiazepine 144 as the major product, two isomers of the Michael adduct 
without HCl 142, a cyclic cysteamine adduct with a mass of 389.1297 which was formed by 
intramolecular SN2 replacement of Cl by the amine functionality of cysteamine and finally a 
compound (exact mass: 223.0667) that was formed upon reaction of cysteamine with the 
aldehyde produced from a retro-Aldol reaction. Moreover, traces of the starting material       
-Cl-HC (98) both in the chalcone and in the flavanone form could be detected. 
The behavior of -Br-HC (97) was similar to the Cl derivative 98 in producing many 
subsequent products. Beside the respective chalcone and the flavanone form, -CF3-HC (99) 
showed three unidentified products in presence of cysteamine (107), two of them were also 
detected in the absence of cysteamine (107). 
 
                                                 
*
 The measurement was done after about 1:45 hr of incubation. 
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Figure 46: LC-MS analysis of -Cl-HC (98) dissolved in 100 mM TRIS-HCl buffer pH 7.4,                                    
2 mM ETDA/ethylene glycol (20:80) in presence of 60 fold cysteamine (107), the incubation time was about 
1:45 h. The top graph shows the HPLC chromatogram with DAD detection (relative quantification). For 
particular retention times (peaks) the UV scans are displayed (right side) and the ESI (+ mode) MS spectrum 
(left side). * Fragment by HCl elimination. 
In presence of 60 fold cysteamine (107), the -H-HC (61) and -F-HC (94) gave the expected 
addition product 141 in good quantities, while only traces of such a product was found in the 
case of the Me analogue 96 (in the tested time frame of about 2 h) due to its lower 
electrophilicity compared to 61 and 94 (Table 9). In the case of the -aryl-HC (100), the 
addition product 141 was also the only product found but not in a big amount. -CN-HC (95) 
gave unusual products upon reaction with cysteamine (Scheme 46) which are produced by a 
retro-Aldol condensation followed by reaction of the produced aldehyde with cysteamine 
(107).  
* 
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Scheme 45: The formation of the products which were detected by LC-MS for -CN-HC (95) in presence of 
cysteamine (107). 
So, the CN-, Cl-, Br-, CF3- and p-NO2-C6H4-substituents have been proven to enhance the 
electrophilicity of the -position of the chalcone as they did in the case of -X-TMCs, but 
here this enhancement promotes the conversion of the chalcones into -X-flavanones. 
Whereas, the H and the deactivating groups (F, Me) were not able to induce the cyclization of 
-X-HCs to a reasonable extent. Since the cyclization is not favored in the case of -F-HC 
(94), it was possible to determine its k2 value upon reaction with cysteamine (107). The 
reactivity enhancement gained by the 2’-OH led to a k2 value
*
 of 0.0347 ± 0.0029 M
-1
 s
-1
 for 
chalcone 94 which is about 2 fold the k2 value of -F-TMC (68). 
3.3. Biological tests for the synthesized chalcones 
3.3.1. Influence of -X-TMCs on the cell viability, the HO-1 upregulation and the NO 
production
103-104
 
Hannelore Rücker performed during her PhD work in vitro assays of the murine macrophage 
cell line RAW264.7 with the synthesized -X-TMCs and could show that their chemical 
reactivity which was revealed by the kinetic assay correlates very well with their biological 
activity.  
Firstly, she did cell viability assays in a concentration range of 1 to 25 M and found no 
toxicity in this range for the chemically most reactive chalcones, namely -CN-TMC (69) and 
-NO2-TMC (71), whereas as the third one in the chemical reactivity order (-CF3-TMC (77) 
was very toxic being the most toxic compound in the series of -X-TMCs. The toxicity limits 
                                                 
*
 Measured by Hermina Petkes. 
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of -X-TMCs are given in Table 10. Excluding chalcones 69 and 71, a good correlation was 
found between the cytotoxicity of the chalcones (with X = CF3 (77), Br (73), Cl (74), I (75)) 
and their chemical reactivity (k2 values), i.e. the higher the k2 value the more toxic is the 
chalcone.  
Secondly, Hannelore Rücker and Dita Fritsch made Western blots to show the influence of   
-X-TMCs on the Nrf2-dependent anti-inflammatory protein heme oxygenase-1 (HO-1).  At 
1 M (0.5 M for chalcone 77 due to its higher toxicity) the -X-TMCs 77, 73, 74 and 78 
were active as HO-1 inducers again in the same order of their chemical reactivity. 
Finally, Hannelore Rücker performed Griess assay for the -X-TMCs to determine their 
ability to inhibit NO. As illustrated in the introduction section, the expression of iNOS and its 
activity is connected with the transcription factor NF-B (Figure 4), which implies that the 
inhibition of the NO production can be used as an indication of anti-inflammatory activity.  
Table 10: Results of the in vitro toxicity assay and NO assay of -X-TMCs with RAW264.7 cells.103 104 
# X 
Toxicity 
limit
a,b
 
[M] 
Toxicity limit in 
presence of LPS
a
 
[M] 
Inhibition of NO 
production %
c 
([M]) 
69 CN 25 25 16.4 ± 8.7 (1) 
71 NO2 25 10 1.7 ± 8.5 (1) 
77 CF3 0.5 0.5 84.6 ± 8.9 (0.5) 
73 Br 1 1 67.4 ± 11.7 (1) 
74 Cl 5 1 47.2 ± 14.6 (1) 
78 p-NO2-C6H4 25 10 1.1 ± 9.8 (1) 
75 I 5 5 22.0 ± 12.4 (1) 
72 COOEt 10 10 46.0 ± 9.4 (5) 
60 H 10 10 60.9 ± 18.8 (5) 
68 F 25 25 29.6 ± 20.2 (5) 
80 p-OMe-C6H4 25 10 -2.2 ± 4.3 (5) 
70 Me 25 10 -34.7 ± 15.2 (5) 
79 Ph 25 25 9.7 ± 12.9 (5) 
76 COOH 25 25 -0.7 ± 12.2 (5) 
a
 Determined by MTT assay. 
b
 no LPS was added. 
c
 Determined by Griess assay with LPS-stimulated 
(10 ng mL
-1
) cells. Chalcones are ordered according to their chemical reactivity. Measurements were 
done by Hannelore Rücker. 
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The chemically active compounds were tested at 1 M (0.5 M for 77) and the others at 
5M. The most active chalcone was -CF3-TMC (77) which gave about 85% reduction of 
the NO production at 0.5 M. Chalcones -Br-TMC (73), -Cl-TMC (74), -I-TMC (75) 
displayed also good activity at 1 M. The activity of these four compounds is also in the order 
of their chemical reactivity: 77 > 73 > 74 > 75. The other -X-TMCs did not show significant 
activity at 1 M and even at 5 M only chalcones 60, 68, 72 were active (Table 10). 
It is noteworthy that despite the high chemical reactivity of the -CN 69 and -NO2 71 
derivatives, they were not biologically active both in the HO-1 induction and the reduction 
of the NO production. This can be referred to their extremely high electrophilicity which 
makes them targets for the cellular electrophile trap GSH.
105
 So it is important to find a 
certain reactivity window to retain activity. The reactivity that was determined by k2 values of 
2-20 M
-1
 s
-1
 led to high potency, but a good potency was found down to k2 values of 0.2       
M
-1
 s
-1
.  
In conclusion, these results indicate that a prominent modulation in both chemical reactivity 
and biological activity of TMCs was achieved merely by a single modification. The chemical 
reactivity-biological activity relationship for -X-TMCs can be stated as follows: 
[Michael acceptor activity (-X-TMCs)] ∞ [Inhibition of NO production (-X-TMCs)] 
                                                        for X = H, F, Cl, Br, I, CF3;  
Chemical reactivity-biological activity order:   CF3 > Br > Cl > I > H > F. 
3.3.2. Influence of -X-pHCs and -X-HCs on the cell viability and the NO production  
2’-O-Isopropyl (protected) chalcones-F-pHC (104) and -CN-pHC (105) 
test 
In contrast to -F-TMC (68)103-104 which was not toxic at 1-25 M, -F-pHC (104) reduced 
the cell viability by about 20% at 10-25 M. This difference can be referred to structural 
differences shown by their X-ray analysis. The B-ring of 104 (Figure 24) is rotated to be in a 
different situation from that in 68 (Figure 29) which may affect the activity of 104 compared 
to 68. No toxicity difference was found between -CN-pHC (105) and -CN-TMC (69) in the 
range of 1-25 M. Chalcones 104 and 105 were also tested at higher concentrations, 104 
showed a reduction of 60% in cell viability at 50-100 M, while 105 that was tested up to 75 
M reduced the cell viability by 29% at this concentration. Figure 47 (A and B) show the 
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results on MTT assays of 68 and 104 without LPS (which was discussed above) and with LPS 
(which was done to be sure about the cell viability in presence of LPS which is needed for the 
NO assay). 
NO (Griess) assay 
-F-pHC (104) was tested for its ability to inhibit the production of NO at 5 M as it was 
toxic at higher concentrations. At this concentration it showed 17% inhibition of the NO 
production (Figure 47C), while its TMC analogue 68
103-104
 inhibited the production of NO by 
30% at the this concentration. At 50 M-CN-pHC (105) gave an inhibition of 36% (Figure 
47C). No inhibition was found at 1 M while its TMC analogue 69 showed a 16% inhibition 
at the same concentration. The lower activity of 105 is consistent with its lower k2 value (3060 
± 58 M
-1
 s
-1
) upon reaction with cysteamine compared to that of 69 (5750 M
-1
 s
-1
). This 
implies less electrophilicity for 105 as a result of the reduced conjugation of the  system 
which can be attributed to the steric influence of the isopropyl group in 105.  
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Figure 47: Results of in vitro tests of -X-pHCs 104 and 105 with RAW264.7 cells after an incubation time of 
24 h. A) MTT test (no LPS was added), B) MTT tests in presence of 10 ng·mL
-1
 LPS, C) Griess assays in 
presence of 10 ng·mL
-1
 LPS. Data represent at least three independent experiments performed in quadruplicates. 
Levels of significance: ***: p < 0.001; **: p < 0.01; *: p < 0.05. 
-X-HCs ( X = H (61), F (94), CN (95), Me (96), Br (97), Cl (98), CF3 (99), p-NO2-C6H4 
(100))
*
 
MTT test 
The -unsubstituted chalcone 61 has a toxicity limit of 25 M where it reduced the cell 
viability only by 18%, whereas its TMC analogue 60 was toxic at this concentration with a 
54% reduction of the cell viability.
103-104
 A significant toxicity was found for -F-HC (94) at 
25 M up to 100 M (Figure 48). At 25 M it reduced the cell viability by 43%, while -F-
TMC 68 did not affect the cell viability at this concentration (Table 10). This reflects the 
enhanced electrophilicity of the HC 94 compared to the TMC 68. At 10 M, 17% reduction in 
cell viability was found for chalcone 94 (Figure 48). In presence of LPS, the reduction was 
                                                 
*
 The -H-HC (61) was tested by Hannelore Rücker. All the other -X-HCs were tested by Nafisah Al-Rifai. 
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elevated to 28% at the same concentration (Figure 49), therefore this concentration was 
excluded from the Griess assay of 94. -CN-TMC (69) was not toxic at 1-25 M (Table 10), 
and so is -CN-HC (95) that has no significant effect on the cell viability up to 50 M. It was 
not possible to do the MTT assay for 95 at higher concentrations due to its insolubility. 
Regarding the -Me-HC (96), a significant toxicity was found at the highest concentration 
(100 M) with a 36% reduction in cell viability (Figure 48), whereas in presence of LPS 
(Figure 49) the cell viability was reduced at 75 M so this concentration was not taken in the 
following NO test. No toxicity was reported for -Me-TMC (70) up to 25 M.  
 
Figure 48: Results of in vitro cell viability assays of -X-HCs 61 and 94-100 with RAW264.7 cells for 24 h (no 
LPS was added). Data represent at least three independent experiments performed in quadruplicates. Levels of 
significance: ***: p < 0.001; **: p < 0.01; *: p < 0.05. The testing of 61 was done by Hannelore Rücker, while 
the other chalcones were tested by Nafisah Al-Rifai.  
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Figure 49: Results of in vitro cell viability assays of -X-HCs 61 and 94-100 with RAW264.7 cells for 24 h 
(with 10 ng·mL
-1
 LPS). Data represent at least three independent experiments performed in quadruplicates. 
Levels of significance: ***: p < 0.001; **: p < 0.01; *: p < 0.05. The testing of 61 was done by Hannelore 
Rücker, while the other chalcones were tested by Nafisah Al-Rifai.  
Regarding the Br chalcones, both the TMC 73 and its HC analogue 97 were toxic above         
1 M. The toxicity limit for -Cl-TMC (74) was 5 M as shown in Table 10, but -Cl-HC 
(98) was less toxic; i.e. it did not show a significant toxicity at 1-25 M. This reduction in 
toxicity is very prominent in the CF3 case, where the -CF3-TMC (77) has a toxicity limit of 
0.5 M (Table 10) while the HC derivative 99 was not toxic up to 50 M where it reduced the 
cell viability by 12% only. No influence on cell viability was found for the -aryl-HC 100 at 
all and its TMC analogue 78 did not show toxicity in its tested range (1-25 M). In 
conclusion, it was expected that the increase in electrophilicity will lead to an increase in 
toxicity, but the opposite was true which again refers to the conversion of the HCs into their 
cyclized isomers. 
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NO (Griess) assay 
Since the TMCs with the same X-substituents in -CF3-HC (99), -Br-HC (97) and -Cl-HC 
(98) were reported to inhibit the NO production to a large extent,
103-104
 it was assumed that the 
2’-OH analogues might behave similarly. But, no activity was found in the Griess assay for -
CF3-HC (99), -Br-HC (97) and -F-HC (95). Additionally, -Cl-HC (98) inhibited the NO 
production with only 37% at 25 M. On the other hand, -CN-HC (95) showed about 75% 
inhibition at 50 M and about 38% at 25 M, while -CN-TMC (69) did not show any 
activity at 25 M. The activity of 95 may be attributed to the reversibility of the isomerization 
between the chalcone and its cyclized form. This is consistent with the data obtained from the 
LC-MS analysis of 95 in presence of cysteamine (107) where no flavanone was detected. The 
products in this case prove that the Michael addition occurred to the open form of 95. In the 
case of CF3-, Br- and Cl-substituents, the cyclization of HCs 99, 97 and 98 cannot be 
reversible due to subsequent reactions of the cyclization such as the elimination of HX that 
was proven by the LC-MS analysis of chalcone 97 and 98 as mentioned before. The              
-Me-HC (96) with the deactivating X substituent showed a maximum inhibition of NO 
formation of 42% at 50 M, but no inhibition at 1-10 M. This is just like its TMC analogue 
70 which did not show any activity in this concentration range.The maximum inhibition of the 
-aryl-HC 100 was 39% at 100 M, while at 10 M it showed 18% inhibition. That is lower 
than the inhibition of its TMC analogue 78 (36%) at the same concentration (10 M).  
In conclusion, it was found that the enhancement of electrophilicity in -H-HCs compared to 
their TMC analogues by the presence of 2’-OH group did not lead to more biological activity, 
but instead to a reduction or loss in their anti-inflammatory activity. This finding can be 
rationalized by the common conversion of the HCs into their cyclized form, i.e. flavanones 
which are not considered as Michael acceptors. In the case of the CN chalcone 95, activity 
was gained due to the reversible isomerization that yields a small amount of the chalcone 
form which can escape from the GSH trap and subsequently reach its target. So overall, the 
fine-tuning regime by an -substitution is not compatible with the 2’-OH chalcones, since the 
activation of the -position will enhance the cyclization to -X-flavanones. 
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Figure 50: Results of in vitro Griess assay of -X-HCs 61 and 94-100 with RAW264.7 cells for 24 h (with 10 
ng·mL
-1
 LPS). Data represent at least three independent experiments performed in quadruplicates. Levels of 
significance: ***: p < 0.001; **: p < 0.01; *: p < 0.05. The testing of 61 was done by Hannelore Rücker, while 
the other chalcones were tested by Nafisah Al-Rifai.  
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4. SUMMARY 
The chalcone motif can be a privileged structure in drug design if the reactivity is modulated 
to reach a suitable range. Chalcones are relatively easily synthesized and they have a 
structural versatility that can affect their reactivity as Michael acceptors.  
Since the reactivity of chalcones as Michael acceptors is essential for their biological activity, 
the assessment of this reactivity is of great interest. Hence, a new simple kinetic assay was 
developed to study the electrophilicity of chalcones upon reaction with thiols by determining 
the second-order rate constants. The solvent system used in the assay permits inclusion of 
compounds with quite diverse electrophilicity. A clear structure-activity relationship was 
shown within 16 -H-chalcones.  
After that, the reactivity of chalcones was fine-tuned by modifying the -position, a strategy 
which is not that common in literature for this aim. A library of -X-TMCs with different    
X- substituents of diverse electronic properties was prepared (Figure 51). Then the reactivity 
of these chalcones was assessed utilizing the developed kinetic assay. 
 
Figure 51: The synthesized -X-TMCs. 
The anti-inflammatory activity of -X-TMCs was evaluated based on their ability to inhibit 
the production of NO by the proinflammatory enzyme iNOS. A strong correlation was found 
between Michael acceptor activity and inhibition of NO production of the -X-TMCs for X = 
H, F, Cl, Br, I, CF3. The chemical reactivity-biological activity order is:  
CF3 > Br > Cl > I > H > F. 
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The data prove that it is essential to find a certain reactivity window in order to retain activity. 
This reactivity window was identified by the kinetic assay to be in the range of 2-20 M
-1
 s
-1
 
for the k2 values. So, it was proven chemically and biologically that a single simple 
modification on the structure of chalcones has a tremendous effect on their activity. 
Finally, it was tried to enhance the activity of 2’-OH chalcones which are proven to be more 
active than their 2’-alkoxy analogues by -substitution. Seven -X-HCs (Figure 52) were 
synthesized and their biological activity was compared with the corresponding -X-TMCs. 
The conversion of these chalcones to flavanones was proven by LC-MS analysis. It was found 
that this isomerization is affected by the electron-withdrawing ability if the X-substituent, i.e. 
the more this ability, the higher is the tendency of the -X-HCs to cyclize. This cyclization 
made it difficult to get clean kinetics for the reaction of -X-HCs with thiols and led to loss of 
activity that was supposed to be enhanced by the 2’-OH group. A gain in activity was 
observed only for -CN-HC (95). 
 
Figure 52: The synthesized -X-HCs. 
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5. ZUSAMMENFASSUNG 
Chalkone können als vielversprechende Strukturen für die Arzneimittelforschung betrachtet 
werden, wenn sich deren Reaktivitäten in einem bestimmten Rahmen befinden. Sie können 
relativ leicht synthetisiert werden. Aufgrund ihrer strukturellen Vielfalt ist eine Beeinflussung 
ihrer Michael-Akzeptor-Aktivität möglich. 
Da die Reaktivität der Chalkone als Michael-Akzeptoren essentiell für ihre biologischen 
Aktivitäten ist, ist die Analyse dieser von großem Interesse. Deshalb wurde ein neuer, 
einfacher, kinetischer Assay zur Ermittlung der Elektrophilie der Chalkone durch Reaktionen 
mit Thiolen entwickelt. Die Analyse erfolgte durch Ermittlung der Geschwindigkeits-
konstanten zweiter Ordnung (k2). Das Lösungsmittelsystem des Assays erlaubte die Testung 
von Substanzen mit unterschiedlichen elektrophilen Eigenschaften. Eine deutliche Struktur-
Wirkungsbeziehung wurde für 16 -H-Chalkone gezeigt. 
Im Anschluss wurden die Reaktivitäten der Chalkone durch Modifizierung der -Position 
verändert. Diese Strategie ist in der Literatur mit dieser Absicht nicht üblich. Eine 
Substanzbibliothek von -X-Tetramethoxychalkonen (-X-TMCs) wurde hergestellt, wobei 
die X-Substituenten die elektronischen und sterischen Eigenschaften beeinflussen (Abbildung 
51). Folglich wurden die Reaktivitäten dieser Chalkone mithilfe des entwickelten 
Kinetikassays bestimmt.  
 
Abblidung 51: Die synthetisierten -X-TMCs. 
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Die entzündungshemmende Wirkung der -X-TMCs wurde mittels einer Hemmung des 
entzündungsfördernden Enzyms iNOS untersucht. Dabei wurde die NO Produktion wurde 
inhibiert. Eine Korrelation zwischen der Michael-Akzeptor-Aktivität und der Inhibierung der 
NO Produktion für die -X-TMCs (X = H, F, Cl, Br, I, CF3) wurde nachgewiesen. Die 
chemische Reaktivitäts-biologische Aktivitätsreihenfolge ist wie folgt: 
CF3 > Br > Cl > I > H > F. 
Die Daten beweisen, dass die Einhaltung eines Reaktivitätsfensters essentiell zur Erhaltung 
der Aktivität ist. Das Reaktivitätsfenster wurde mithilfe des kinetischen Assays in einem k2-
Wert Bereich von 2 -20 M
-1
 s
-1
 ermittelt. Es ist chemisch sowie biologisch bewiesen worden, 
dass eine einfache Modifizierung der Chalkonstruktur eine starke Änderung der Aktivität zur 
Folge hat. 
Es wurde gezeigt, dass die Reaktivität einzelner 2’-OH Chalkone höher ist als dessen           
2’-alkoxy Analoge. Durch Derivatisierung der 2’-OH Chalkone mit -X-Substituenten wurde 
versucht, deren Aktivität zu verbessern. Sieben -X-Hydroxychalkone (-X-HCs) 
(Abbildung 52) wurden synthetisiert und deren biologische Aktivitäten mit den 
entsprechenden -X-TMCs verglichen. Die Cyclisierung dieser Chalkone zu Flavanonen 
wurde durch LC-MS analysiert. Diese Isomerisierung wurde durch die elektronenziehenden 
Eigenschaften des X-Substituenten beeinflusst. Je elektronenziehender die Substituenten sind, 
desto höher ist die Tendenz zur Cyclisierung des -X-HCs. Diese Cyclisierung erschwerte die 
Ermittlung der kinetischen Daten für die Reaktionen der -X-HCs mit Thiolen. Eine 
Zunahme der Aktivität konnte für das -CN-HC (95) erzielt werden.  
 
Abbildung 52: Die synthetisierten -X-HCs. 
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6. EXPERIMENTAL PART 
6.1. General methods and materials 
All reactions were carried out under a N2 atmosphere in oven-heated glassware (110 °C) when 
dry conditions were required, and monitored by TLC on silica gel plates 60 F254 by Merck 
(Darmstadt, Germany). Spots were detected under UV light (λ = 254 and 366 nm) or 
visualized by staining with vanillin/H2SO4 (6.0 g vanillin in 100 mL 95% EtOH/conc. H2SO4 
100:1). Column chromatography was performed on silica gel Geduran Si 60 (0.063-0.200 
mm) by Merck. Preparative plates were prepared using silica gel 60 GF254 by Merck. Melting 
points are determined with an automated melting point system (OptiMelt apparatus, USA) and 
were uncorrected. IR spectroscopy was carried on a Specac Golden Gate Diamond Single 
Reflection ATR System Excalibur Series FTS3000MX by Bio-Rad (Munich, Germany). 
NMR spectra were recorded on Bruker spectrometers (USA): Avance 300, Avance 400, and 
Avance III 600. 
1
H NMR spectra are referenced to CDCl3 (7.26 ppm); 
13
C NMR spectra to 
CDCl3 (77.0 ppm). The following abbreviations are used to explain the multiplicities: s, 
singlet; d, doublet; dd, doublet of doublets; ddd, doublet of doublets of doublet; sept, septet; 
m, multiplet. Mass spectra were obtained on Agilent Technologies 6540 UHD (USA), 
Finnigan MAT 95 or Thermo Quest Finnigan TSQ 7000 instruments (Bremen, Germany). 
The samples for X-ray analysis were recrystallized from EtOAc/petroleum ether by vapor 
diffusion technique and the X-ray data were collected using a SuperNova, Single source at 
offset, Atlas diffractometer (Agilent Technologies, USA) or an Xcalibur, Ruby, Gemini Ultra 
diffractometer (Oxford Instruments, UK). All reagents were purchased from commercial 
sources and were used without further purification. Solvents were distilled before use and 
dried if water-free conditions were necessary. The used petroleum ether is the one with a 
boiling range of 40-60 °C. Ethylene glycol was used in spectrophotometric grade from Sigma-
Aldrich (Taufkirchen, Germany). 
Chalcone (1) was from Merck (Darmstadt, Germany) and xanthohumol (5) from Carl Roth 
(Karlsruhe, Germany). The other -H-chalcones which were tested in the kinetic thiol assay 
and were not synthesized during this PhD work were prepared by my colleagues in our group. 
The cysteamine (107) that was used in the thiol assay is a hydrochloride salt (i.e. cysteamine 
hydrochloride). 
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6.2. Synthetic procedures
*
 
6.2.1. General procedure for the synthesis of chalcones -H-chalcones 3, 60-62,66           
-F-TMC (68) and -Me-TMC (70)  
Benzaldehydes (1.0 eq.) and the corresponding dimethoxyacetophenones (1.0 eq.) were 
dissolved in MeOH (0.2 M). Ba(OH)2·8 H2O (1.0 eq.) was added and the reaction mixture 
was stirred at 60 °C or under reflux. The reaction mixture was subsequently concentrated in 
vacuo. Then H2O was added, the resulting solution was neutralized with 1 M aq. HCl, and 
extracted with EtOAc. The combined organic layers were dried over MgSO4 and evaporated 
under reduced pressure. The product was purified by column chromatography, on preparative 
TLC plates, or by recrystallization to afford the corresponding chalcones. 
-H-chalcones 3, 60-62 
 
(E)-1-(2-Hydroxy-4,6-dimethoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one 
(Flavokawain A) (3). Flavokawain A (3) was prepared according to the general procedure 
(5.2.1) starting from 1-(2-hydroxy-4,6-dimethoxyphenyl)-
ethanone (55) (300 mg, 1.53 mmol, 1.0 eq.) and 4-methoxy-
benzaldehyde (59) (208 mg, 1.53 mmol, 1.0 eq.). The reaction 
mixture was stirred at 60 °C for 24 h. Purification by 
recrystallization from MeOH afforded chalcone 3 (354 mg, 1.13 
mmol, 74%) as yellow crystals. 
                                                 
* Structures of the synthesized compounds in this study with numbers are listed in Appendix 6.1 for easy 
referral. The X-Ray data are given in Appendix 6.2 and the NMR spectra in Appendix 6.3. 
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1
H NMR (400 MHz, CDCl3):  = 14.41 (s, 1 H; 2’-OH), 7.82 (d, J = 15.6 Hz, 1 H; -CH), 
7.77 (d, J = 15.7 Hz, 1 H, -CH), 7.63-7.52 (m, 2 H), 7.04-6.82 (m, 2 H), 6.11 (d, J = 2.4 Hz, 
1 H), 5.96 (d, J = 2.4 Hz, 1 H), 3.92 (s, 3 H; OCH3), 3.85 (s, 3 H, OCH3), 3.84 (s, 3 H, OCH3) 
ppm. 
13
C NMR (75 MHz, CDCl3):  = 192.6 (C=O), 168.4, 166.0, 162.5, 161.4, 142.5 (-CH), 
130.1 (2 CH), 128.3, 125.1 (-CH), 114.4 (2 CH), 106.4, 93.8 CH, 91.2 (CH), 55.9 (OCH3), 
55.6 (OCH3), 55.4 (OCH3) ppm. 
The NMR spectral data are in accordance with the literature.
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(E)-1-(2,4-Dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one (-H-TMC, 60). 
Chalcone 60 was prepared according to the general procedure 
(5.2.1) starting from 1-(2,4-dimethoxyphenyl)ethanone (56) 
(3.60 g, 20.0 mmol, 1.0 eq.) and 3,4-dimethoxybenzaldehyde 
(29) (3.30 g, 20.0 mmol, 1.0 eq.). The reaction mixture was 
stirred at 60 °C for 24 h. Purification by column chromatography 
(SiO2, petroleum ether/EtOAc, 3:1) afforded -H-TMC (60) (4.84 g, 14.7 mmol, 74%) as a 
yellow solid; m.p. 81 °C (recrystallized from EtOAc/petroleum ether); lit. m.p. 89 °C.
107
  
1
H NMR (300 MHz, CDCl3):  = 7.73 (d, J = 8.6 Hz, 1 H), 7.62 (d, J = 15.7 Hz, 1 H; β-H), 
7.35 (d, J = 15.7 Hz, 1 H; α-H), 7.19 (dd, J = 8.3, 1.9 Hz, 1 H), 7.12 (d, J = 1.9, 1 H), 6.88 (d, 
J = 8.3 Hz, 1 H), 6.57 (dd, J = 8.6, 2.3 Hz, 1 H), 6.50 (d, J = 2.2 Hz, 1 H), 3.92 (s, 3 H; 
OCH3), 3.92 (s, 3 H; OCH3), 3.90 (s, 3 H; OCH3), 3.87 (s, 3 H; OCH3) ppm. 
13
C NMR (75 MHz, CDCl3):  = 190.8 (C=O), 164.0, 160.2, 151.0, 149.1, 142.5 (β-CH), 
132.7 (CH), 128.4, 125.3 (α-CH), 122.6 (CH), 122.5, 111.1 (CH), 110.2 (CH), 105.1 (CH), 
98.8 (CH), 56.0 (OCH3), 55.9 (OCH3), 55.8 (OCH3), 55.6 (OCH3) ppm.  
The 
1
H NMR spectral data are in accordance with the literature.
36
 
(E)-3-(3,4-Dimethoxyphenyl)-1-(2-hydroxy-4-methoxy-phenyl)prop-2-en-1-one             
(-H-HC, 61). The 2’-hydroxychalcone 61 was prepared 
according to the general procedure (5.2.1) starting from 1-(2-
hydroxy-4-methoxyphenyl)ethanone (57) (2.50 g, 15.1 mmol, 
1.0 eq.) and 3,4-dimethoxybenzaldehyde (29) (2.50 g, 15.1 
mmol, 1.0 eq.). The reaction mixture was heated to reflux for   
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48 h. Purification by recrystallization from acetone afforded -H-HC (61) (3.78 g, 12.0 mmol, 
80%) as yellow crystals; m.p. 160 ºC; lit. m.p. 170 ºC (recrystallized from MeOH).
108
 
1
H NMR (300 MHz, CDCl3):  = 13.56 (s, 1 H; 2’-OH), 7.87-7.81 (m, 2 H), 7.43 (d, J = 15.4 
Hz, 1 H), 7.24 (dd, J = 8.4, 1.9, 1 H), 7.15 (d, J = 1.9 Hz, 1 H), 6.90 (d, J = 8.3 Hz, 1 H), 
6.50-6.47 (m, 2 H), 3.96 (s, 3 H; OCH3), 3.93 (s, 3 H; OCH3), 3.85 (s, 3 H; OCH3) ppm. 
13
C NMR (75 MHz, CDCl3):  = 191.8 (C=O), 166.7, 166.1, 151.6, 149.3, 144.6 (-CH), 
131.1 (CH), 127.8, 55.6 (OCH3), 123.4 (CH), 118.0 (-CH), 114.1, 111.1 (CH), 110.2 (CH), 
107.7 (CH), 101.0 (CH), 56.0 (OCH3), 56.0 (OCH3) ppm. 
The 
1
H NMR spectral data are in accordance with the literature.
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(E)-1-(2-Hydroxyphenyl)-3-phenylprop-2-en-1-one (62). Chalcone 62 was prepared 
according to the general procedure (5.2.1) starting from 1-(2-
hydroxyphenyl)ethanone (58) (640 mg, 4.70 mmol, 1.0 eq.) and 
benzaldehyde (16) (500 mg, 4.70 mmol, 1.0 eq.). The reaction 
mixture was stirred at 60 °C for 24 h. Purification by recrystallization 
from MeOH afforded the yellow 2’-hydroxychalcone (62) (967 mg, 
4.31 mmol, 92%). 
1
H NMR (300 MHz, CDCl3):  = 12.82 (s, 1 H; 2’-OH), 7.94 (d, J = 15.5 Hz, 1 H; -CH), 
7.94 (dd, J = 8.1, 1.6 Hz, 1 H), 7.67 (d, J = 15.4 Hz, 1 H; -CH), 7.69-7.67 (m, 2 H), 7.51 
(ddd, J = 8.6, 7.2, 1.6 Hz, 1 H), 7.48-7.42 (m, 3 H), 7.04 (dd, J = 8.4, 1.1 Hz, 1 H), 6.96 (ddd, 
J = 8.2, 7.2, 1.1 Hz, 1 H) ppm. 
13
C NMR (75 MHz, CDCl3):  = 193.7 (C=O), 163.6, 145.5 (-CH), 136.4 (CH), 134.6, 
130.9 (CH), 129.6 (-CH), 129.0 (2 CH), 128.7 (2 CH), 120.1 (CH), 120.0, 118.8 (CH), 118.6 
(CH) ppm. 
The 
1
H NMR spectral data are in accordance with the literature.
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(Z/E)-1-(2,4-Dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)-2-fluoroprop-2-en-1-one (-F-
TMC, 68) 
  
2-Bromo-1-(2,4-Dimethoxyphenyl)ethanone (81). 1-(2,4-Dimethoxyphenyl)ethanone (56) 
(1.30 g, 7.21 mmol, 1.0 eq.) was dissolved in 1.5 L of a CHCl3/EtOAc 
mixture (1:1). The mixture was heated to reflux. CuBr2 (3.30 g, 14.8 mmol, 
2.05 eq.) was added in three portions over 3 h. The reflux was stopped after 
7 h of the first addition. The mixture was cooled to room temperature then 
filtered over silica gel and washed with EtOAc. The solvent was evaporated in vacuo and the 
residue was subjected to column chromatography (SiO2, petroleum ether/CH2Cl2, 1:1) to yield 
2-bromoacetophenone 81 as a white solid (1.50 g, 5.79 mmol, 80%). 
1
H NMR (300 MHz, CDCl3):  = 7.92 (d, J = 8.8 Hz, 1 H), 6.57 (dd, J = 8.8, 2.3 Hz, 1 H), 
6.47 (d, J = 2.3 Hz, 1 H), 4.58 (s, 2 H; CH2Br), 3.93 (s, 3 H; OCH3), 3.87 (s, 3 H; OCH3) 
ppm. 
13
C NMR (101 MHz, CDCl3):  = 190.2 (C=O), 165.4, 160.9, 133.8 (CH), 117.9, 105.9 (CH), 
98.3 (CH), 55.7 (OCH3), 55.7 (OCH3), 38.0 (CH2Br) ppm. 
1
H NMR spectral data is in accordance with the literature data.
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1-(2,4-Dimethoxyphenyl)-2-fluoroethanone (63).
13
 To freshly dried KF (3.36 g, 57.9 mmol, 
20.0 eq.), 2-bromoacetophenone 81 (750 mg, 2.89 mmol, 1.0 eq.) and        
18-crown-6 (153 mg, 0.579 mmol, 0.2 eq.) in dry MeCN (200 mL) were 
added under a N2 atmosphere. The mixture was refluxed for 6 days. The 
solvent was then removed in vacuo and the residue partitioned between 
CH2Cl2 and H2O. The organic fraction was dried and evaporated to gain a yellow oil. 
Purification by column chromatography (SiO2, petroleum ether/EtOAc, 4:1) yielded              
2-fluoroacetophenone 63 as a white solid (361 mg, 1.82 mmol, 63%); m.p. 142 °C. 
1
H NMR (400 MHz, CDCl3):  = 8.05 (d, J = 8.8 Hz, 1 H), 6.60 (dd, J = 8.8, 2.2 Hz, 1 H), 
6.45 (d, J = 2.2 Hz, 1 H), 5.38 (d, J = 48.3 Hz, 2 H; CH2F), 3.91 (s, 3 H; OCH3), 3.87 (s, 3 H; 
OCH3) ppm. 
13
C NMR (75 MHz, CDCl3):  = 192.1 (d, J = 14.2 Hz, CH2F-C=O), 165.6, 161.5, 133.0 (d,  
J = 2.7 Hz, CH2F-C(O)-C-CH), 117.1, 106.1 (CH), 98.0 (CH), 86.2 (d, J = 178.0 Hz, CH2F), 
55.7 (OCH3), 55.6 (OCH3) ppm. 
19
F-NMR (376 MHz, CDCl3):  = -224.3 (t, J = 48 Hz) ppm.  
IR (neat): 1665, 1602, 1225, 1211, 1018, 969, 834 cm
-1
.
MS (EI): m/z (%): 198 [M
•+
] (17), 165 (100).  
HRMS (EI): calcd for C10H11FO3: 198.0692 [M
•+
]; found 198.0694. 
(Z/E)-1-(2,4-Dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)-2-fluoroprop-2-en-1-one (-F-
TMC, 68). The -fluorochalcone 68 was prepared according to 
the general procedure (5.2.1) starting from 2-fluoro-
acetophenone 63 (99.0 mg, 0.500 mmol, 1.0 eq.) and 3,4-
dimethoxybenzaldehyde (29) (83.0 mg, 0.500 mmol, 1.0 eq.), 
which were dissolved in dry MeOH under a N2 atmosphere. The suspension was stirred at 60 
°C for 24 h. Column chromatography (SiO2, petroleum ether/EtOAc, 7:3) afforded -F-TMC 
(68) as a yellow solid (67.0 mg, 0.194 mmol, 39%) as a Z/E mixture of 92:8; m.p. 112 °C. 
Z-68: 
1
H NMR (600 MHz, CDCl3):  = 7.40 (d, J = 8.4 Hz, 1 H), 7.27 (s, 1 H), 7.20 (dd, J = 
8.4, 1.9 Hz, 1 H), 6.87 (d, J = 8.4 Hz, 1 H), 6.64 (d, J = 35.6 Hz, 1 H; β-H), 6.54 (dd, J = 8.5, 
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2.2 Hz, 1 H), 6.51 (d, J = 2.2 Hz, 1 H), 3.91 (s, 3 H; OCH3), 3.89 (s, 3 H; OCH3), 3.86 (s, 3 H; 
OCH3), 3.82 (s, 3 H; OCH3) ppm. 
Z-68: 
13
C NMR (101 MHz, CDCl3):  = 187.7 (d, J = 30.0 Hz, C=O), 163.6, 159.6, 154.1 (d, 
J = 267.7 Hz, α-C), 150.5 (d, J = 3.4 Hz), 148.9, 131.5 (CH), 124.61 (d, J = 4.8 Hz), 124.60 
(d, J = 7.3 Hz, CH), 120.0, 119.2 (d, J = 6.4 Hz, β-CH), 112.8 (d, J = 10.0 Hz, CH), 111.0 
(CH), 104.7 (CH), 98.8 (CH), 55.9 (OCH3), 55.8 (OCH3), 55.8 (OCH3), 55.5 (OCH3) ppm.  
Z-68: 
19
F NMR (376 MHz, CDCl3):  = -124.2 (d, J = 35.7 Hz) ppm.  
E-68: 
1
H NMR (600 MHz, CDCl3):  = 7.58 (d, J = 8.6 Hz, 1 H), 7.17 (d, J = 2.0 Hz, 1 H), 
6.95 (dd, J = 8.3, 1.9 Hz, 1 H), 6.74 (d, J = 8.3 Hz, 1 H), 6.63 (d, J = 23.7 Hz, 1 H; β-H), 6.48 
(dd, J = 8.6, 2.3 Hz, 1 H), 6.38 (d, J = 2.2 Hz, 1 H), 3.84 (s, 3 H; OCH3), 3.82 (s, 3 H; OCH3), 
3.81 (s, 3 H; OCH3), 3.81 (s, 3 H; OCH3) ppm. 
E-68: 
19
F NMR (376 MHz, CDCl3):  = -111.3 (d, J = 23.8 Hz) ppm.  
IR (Z/E-68, neat): 1652, 1632, 1604, 1519, 1333, 1260, 1211, 1025 cm
-1
. 
MS (EI): m/z (%): 346 [M
•+
] (99), 165 (100).  
HRMS (EI): calcd for C19H19FO5: 346.1217 [M
•+
]; found 346.1213. 
(E)-1-(2,4-Dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)-2-methylprop-2-en-1-one (-Me-
TMC, 70) 
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1-(2,4-Dimethoxyphenyl)propan-1-one (65).
71
 Anhydrous K2CO3 (1.80 g, 13.2 mmol, 2.2 
eq.) was added to a stirred solution of 1-(2,4-dihydroxyphenyl)ethanone 
(83) (1.00 g, 6.00 mmol, 1.0 eq.) in dry acetone (15 mL). After a few 
minutes, CH3I (7.5 mL, 120 mmol, 20.0 eq.) was added to the suspension. 
The reaction mixture was heated to reflux for 2 days, cooled, filtered and 
the remaining solid was washed with hot acetone. After evaporating the solvent in vacuo, the 
residue was dissolved in CH2Cl2, washed with H2O, dried over MgSO4 and the solvent 
evaporated. The crude product was subjected to column chromatography (SiO2, petroleum 
ether/EtOAc, 10:1) to give 2-methylacetophenone 65 (646 mg, 3.33 mmol, 55%) as a white 
solid. 
1
H NMR (300 MHz, CDCl3):  = 7.79 (d, J = 8.7 Hz, 1 H), 6.50 (dd, J = 8.7, 2.3 Hz, 1 H), 
6.43 (d, J = 2.3 Hz, 1 H), 3.86 (s, 3 H; OCH3), 3.82 (s, 3 H; OCH3), 2.94 (q, J = 7.3 Hz, 2 H; 
CH2), 1.13 (t, J = 7.3 Hz, 3 H; CH3) ppm. 
13
C NMR (75 MHz, CDCl3):  = 201.0 (C=O), 164.1, 160.6, 132.5 (CH), 121.0, 104.9 (CH), 
98.2 (CH), 55.4 (OCH3), 55.3 (OCH3), 36.7 (CH2), 8.5 (CH3) ppm.  
The 
1
H NMR spectral data is in accordance with the literature.
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(E)-1-(2,4-Dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)-2-methylprop-2-en-1-one (-Me-
TMC, 70). The -methylchalcone 70 was prepared according 
to the general procedure (5.2.1) starting from 2-methyl-
acetophenone 65 (350 mg, 1.80 mmol, 1.0 eq.) and 3,4-
dimethoxybenzaldehyde (29) (300 mg, 1.80 mmol, 1.0 eq.). The 
reaction mixture was stirred at reflux for 5 days. Purification on preparative TLC plates (SiO2, 
petroleum ether/EtOAc, 7:3) afforded a sticky solid material, which was precipitated from 
petroleum ether to give -Me-TMC (70) (250 mg, 0.730 mmol, 41%) as a pale yellow solid; 
m.p. 71 °C; the configuration of the double bond was assigned according to the literature.
78
  
1
H NMR (400 MHz, CDCl3):  = 7.28 (d, J = 8.2 Hz, 1 H), 7.11 (br s, 1 H; β-CH), 7.03 (dd,  
J = 8.4, 1.9 Hz, 1 H), 6.92 (d, J = 1.9 Hz, 1 H), 6.88 (d, J = 8.4 Hz, 1 H), 6.54-6.51 (m, 2 H), 
3.91 (s, 3 H; OCH3), 3.88 (s, 3 H; OCH3), 3.86 (s, 3 H; OCH3), 3.79 (s, 3 H; OCH3), 2.24 (d,  
J = 1.2 Hz, 3 H; CH3) ppm.  
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13
C NMR (101 MHz, CDCl3):  = 198.5 (C=O), 162.4, 158.8, 149.4, 148.6, 142.3 (β-CH), 
136.7, 130.9 (CH), 129.1, 123.4 (CH), 122.4, 113.0 (CH), 110.9 (CH), 104.3 (CH), 98.9 
(CH), 55.9 (OCH3), 55.9 (OCH3), 55.7 (OCH3), 55.5 (OCH3), 13.6 (CH3) ppm.  
IR (neat): 1616, 1595, 1514, 1262, 1212, 1021, 1010, 819 cm
-1
. 
MS (ESI
+
): m/z (%): 343 [M+H]
+
 (100).  
HRMS (ES-MS): calcd for C20H23O5: 343.1540 [M+H]
+
; found 343.1545. 
6.2.2. Synthesis of (E)-2-cyano-1-(2,4-dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)prop-2-
en-1-one (-CN-TMC, 69) 
 
2-Chloro-1-(2,4-dimethoxyphenyl)ethanone (82). A saturated aqueous solution of NaCl (70 
mL) was added to 2-bromoacetophenone 81 (710 mg, 2.74 mmol) in a 
round-bottom flask. The resulting mixture was heated at 80 ºC for 7 days. 
After cooling to room temperature the mixture was extracted with EtOAc   
(5 × 50 mL), the organic extract dried over MgSO4 and the solvent was 
evaporated. The product was then purified on preparative TLC plates (petroleum 
ether/EtOAc, 4:1) to afford 2-chloroacetophenone 82 (530 mg, 2.47 mmol, 90%) as a white 
solid. 
1
H NMR (300 MHz, CDCl3):  = 7.94 (d, J = 8.8, 1 H), 6.56 (dd, J = 8.8, 2.3 Hz, 1 H), 6.45 
(d, J = 2.3 Hz, 1 H), 4.74 (s, 2 H; CH2Cl), 3.91 (s, 3 H; OCH3), 3.86 (s, 3 H; OCH3) ppm. 
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13
C NMR (75 MHz, CDCl3):  = 190.0 (C=O), 165.4, 160.9, 133.5 (CH), 117.9, 105.9 (CH), 
98.1 (CH), 55.6 (2 OCH3), 51.3 (CH2Cl) ppm.  
The 
1
H NMR spectral data are in accordance with the literature data.
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3-(2,4-Dimethoxyphenyl)-3-oxopropanenitrile (64).
70
 KCN (455 mg, 6.99 mmol, 5.0 eq.) in 
H2O (1.4 mL) was added to a solution of 2-chloroacetophenone 82 (300 
mg, 1.40 mmol, 1.0 eq.) in EtOH (1.4 mL). The resulting mixture was 
gradually heated in a water bath up to 80 ºC until the solution was brown      
(~ 30 min). After cooling to room temperature, the reaction mixture was 
diluted with H2O (30 mL), acidified with 1 M aq. HCl (pH 4-5), and cooled in an ice-bath. 
The formed precipitate was filtered and crystallized from EtOH to get 64 (130 mg) as light 
brown crystals. The filtrate was extracted with CH2Cl2 (5 × 30 mL), the organic extract dried 
over MgSO4 and the solvent evaporated under reduced pressure. The product was purified on 
preparative TLC plates (petroleum ether/EtOAc, 7:3) to afford another crop of 64 (66 mg). 
The total yield of 2-cyanoacetophenone 64 was 196 mg (0.955 mmol, 68%). 
1
H NMR (300 MHz, CDCl3):  = 7.94 (d, J = 8.9 Hz, 1 H), 6.59 (dd, J = 8.8, 2.3 Hz, 1H), 
6.47 (d, J = 2.3 Hz, 1 H), 4.03 (s, 2 H; CH2CN), 3.95 (s, 3 H; OCH3), 3.88 (s, 3 H; OCH3) 
ppm. 
13
C NMR (101 MHz, CDCl3):  = 185.9 (C=O), 166.0, 161.2, 133.6 (CH), 117.7, 114.9 (CN), 
106.2 (CH), 98.2 (CH), 55.7 (2 OCH 3), 33.9 (CH2CN) ppm.  
The 
1
H NMR spectral data are in accordance with the literature data.
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(E)-2-Cyano-1-(2,4-dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one (-CN-
TMC, 69).
13
 The 2-cyanoacetophenone 64 (100 mg, 0.478 
mmol, 1.0 eq.) and 3,4-dimethoxybenzaldehyde (29) (81.0 mg, 
0.478 mmol, 1.0 eq.) were warmed in EtOH (50 mL) using the 
heating gun until they dissolved. The solution was then cooled 
to room temperature and piperidine (100 μL, 1.01 mmol, 2.1 eq.) was added. After 24 h of 
stirring at this temperature, EtOH was removed under vacuum and the residue partitioned 
between CH2Cl2 and H2O. The CH2Cl2 fraction was dried over MgSO4 and evaporated. The 
product was purified on preparative TLC plates (petroleum ether/EtOAc, 7:3) to afford -CN-
TMC (69) (126 mg, 0.357 mmol, 73%) as a yellow solid that was recrystallized from a 
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EtOAc/petroleum ether mixture affording yellow crystals of the pure E isomer (100 mg, 0.283 
mmol, 58%); m.p. 139 °C.  
1
H NMR (300 MHz, CDCl3):  = 7.99 (s, 1 H; β-H), 7.82 (d, J = 2.1 Hz, 1 H), 7.55-7.47 (m, 
2 H), 6.95 (d, J = 8.5 Hz, 1 H), 6.58 (dd, J = 8.5, 2.2 Hz, 1 H), 6.51 (d, J = 2.2 Hz, 1 H), 3.97 
(s, 3 H; OCH3), 3.96 (s, 3 H; OCH3), 3.88 (s, 3 H; OCH3), 3.88 (s, 3 H; OCH3) ppm. 
13
C NMR (75 MHz, CDCl3):  = 188.1 (C=O), 164.5, 159.8, 153.3, 152.6 (β-CH), 149.2, 
132.2 (CH), 127.6 (CH), 125.3, 120.2, 118.1, 111.9 (CH), 110.9 (CH), 109.6, 105.5 (CH), 
98.5 (CH), 56.1 (OCH3), 56.0 (OCH3), 55.7 (OCH3), 55.6 (OCH3) ppm. 
IR (neat): 2932, 2839, 2205, 1658, 1596, 1255, 1213, 1114, 1020, 834 cm
-1
. 
MS (EI): m/z (%): 353 [M
•+
] (31), 165 (100). 
HRMS (EI): calcd for C20H19NO5: 353.1263 [M
•+
]; found 353.1258. 
6.2.3. Synthesis of (E)-1-(2,4-dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)-2-nitroprop-2-
en-1-one (-NO2-TMC, 71) 
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1-(2,4-Dimethoxyphenyl)-2-nitroethanone (66).
75
 2,4-Dimethoxybenzaldehyde (84) (300 
mg, 1.81 mmol, 1.0 eq.) was added to a solution of CH3NO2 (1.40 mL, 
25.3 mmol, 14 eq.) in abs. EtOH (8 mL). NaOAc (2.08 g, 25.3 mmol, 14 
eq.) was added to the reaction mixture and stirred at room temperature for 
24 h. After that, EtOH and excess CH3NO2 were evaporated using a N2 
stream. H2O (20 mL) was added to the residue and the mixture was extracted with EtOAc     
(3 × 10 mL), the organic extract dried over MgSO4 and the solvent evaporated under reduced 
pressure to afford 335 mg (1.47 mmol) of the corresponding nitroalcohol,
113
 that was directly 
used in the next step. It was dissolved in dry CH2Cl2 (10 mL) and cooled to 0 °C, then 
pyridinium chlorochromate (PCC) (759 mg, 3.52 mmol, 2.4 eq.) was added and the reaction 
was allowed to warm up to room temperature overnight. The solvent mixture was filtered and 
the solvent evaporated under reduced pressure. The product was purified on preparative TLC 
plates (petroleum ether/EtOAc, 1:1) to afford 2-nitroacetophenone 66 (224 mg, 0.995 mmol, 
55% over 2 steps) as a beige solid; m.p. 130 ºC. 
1
H NMR (400 MHz, CDCl3):  = 8.02 (d, J = 8.9 Hz, 1 H), 6.61 (dd, J = 8.9, 2.2 Hz, 1 H), 
6.46 (d, J = 2.2 Hz, 1 H), 5.73 (s, 2 H; CH2NO2), 3.92 (s, 3 H; OCH3), 3.89 (s, 3 H; OCH3) 
ppm. 
13
C NMR (101 MHz, CDCl3):  = 184.1 (C=O), 166.5, 161.5, 133.7 (CH), 116.8, 106.6 (CH), 
98.1 (CH), 85.2 (CH2NO2), 55.8 (OCH3), 55.7 (OCH3) ppm. 
IR (neat): 3031, 2940, 1651, 1595, 1553, 1453, 1392, 1253, 1212, 1021, 828 cm
-1
. 
MS (EI): m/z (%): 225 [M
•+
] (32), 165 (100). 
HRMS (EI): calcd. for C10H11NO5: 225.0637 [M
•+
]; found 225.0635. 
(E)-1-(2,4-Dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)-2-nitroprop-2-en-1-one (-NO2-
TMC, 71).
59
 A mixture of 2-nitroacetophenone 66 (589 mg, 2.62 
mmol, 1.0 eq.), 3,4-dimethoxybenzaldehyde (29) (696 mg, 4.19 
mmol, 1.6 eq.), β-alanine (19.6 mg, 0.220 mmol, 0.084 eq.) and 
glacial AcOH (420 μL, 7.34 mmol, 2.8 eq.) in benzene (15 mL) 
was heated to reflux overnight by using a Dean Stark apparatus. 
The reaction mixture was washed with H2O (3 × 10 mL) then the 
aqueous layer was extracted with CH2Cl2 (3 × 10 mL), the organic extracts were combined 
and dried over MgSO4. The solvent was evaporated in vacuo and the resulting residue was 
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subjected to column chromatography (SiO2, petroleum ether/EtOAc, 7:3) to afford -NO2-
TMC (71) (820 mg, 2.20 mmol, 84%) as a yellow solid; m.p. 44 °C. The stereochemistry of 
chalcone 71 was assigned as the E isomer based on literature.
79 
1
H NMR (400 MHz, CDCl3):  = 8.15 (d, J = 8.9 Hz, 1 H), 7.94 (s, 1 H; β-H), 7.08 (dd, J = 
8.5, 2.0 Hz, 1 H), 6.91 (d, J = 2.1 Hz, 1 H), 6.81 (d, J = 8.4 Hz, 1 H), 6.63 (dd, J= 8.9, 2.3 Hz, 
1 H), 6.41 (d, J =2.3 Hz, 1 H), 3.88 (s, 6 H; 2 OCH3), 3.76 (s, 3 H; OCH3), 3.68 (s, 3 H; 
OCH3) ppm. 
13
C NMR (101 MHz, CDCl3):  = 184.3 (C=O), 166.6, 162.2, 152.1, 149.0, 147.5, 133.5 
(CH), 133.2 (β-CH), 126.3 (CH), 122.6, 118.6, 112.3 (CH), 111.1 (CH), 106.8 (CH), 98.3 
(CH), 56.0 (OCH3), 55.9 (OCH3), 55.7 (OCH3), 55.6 (OCH3) ppm.  
IR (neat): 2939, 2839, 1660, 1590, 1508, 1313, 1249, 1018 cm
-1
. 
MS (ESI
+
): m/z (%): 374 [M+H]
+
 (100). 
HRMS (ES-MS): calcd for C19H20NO7: 374.1234 [M+H]
+
; found 374.1235. 
6.2.4. Synthesis of (E)-2-ethoxycarbonyl-1-(2,4-dimethoxyphenyl)-3-(3,4-dimethoxy-
phenyl)propen-1-one (-COOEt-TMC, 72) 
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Ethyl 3-(2,4-dimethoxyphenyl)-3-oxopropanoate (67).
76
 NaH (1.24 g (60% in paraffin oil), 
31.0 mmol, 2.8 eq.) was added to a solution of diethyl carbonate 
(2.60 g, 22.0 mmol, 2.0 eq.) in toluene (11.0 mL). The mixture was 
heated to reflux then a solution of 1-(2,4-dimethoxyphenyl)ethanone 
(56) (2.00 g, 11.0 mmol, 1.0 eq.) in toluene (5.5 mL) was added 
dropwise over about 1.5 h. After the addition, the reflux was continued until the evolution of 
hydrogen ceased (30 min). Subsequently, the reaction was cooled to room temperature and 
glacial AcOH (3.3 mL) was added dropwise leading to a precipitate that was dissolved upon 
addition of cold H2O (30 mL). The toluene layer was separated, and the aqueous layer was 
extracted with EtOAc (3 × 35 mL). The combined organic solution was washed with H2O (35 
mL) and brine (35 mL), and finally dried over MgSO4. After evaporation of the solvent in 
vacuo, the mixture was subjected to column chromatography (SiO2 , petroleum ether/EtOAc, 
5:1) to give the desired -keto ester 67 (2.32 g, 9.20 mmol, 84%) as a pale yellow oil. 
1
H NMR (300 MHz, CDCl3):  = 7.93 (d, J = 8.8 Hz, 1 H), 6.54 (dd, J = 8.8, 2.3 Hz, 1 H), 
6.43 (d, J = 2.3 Hz, 1 H), 4.17 (q, J = 7.1 Hz, 2 H; CH2), 3.91 (s, 2 H; CH2), 3.86 (s, 3 H; 
OCH3), 3.85 (s, 3 H; OCH3), 1.23 (t, J = 7.1 Hz, 3 H; CH3) ppm. 
13
C NMR (75 MHz, CDCl3):  = 191.2 (C=O), 168.5, 165.2, 161.1, 133.2 (CH), 119.5, 105.6 
(CH), 98.0 (CH), 60.8 (CH2), 55.5 (OCH3), 55.2 (OCH3), 50.6 (CH2), 14.1 (CH3) ppm.  
The 
1
H NMR spectral data are in accordance with the literature data.
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(E)-2-Ethoxycarbonyl-1-(2,4-dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)propen-1-one 
(-COOEt-TMC, 72).53 A solution of 3,4-dimethoxybenzaldehyde 
(29) (60.0 mg, 0.361 mmol, 1.0 eq.), β-keto ester 67 (100 mg, 
0.396 mmol, 1.1 eq.), piperidine (3.60 μL, 0.0361 mmol, 0.1 eq.) 
and glacial AcOH (10.4 μL, 0.180 mmol, 0.5 eq.) in dry benzene (2 
mL) was heated to reflux over 4 Å molecular sieves until no more 
change was observed by TLC (2 days). The reaction mixture was 
cooled to room temperature and diluted with EtOAc (35 mL). This mixture was washed with 
1 M aq. HCl (2 × 10 mL), 1 M aq. NaOH (2 × 10 mL) and brine (2 × 10 mL). The organic 
layer was dried with MgSO4, filtered, and the solvent was evaporated in vacuo. The product 
was purified on preparative TLC plates (SiO2, petroleum ether/EtOAc, 7:3) to afford -
COOEt-TMC (72) (103 mg, 0.257 mmol, 71%) as a pale yellow oil. The stereochemistry of 
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chalcone 72 was assigned as the E isomer based on the 
3
J(C,H) coupling constants of Cketone,H 
and Cester,H.
56
 
3
J(C,H) = 10.1 Hz for Cketone,H; 
3
J(C,H) = 8.1 Hz for Cester,H.  
1
H NMR (300 MHz, CDCl3):  = 8.05 (d, J = 8.8 Hz, 1 H), 7.54 (s, 1 H; β-H), 6.97 (dd, J = 
8.4, 2.0 Hz, 1 H), 6.88 (d, J = 2.1 Hz, 1 H), 6.74 (d, J = 8.4 Hz, 1 H), 6.55 (dd, J = 8.8, 2.3 
Hz, 1 H), 6.40 (d, J = 2.3 Hz, 1 H), 4.21 (q, J = 7.1 Hz, 2 H; CH2), 3.85 (s, 3 H; OCH3), 3.83 
(s, 3 H; OCH3), 3.77 (s, 3 H; OCH3), 3.65 (s, 3 H; OCH3), 1.17 (t, J = 7.1 Hz, 3 H; CH3) ppm. 
13
C NMR (75 MHz, CDCl3):  = 192.3 (Cketone=O), 165.6 (Cester=O), 165.6, 162.0, 150.3, 
148.6, 137.9 (β-CH), 133.6, 133.4 (CH), 126.4, 124.4 (CH), 120.1, 112.0 (CH), 110.8 (CH), 
105.8 (CH), 98.5 (CH), 60.8 (CH2), 55.8 (OCH3), 55.6 (OCH3), 55.6 (OCH3), 55.5 (OCH3), 
14.2 (CH3) ppm. 
IR (neat): 2938, 2839, 1711, 1645, 1592, 1513, 1461, 1247, 1220, 1142, 1083, 1019 cm
-1
. 
MS (EI): m/z (%): 400 [M
•+
] (54), 354 (21), 299 (40), 165 (100).  
HRMS (EI): calcd for C22H24O7: 400.1522 [M
•+
]; found 400.1524. 
6.2.5. Synthesis of (E)-2-(2,4-dimethoxybenzoyl)-3-(3,4-dimethoxyphenyl)propenoic acid 
(-COOH-TMC, 76)55 
 
After dissolving the -ester chalcone 72 (167 mg, 0.417 mmol, 1.0 eq.) in EtOH (3 mL), a 
20% aqueous solution of NaOH (1.25 mL, 6.25 mmol, 15.0 eq.) was added and the mixture 
was stirred at room temperature for 24 h. Subsequently, brine (10 mL) was added to the 
reaction mixture and the solution was extracted with EtOAc (3 × 20 mL). The aqueous layer 
was acidified with 1 M aq. HCl to pH 1 and the mixture was extracted again with EtOAc (3 × 
20 mL). The organic layers were combined, dried over MgSO4, filtered, and the solvent was 
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evaporated in vacuo. The product was purified on preparative TLC plates (SiO2, 
CH2Cl2/EtOH/HCO2H, 50:1:0.5) to afford -acid chalcone 76 (116 mg, 0.312 mmol, 75%) as 
a yellow solid, which was recrystallized from EtOAc/petroleum ether; m.p. 133 °C; the same 
double bond configuration as for -COOEt-TMC (72) is assumed which is E. 
1
H NMR (400 MHz, CDCl3):  = 8.05 (d, J = 8.8 Hz, 1 H), 7.65 (s, 1 H; β-H), 6.99 (dd, J = 
8.4, 1.9 Hz, 1 H), 6.89 (d, J = 1.9 Hz, 1 H), 6.75 (d, J = 8.4 Hz, 1 H), 6.55 (dd, J = 8.9, 2.2 
Hz, 1 H), 6.40 (d, J = 2.2 Hz, 1 H), 3.85 (s, 3 H; OCH3), 3.84 (s, 3 H; OCH3), 3.78 (s, 3 H; 
OCH3), 3.66 (s, 3 H; OCH3) ppm. 
13
C NMR (101 MHz, CDCl3):  = 192.0 (Cketone=O), 170.3 (Cacid=O), 165.8, 162.2, 150.8, 
148.7, 140.5 (β-CH), 133.5 (CH), 132.3, 126.2, 124.9 (CH), 119.9, 112.3 (CH), 110.8 (CH), 
106.1 (CH), 98.6 (CH), 55.9 (OCH3), 55.7 (OCH3), 55.6 (2 OCH3) ppm. 
IR (neat): 2959, 2835, 1671, 1638, 1592, 1518, 1253, 1146, 1020 cm
-1
. 
MS (ESIˉ): m/z (%): 417.0 [M+HCOO]ˉ (47), 743.2 [2M-H]ˉ (100). 
HRMS (ES-MS): calcd for C20H19O7: 371.1136 [M-H]ˉ; found 371.1147. 
6.2.6. General procedure for the synthesis of -halogen-chalcones (-Br/Cl/I-TMCs,   
73-75)  
 
The known procedure to prepare an -bromochalcone49 could be also applied to synthesize 
the -chloro and -iodo compounds. Et4NX (X = Cl, Br, I) (1.2 or 2.0 eq.) was added in one 
portion to a stirred suspension of Dess-Martin periodinane (DMP, 19) (1.2 or 2.0 eq.) in dry 
CH2Cl2, so that the color of the solution turned to orange-yellow. After 10 min of stirring at 
room temperature, chalcone 60 (1.0 eq.) was added and the reaction mixture stirred at the 
same temperature. The formed precipitate was filtered off and washed with CH2Cl2. The 
filtrate was washed with a saturated aqueous solution of NaHSO3 or Na2S2O5, followed by a 
EXPERIMENTAL PART 
108 
saturated aqueous solution of NaHCO3, then H2O. The organic layer was dried over MgSO4 
and then concentrated in vacuo. The products were purified on preparative TLC plates.
(Z)-2-Bromo-1-(2,4-dimethoxyphenyl)-3-(3,4-dimethoxy-phenyl)prop-2-en-1-one (-Br-
TMC, 73). The -bromochalcone 73 was prepared according to 
the general procedure (5.2.2) starting from Et4NBr (230 mg, 
1.10 mmol, 1.2 eq.) and DMP (19) (465 mg, 1.10 mmol, 1.2 eq.) 
in dry CH2Cl2 (2 mL). -H-TMC (60) (300 mg, 0.914 mmol, 
1.0 eq.) was added and the reaction mixture stirred for 24 h.
49
 
The product was purified first on preparative TLC plates (SiO2, petroleum ether/EtOAc, 7:3) 
and then recrystallized from EtOAc/petroleum ether to afford yellow crystals of -Br-TMC 
(73) (216 mg, 0.530 mmol, 58%) as the pure Z isomer; m.p. 125 °C. 
1
H NMR (400 MHz, CDCl3):  = 7.67 (d, J = 2.0 Hz, 1 H), 7.65 (s, 1 H; β-H), 7.39-7.33 (m, 
2 H), 6.88 (d, J = 8.5 Hz, 1 H), 6.55 (dd, J = 8.4, 2.3 Hz, 1 H), 6.50 (d, J = 2.2 Hz, 1 H), 3.92 
(s, 6 H; 2 OCH3), 3.87 (s, 3 H; OCH3), 3.79 (s, 3 H; OCH3) ppm. 
13
C NMR (101 MHz, CDCl3):  = 190.4 (C=O), 163.2, 159.0, 151.0, 148.5, 142.3 (β-CH), 
131.4 (CH), 126.7, 125.4 (CH), 122.6, 120.5, 112.7 (CH), 110.6 (CH), 104.7 (CH), 98.9 
(CH), 56.0 (OCH3), 55.9 (OCH3), 55.8 (OCH3), 55.5 (OCH3) ppm. 
IR (neat): 1637, 1602, 1589, 1511, 1259, 1247, 1212, 1145, 1018, 819 cm
-1
. 
MS (EI): m/z (%): 406 [M
•+
] (14), 327 (49), 165 (100).  
HRMS (EI): calcd for C19H19BrO5: 406.0416 [M
•+
]; found 406.0423. 
(Z)-2-Chloro-1-(2,4-dimethoxyphenyl)-3-(3,4-dimethoxy-phenyl)prop-2-en-1-one (-Cl-
TMC, 74). The -chlorochalcone 74 was prepared according to 
the general procedure starting (5.2.2) from Et4NCl (510 mg, 
3.05 mmol, 2.0 eq.) and DMP (1.29 g, 3.05 mmol, 2.0 eq.) in 
dry CH2Cl2 (3.5 mL). -H-TMC (60) (500 mg, 1.53 mmol, 1.0 
eq.) was added and the reaction mixture was stirred, until no 
more change was observed by TLC (5 days). The product was purified first on preparative 
TLC plates (SiO2, petroleum ether/EtOAc, 7:3) and then recrystallized from EtOAc/petroleum 
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ether to afford yellow crystals of -Cl-TMC (74) (108 mg, 0.298 mol, 20%) as the pure Z 
isomer; m.p. 119 °C. 
1
H NMR (400 MHz, CDCl3):  = 7.58 (d, J =2.0 Hz, 1 H), 7.40 (s, 1 H; β-H), 7.39-7.33 (m, 
2 H), 6.89 (d, J = 8.5 Hz, 1 H), 6.56 (dd, J = 8.4, 2.2 Hz, 1 H), 6.51 (d, J = 2.2 Hz, 1 H), 3.93 
(s, H, OCH3), 3.92 (s, 3 H; OCH3), 3.88 (s, 3 H; OCH3), 3.80 (s, 3 H; OCH3) ppm. 
13
C NMR (101 MHz, CDCl3):  = 190.4 (C=O), 163.3, 159.1, 151.0, 148.7, 138.9 (β-CH), 
131.3 (CH), 130.1, 126.2 (CH), 125.6, 120.7, 113.1 (CH), 110.8 (CH), 104.7 (CH), 98.9 
(CH), 56.0 (OCH3), 56.0 (OCH3), 55.8 (OCH3), 55.6 (OCH3) ppm. 
IR (neat): 1639, 1600, 1592, 1513, 1260, 1248, 1146, 1020, 821 cm
-1
.  
MS (ESI
+
): m/z (%): 363 [M+H]
+
 (100).  
HRMS (ES-MS): calcd for C19H20ClO5: 363.0994 [M+H]
+
; found 363.0997. 
(Z/E)-1-(2,4-Dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)-2-iodoprop-2-en-1-one (-I-
TMC, 75). The -iodochalcone 75 was prepared according to 
the general procedure (5.2.2) starting from Et4NI (784 mg, 3.05 
mmol, 2.0 eq.) and DMP (1.29 g, 3.05 mmol, 2.0 eq.) in dry 
CH2Cl2 (3.5 mL). -H-TMC (60) (500 mg, 1.53 mmol, 1.0 eq.) 
was added and the reaction mixture was stirred until no more 
change was observed by TLC (5 days). The product was purified on preparative TLC plates to 
afford the yellow solid -I-TMC (75) (200 mg, 0.440 mmol, 29%) as a Z/E mixture of 93:7; 
m.p. 97 °C. 
Z-75: 
1
H NMR (400 MHz, CDCl3):  = 7.67 (d, J = 1.9 Hz, 1 H), 7.64 (s, 1 H; β-H), 7.33 (d, 
J = 8.4 Hz, 1 H), 7.29 (dd, J = 8.5, 1.9 Hz, 1 H), 6.87 (d, J = 8.4 Hz, 1 H), 6.52 (dd, J = 8.4, 
2.2 Hz, 1 H), 6.48 (d, J = 2.2 Hz, 1 H), 3.91 (s, 3 H; OCH3), 3.90 (s, 3 H; OCH3), 3.84 (s, 3 H; 
OCH3), 3.77 (s, 3 H; OCH3) ppm. 
13
C NMR (101 MHz, CDCl3):  = 191.8 (C=O), 163.3, 159.0, 150.9, 148.6 (β-CH), 148.3, 
131.6 (CH), 127.7, 124.9 (CH), 119.6, 112.0 (CH), 110.5 (CH), 104.7 (CH), 104.2, 98.9 
(CH), 56.0 (OCH3), 55.9 (OCH3), 55.8 (OCH3), 55.5 (OCH3) ppm.  
IR (neat): 1631, 1598, 1510, 1259, 1231, 1212, 1144, 1017, 817 cm
-1
. 
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MS (ESI
+
): m/z (%): 455 [M+H]
+
 (100). 
HRMS (ES-MS): calcd for C19H20IO5: 455.0350 [M+H]
+
; found 455.0347. 
6.2.7. Synthesis of (E)-1-(2,4-dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)-2-(trifluoro-
methyl)prop-2-en-1-one (-CF3-TMC, 77)
83
  
 
A mixture of α-Br-TMC (73) (200 mg, 0.491 mmol, 1.0 eq.), CuI (112 mg, 0.589 mmol, 1.2 
eq.) and methyl fluorosulfonyldifluoroacetate (MFSDA) (456 μL, 3.58 mmol, 7.3 eq.) in dry 
DMF (20 mL) was stirred at 75 °C under a N2 atmosphere for 3 days. Upon completion of the 
reaction, the mixture was diluted with Et2O (40 mL) and filtered. The solution was poured 
into H2O (40 mL) and the mixture extracted with Et2O (4 × 40 mL). The combined extracts 
were washed with H2O (3 × 5 mL), dried over MgSO4, filtered, and concentrated in vacuo. 
The product was purified on preparative TLC plates (SiO2, CHCl3/MeOH, 99:1) to afford     
-CF3-TMC (77) (120 mg, 0.303 mmol, 62 %) as a pale yellow oil. The stereochemistry of 
chalcone 77 was assigned as the E isomer based on its 
19
F NMR shift.
84
  
1
H NMR (400 MHz, CDCl3):  = 7.82 (d, J = 8.8 Hz, 1 H), 7.11 (d, J = 1.4 Hz, 1 H; β-H), 
6.86 (dd, J = 8.3, 2.0 Hz, 1 H), 6.78 (d, J = 2.0 Hz, 1 H), 6.70 (d, J = 8.4 Hz, 1 H), 6.44 (dd,   
J = 8.8, 2.3 Hz, 1 H), 6.34 (d, J = 2.3 Hz, 1 H), 3.80 (s, 6 H; 2 OCH3), 3.77 (s, 3 H; OCH3), 
3.64 (s, 3 H; OCH3) ppm.  
13
C NMR (101 MHz, CDCl3):  = 189.7 (C=O), 165.7, 162.0, 150.1, 148.5, 134.2 (CH), 
133.8 (q, J = 5.9 Hz, β-CH), 130.2 (q, J = 29.3 Hz, α-C), 125.4, 123.4 (CH), 122.8 (q, J = 
274.0 Hz, CF3), 119.6, 111.7 (CH), 110.7 (CH), 105.5 (CH), 98.5 (CH), 55.7 (OCH3), 55.5 
(OCH3), 55.49 (OCH3), 55.48 (OCH3) ppm.  
19
F NMR (376 MHz, CDCl3):  = -62.1 (d, J = 1.1 Hz) ppm.  
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IR (neat): 3005, 2939, 2842, 1642, 1593, 1515, 1252, 1111, 1021 cm
-1
.  
MS (ESI
+
): m/z (%): 397 [M+H]
+
 (100).  
HRMS (ES-MS): calcd for C20H20F3O5: 397.1257 [M+H]
+
; found 397.1265. 
6.2.8. General procedure for synthesis of -Ar-TMCs 78-8048 
 
A mixture of -Br-TMC (73) (150 mg, 0.368 mmol, 1.0 eq.), the corresponding boronic acid 
(0.442 mmol, 1.2 eq.), [Pd2(dba)3]·CHCl3 (8.0 mg, 0.0080 mmol, 0.022 eq.), and PPh3 (4.0 
mg, 0.015 mmol, 0.042 eq.) was dissolved in toluene (2.2 mL) and n-PrOH (0.75 mL) and 
degassed. After stirring for 10 min, HNEt2 (50 μL, 0.478 mmol, 1.3 eq.) and H2O (0.60 mL) 
were added, the mixture was degassed again and then stirred under reflux for 24 h. After 
cooling to room temperature, it was poured into EtOAc (50 mL). The organic layer was 
washed with 0.2 M aq. NaOH (25 mL), 0.05 M aq. HCl (25 mL), and H2O (2 × 25 mL), dried 
over MgSO4, and filtered. The solvent was removed in vacuo and the product was purified on 
preparative TLC plates (SiO2, EtOAc/petroleum ether 3:7) to afford E-α-aryl-chalcones. The 
pure isomers from preparative TLC isomerized upon handling and analysis in solution to E/Z 
mixtures. The configuration of the double bond was assigned based on literature data to be the 
same as for starting chalcone 73.
48
 
(E)-1-(2,4-Dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)-2-(4-nitrophenyl)prop-2-en-1-one 
(-p-NO2-C6H4-TMC, 78). Yellow solid (65%, E isomer); 
m.p. 59 °C; the E/Z ratio observed later for the isomerized 
product in CDCl3 is 4:1.  
E-78: 
1
H NMR (300 MHz, CDCl3):  = 8.24-8.18 (m, 2 H), 
7.48-7.43 (m, 3 H), 7.32 (s, 1 H; β-H), 6.73-6.64 (m, 2 H), 6.56 
(dd, J = 8.5, 2.2 Hz, 1 H), 6.44 (dd, J = 5.5, 1.9 Hz, 2 H), 3.86 
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(s, 3 H; OCH3), 3.84 (s, 3 H; OCH3), 3.74 (s, 3 H; OCH3), 3.49 (s, 3 H; OCH3) ppm.  
E-78: 
13
C NMR (75 MHz, CDCl3):  = 195.7 (C=O), 163.3, 158.9, 150.4, 148.5, 147.1, 
144.6, 142.1 (β-CH), 138.5, 131.5 (CH), 131.4 (2 CH), 126.9, 124.8 (CH), 123.5 (2 CH), 
121.8, 112.7 (CH), 110.7 (CH), 104.8 (CH), 98.6 (CH), 55.8 (OCH3), 55.6 (OCH3), 55.5 
(OCH3), 55.3 (OCH3) ppm. 
IR (neat): 2936, 2837, 1640, 1593, 1511, 1459, 1341, 1259, 1208, 1022 cm
-1
.  
MS (EI): m/z (%): 449 [M
•+
] (47), 311 (24), 165 (91). 
HRMS (EI): calcd for C25H23NO7: 449.1475 [M
•+
]; found 449.1482. 
(E)-1-(2,4-Dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)-2-phenylprop-2-en-1-one (-Ph-
TMC, 79). Yellow solid (65%, E); m.p. 50 °C; the E/Z ratio 
observed later for the isomerized product in CDCl3 is 3:2. 
E-79: 
1
H NMR (400 MHz, CDCl3):  = 7.42 (d, J = 8.4 Hz,      
1 H), 7.39-7.35 (m, 2 H), 7.31-7.27 (m, 3 H), 7.23 (s, 1 H; β-H), 
6.76-6.68 (m, 2 H), 6.53 (dd, J = 8.4, 2.2 Hz, 1 H), 6.44 (dd, J = 
9.6, 2.1 Hz, 2 H), 3.83 (s, 3 H; OCH3), 3.82 (s, 3 H; OCH3), 3.74 (s, 3 H; OCH3), 3.39 (s, 3 H; 
OCH3) ppm. 
E-79: 
13
C NMR (101 MHz, CDCl3):  = 196.8 (C=O), 162.7, 158.8, 149.8, 148.1, 140.8     
(β-CH), 140.5, 137.0, 131.2 (CH), 130.1 (2 CH), 128.5 (2 CH), 127.8, 127.4 (CH), 125.2 
(CH), 122.6, 112.3 (CH), 110.3 (CH), 104.4 (CH), 98.6 (CH), 55.7 (OCH3), 55.6 (OCH3), 
55.4 (OCH3), 55.0 (OCH3) ppm. 
IR (neat): 2934, 2837, 1642, 1593, 1512, 1261, 1245, 1207, 1141, 1020 cm
-1
. 
MS (ESI
+
): m/z (%): 405 [M+H]
+
 (100).  
HRMS (ES-MS): calcd for C25H25O5: 405.1697 [M+H]
+
; found 405.1701. 
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(E)-1-(2,4-Dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)-2-(4-methoxyphenyl)prop-2-en-1-
one (-p-OMe-C6H4-TMC, 80). Yellow solid (75%, E); m.p. 
45 °C; the E/Z ratio observed later for the isomerized product in 
CDCl3 is 8:1. 
E-80: 
1
H NMR (300 MHz, CDCl3):  = 7.41 (d, J = 8.4 Hz,      
1 H), 7.21-7.16 (m, 3 H), 6.93-6.88 (m, 2 H), 6.77-6.68 (m,       
2 H), 6.54-6.50 (m, 2 H), 6.42 (d, J = 2.2 Hz, 1 H), 3.84 (s, 3 H; 
OCH3), 3.83 (s, 3 H; OCH3), 3.80 (s, 3 H; OCH3), 3.74 (s, 3 H; OCH3), 3.47 (s, 3 H; OCH3) 
ppm. 
E-80: 
13
C NMR (75 MHz, CDCl3):  = 197.3 (C=O), 162.7, 159.0, 158.9, 149.7, 148.1, 140.5 
(β-CH), 140.3, 131.3 (2 (CH)), 131.2 (CH), 129.1, 128.1, 125.0 (CH), 122.8, 114.0 (2 CH), 
112.5 (CH), 110.4 (CH), 104.4 (CH), 98.6 (CH), 55.7 (OCH3), 55.6 (OCH3), 55.4 (OCH3), 
55.2 (OCH3), 55.2 (OCH3) ppm.  
IR (neat): 2939, 2835, 1638, 1595, 1575, 1508, 1460, 1241, 1207, 1127, 1020 cm
-1
.  
MS (ESI
+
): m/z (%): 435 [M+H]
+
 (100). 
HRMS (ES-MS): calcd for C26H27O6: 435.1802 [M+H]
+
; found 435.1800. 
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6.2.9. Synthesis of (Z)-3-(3,4-dimethoxyphenyl)-2-fluoro-1-(2-hydroxy-4-methoxy-
phenyl)prop-2-en-1-one (-F-HC, 94) 
 
2-Bromo-1-(2-isopropoxy-4-methoxyphenyl)ethanone (101) was prepared by Martin Wild 
in our group by the same procedure used for preparation of 2-bromo-1-(2,4-
dimethoxyphenyl)ethanone (81).  
2-Fluoro-1-(2-isopropoxy-4-methoxyphenyl)ethanone (102).
13
 To freshly dried KF (1.79 g, 
30.9 mmol, 17.8 eq.), 2-bromoacetophenone 101 (500 mg, 1.74 mmol, 1.0 
eq.) and 18-crown-6 (92.0 mg, 0.348 mmol, 0.2 eq.) in dry MeCN (10 mL) 
were added under N2 atmosphere. The mixture was refluxed for 4 days. The 
solvent was then removed in vacuo and the residue partitioned between 
CH2Cl2 and H2O. The organic fraction was dried and evaporated. The residue 
was subjected to chromatography on preparative TLC plates (SiO2, petroleum ether/EtOAc, 
7:3) yielded 2-fluoroacetophenone 102 as a white solid (195 mg, 0.862 mmol, 49%); m.p.    
72 °C.  
1
H NMR (400 MHz, CDCl3):   8.05 (d, J = 8.9 Hz, 1 H), 6.56 (dd, J = 8.9, 2.3 Hz, 1 H), 
6.42 (d, J = 2.2 Hz, 1 H), 5.40 (d, J = 48.2 Hz, 2 H; CH2F), 4.69 (sept, J = 6.1 Hz, 1 H; 
CH(CH3)2), 3.86 (s, 3 H; OCH3), 1.43 (d, J = 6.1 Hz, 6 H; 2 CH3) ppm. 
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13
C NMR (75 MHz, CDCl3): δ = 192.2 (d, J = 14.1 Hz, CH2F-C=O), 165.4, 159.7, 133.1 (d,  
J = 2.5 Hz, FCH2-C(O)-C), 117.9, 105.8 (CH), 99.3 (CH), 86.2 (d, J = 177.8 Hz, CH2F), 71.0 
(CH(CH3)2) , 55.6 (OCH3), 22.0 (2 CH3) ppm. 
19
F-NMR (376 MHz, CDCl3):  -222.9 (t, J = 49 Hz, 1 F) ppm. 
IR (neat): 1662, 1603, 1286, 1259, 1209, 1073, 990, 832 cm
-1
. 
MS (EI): m/z (%): 226 [M
•+
] (7), 193 [M-
•
CH2F] (7), 151 (100). 
HRMS (EI): calcd. for C12H15FO3: 226.1205 [M
•+
]; found 226.1007.  
(Z)-3-(3,4-Dimethoxyphenyl)-2-fluoro-1-(2-isopropoxy-4-methoxyphenyl)prop-2-en-1-
one (-F-pHC, 104). The -fluorochalcone 104 was prepared 
according to the general procedure (5.2.1) starting from           
2-fluoroacetophenone 102 (195 mg, 0.862 mmol, 1.0 eq.) and 
3,4-dimethoxybenzaldehyde (29) (143 mg, 0.862 mmol, 1.0 
eq.) which were dissolved in dry MeOH under N2 atmosphere. 
The suspension was stirred at 60 °C for 24 h. Purification on preparative TLC plates (SiO2, 
petroleum ether/EtOAc, 7:3) afforded the yellow solid -F-pHC (104) (225 mg, 0.601 mmol, 
70%) which was recrystallized from EtOAc/petroleum ether; m.p. 95 °C. 
1
H NMR (400 MHz, CDCl3):  7.42 (d, J = 8.5 Hz, 1 H), 7.29 (bs, 1 H), 7.20 (dd, J = 8.4, 
1.9 Hz, 1 H), 6.88 (d, J = 8.4 Hz, 1 H), 6.63 (d, J = 35.8 Hz, 1 H; -H), 6.54 (dd, J = 8.5, 2.2 
Hz, 1 H), 6.48 (d, J = 2.2 Hz, 1 H), 4.56 (sept, J = 6.1 Hz, 1 H; CH(CH3)2), 3.92 (s, 3 H; 
OCH3), 3.89 (s, 3 H; OCH3), 3.85 (s, 3 H; OCH3), 1.28 (d, J = 6.0 Hz, 6 H; 2 CH3) ppm. 
13
C NMR (101 MHz, CDCl3):  188.2 (d, J = 30.9 Hz, C=O), 163.5, 157.8, 154.4 (d, J = 
268.1 Hz, -C), 150.3 (d, J = 3.2 Hz), 148.9, 131.6 (CH), 124.8 (d, J = 4.1 Hz), 124.4 (d, J = 
7.5 Hz, CH), 121.2, 118.1 (d, J = 6.4 Hz , -CH), 112.6 (d, J = 10.1 Hz, CH), 111.0 (CH), 
104.8 (CH), 100.4 (CH), 70.8 (CH(CH3)2), 55.8 (OCH3), 55.8 (OCH3), 55.8 (OCH3), 55.4 
(OCH3) ppm. 
19
F NMR (376 MHz, CDCl3):= -123.4 (d, J = 35.8 Hz, 1 F) ppm. 
IR (neat): 2976, 2932, 2845, 1597, 1578, 1512, 1447, 1420, 1300, 1264, 1205, 1143, 1019, 
988, 828 cm
-1
. 
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MS (ESI
+
): m/z (%): 375 [M+H]
+
 (100). 
HRMS (ES-MS): calcd. for C21H24FO5: 375.1602 [M+H]
+
; found 375.1605.  
(Z)-3-(3,4-Dimethoxyphenyl)-2-fluoro-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one 
(-F-HC, 94): To a solution of -F-pHC (104) (164 mg, 0.438 
mmol, 1.0 eq.) in dry CH2Cl2 (5 mL) was added at 78 °C 
dropwise a 1 M solution of BCl3 in hexane (1.31 mL, 1.31 
mmol, 3.0 eq.). Upon addition the yellow solution turned 
immediately deep-red. After 30 min at 78 °C the solution was allowed to warm to 0 °C and 
the solution was stirred for about 3 h at this temperature then it was left overnight to stir at 
room temperature. EtOH (1 mL) and H2O (15 mL) were added to the reaction mixture and the 
resulting mixture extracted with CH2Cl2 (3 × 15 mL). The combined organic layers were 
dried over MgSO4, filtered and the solvent removed under reduced pressure. Purification was 
performed on preparative TLC plates (SiO2, petroleum ether/EtOAc, 7:3) then the product 
was recrystallized from EtOAc/petroleum ether to get -F-HC (94) as a yellow solid (120 mg, 
0.361 mmol, 82%); m.p. 112 °C.  
1
H NMR (400 MHz, CDCl3): = 12.72 (s, 1H, 2’-OH), 8.07-8.00 (m, 1 H), 7.39-7.26 (m,     
2 H), 6.93 (d, J = 37.6 Hz, 1 H; -H), 6.91 (d, J = 8.4 Hz, 1 H), 6.50-6.74 (m, 2 H),  3.93 (s,   
6 H; 2 OCH3), 3.87 (s, 3 H; OCH3) ppm. 
13
C NMR (101 MHz, CDCl3): = 187.5 (d, J = 27.0 Hz, C=O), 167.0, 166.5(d, J = 1.7 Hz), 
154.3 (d, J = 271.4 Hz, -C), 150.7 (d, J = 3.4 Hz), 149.0, 133.0 (d, J = 18.0 Hz, CH), 124.9 
(d, J = 7.6 Hz, CH), 124.5 (d, J = 3.6 Hz), 119.0 (d, J = 5.4 Hz , -CH), 112.9 (d, J = 9.9 Hz, 
CH), 112.3 (d, J = 3.8 Hz), 111.1 (CH), 108.0 (d, J = 2.8 Hz, CH), 101.1 (CH), 56.0 (OCH3), 
55.9 (OCH3), 55.6 (OCH3) ppm. 
19
F NMR (376 MHz, CDCl3): = -119.9 (d, J = 37.5 Hz, 1 F) ppm. 
IR (neat): 3376, 2952, 2845, 1625, 1569, 1513, 1355, 1253, 1142, 1022, 966, 796 cm
-1
. 
MS (ESI
+
): m/z (%): 333 [M+H]
+
 (100). 
HRMS (ES-MS): calcd. for C18H18FO5: 333.1133 [M+H]
+
; found 333.1132. 
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6.2.10 Synthesis of (E)-2-cyano-1-(3,4-dimethoxyphenyl)-1-(2-hydroxy-4-methoxy-
phenyl)prop-2-en-1-one (-CN-HC, 95) 
 
3-(2-Isopropoxy-4-methoxyphenyl)-3-oxopropanenitrile (103). KCN (567 mg, 8.71 mmol, 
5.0 eq.) in H2O (1.7 mL) was added to a solution of 2-bromoacetophenone 
101 (300 mg, 1.40 mmol, 1.0 eq.) in EtOH (1.7 mL). The resulting mixture 
was gradually heated to reflux (2.5 h). After cooling to room temperature, 
the reaction mixture was diluted with H2O (20 mL), acidified with 1 M aq. 
HCl (pH 6), extracted with CH2Cl2 (8 × 50 mL), the organic extract was 
dried over MgSO4 and the solvent evaporated under reduced pressure. The product was 
purified on preparative TLC plates (petroleum ether/EtOAc, 7:1) to afford 2-cyano-
acetophenone 103 (175 mg, 0.751 mmol, 43%) as a beige solid; m.p. 99 °C.
 
1
H NMR (300 MHz, CDCl3): δ = 7.92 (d, J = 8.9 Hz, 1 H), 6.55 (dd, J = 8.9, 2.3 Hz, 1 H), 
6.43 (d, J = 2.2 Hz, 1 H), 4.71 (sept., J = 6.1 Hz, 1 H; CH(CH3)2), 4.04 (s, 2 H; CH2CN), 3.86 
(s, 3 H; OCH3), 1.46 (d, J= 6.1 Hz, 6 H; 2 CH3) ppm. 
13
C NMR (101 MHz, CDCl3): δ = 186.2 (C=O), 165.8, 159.5, 133.8 (CH), 118.4, 115.0 (CN), 
105.7 (CH), 99.5 (CH), 71.2, 55.7 (2 OCH3), 34.1 (CH2CN), 21.9 (2 CH3) ppm.  
IR (neat): 2966, 2926, 2852, 2261, 1660, 1597, 1570, 1440, 1379, 1320,1280, 1253, 1202, 
1105, 978, 929, 840 cm
-1
. 
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MS (EI): m/z (%) = 233 (9.8) [M
•+
], 218 (6.8) [M
•+
-CH3], 251 (100). 
HRMS (EI): calcd. for C13H15NO3: 233.1052 [M
•+
]; found 233.1053.  
(E)-2-Cyano-3-(3,4-dimethoxyphenyl)-1-(2-isopropoxy-4-methoxyphenyl)prop-2-en-1-
one (-CN-pHC, 105).13 The 2-cyanoacetophenone 103 (150 
mg, 0.643 mmol, 1.0 eq.) and 3,4-dimethoxybenzaldehyde (29) 
(107 mg, 0.643 mmol, 1.0 eq.) were warmed in EtOH (66 mL) 
using the heating gun until they dissolved. The solution was 
then cooled to room temperature and piperidine (100 L, 1.01 mmol, 2.1 eq.) was added. 
After 24 h of stirring at this temperature, the EtOH was removed under vacuum and the 
residue partitioned between H2O (40 mL) and CH2Cl2 (3 × 50 mL). The CH2Cl2 fractions 
were dried over MgSO4 and evaporated. The product was purified on preparative TLC plates 
(petroleum ether/EtOAc, 7:3) to afford -CN-pHC (105) (172 mg, 0.451 mmol, 70%) as a 
yellow solid; m.p. 142 °C. 
1
H NMR (400 MHz, CDCl3): δ = 7.85 (s, 1 H, -H), 7.81 (d, J = 2.0, 1 H), 7.49-7.45 (m,       
2 H), 6.94 (d, J = 8.5 Hz, 1 H), 6.54 (dd, J = 8.6, 2.2 Hz, 1 H), 6.46 (d, J = 2.1 Hz, 1 H), 4.58 
(sept, J = 6.0 Hz, 1 H; CH(CH3)2), 3.96 (s, 3 H; OCH3), 3.95 (s, 3 H; OCH3), 3.85 (s, 3 H; 
OCH3), 1.31 (d, J = 6.0 Hz, 6 H; 2 CH3) ppm.  
13
C NMR (101 MHz, CDCl3): δ = 189.1 (C=O), 164.2, 157.9, 153.1, 152.1 (-CH), 149.2, 
132.3 (CH), 127.2 (CH), 125.3, 120.9, 118.0, 111.6 (CH), 111.0 (CH), 110.3, 105.1 (CH), 
99.9 (CH), 71.0 (CH(CH3)2),) 56.1 (OCH3), 56.0 (OCH3), 55.5 (OCH3), 21.7 (2 CH3) ppm.  
IR (neat): 2972, 2200, 1662, 1600, 1565, 1506, 1422, 1265, 1167, 1143, 1116, 1013, 981,  
822 cm
-1
. 
MS (ESI
+
) m/z (%): 382 [M+H]
+
 (100). 
HRMS (ES-MS): calcd. for C22H24NO5: 382.1649 [M+H]
+
; found 382.1648.  
(E)-2-Cyano-3-(3,4-dimethoxyphenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one 
(-CN-HC, 95): To a solution of -CN-pHC (105) (144 mg, 
0.378 mmol, 1.0 eq.) in dry CH2Cl2 (6 mL) was added at           
–78 °C dropwise a 1 M solution of BCl3 in hexane (1.11 mL, 
1.11 mmol, 3.0 eq.). Upon addition the yellow solution turned 
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immediately deep-red. After 30 min at –78 °C the solution was allowed to warm to 0 °C and 
the solution was stirred for about 3 h at this temperature then it was left overnight to stir at 
RT. Then 1.5 mL EtOH and 40 mL H2O were added to the reaction mixture and the resulting 
mixture extracted with CH2Cl2 (3 × 50 mL). The combined organic layers were dried over 
MgSO4, filtered and the solvent removed under reduced pressure. Purification by 
recrystallization from EtOAc/petroleum ether afforded -CN-HC (95) as a yellow solid (120 
mg, 0.354 mmol, 94%); m.p. 183 °C. 
1
H NMR (400 MHz, CDCl3): δ = 12.06 (s, 1 H; 2’-OH), 7.99 (dd, J = 7.8, 1.6 Hz, 1 H), 7.89 
(s, 1 H; -H), 7.85 (d, J = 2.1, 1 H), 7.48 (dd, J = 8.4, 2.1 Hz, 1 H), 6.96 (d, J = 8.5 Hz, 1 H), 
6.53-6.50 (m, 2 H), 3.98 (s, 3 H; OCH3), 3.97 (s, 3 H; OCH3), 3.87 (s, 3 H; OCH3) ppm. 
13
C NMR (101 MHz, CDCl3): δ = 190.2 (C=O), 166.7, 166.2, 154.5 (-CH), 153.6, 149.3, 
132.9 (CH), 127.8 (CH), 125.1, 117.8, 112.2, 111.5 (CH), 111.0 (CH), 107.9, 105.8, 
101.4(CH), 56.2 (OCH3), 56.1 (OCH3), 55.7 (OCH3) ppm. 
IR (neat): 2199, 1630, 1600, 1579, 1511, 1343, 1262, 1212, 1145, 1019, 842 cm
-1
. 
MS (ESI
+
): m/z (%): 340 [M+H]
+
 (100).  
HRMS (ES-MS): calcd. for C19H18NO5: 340.1179 [M+H]
+
; found 340.1179. 
6.2.11 Synthesis of (E)-3-(3,4-dimethoxyphenyl)-1-(2-hydroxy-4-methoxyphenyl)-2-
methylprop-2-en-1-one (-Me-HC, 96)  
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1-(2-Hydroxy-4-methoxyphenyl)propan-1-one (106).
71
 Anhydrous K2CO3 (912 mg, 6.60 
mmol, 1.1 eq.) was added to a stirred solution of 1-(2,4-dihydroxyphenyl)-
ethanone (83) (1.00 g, 6.00 mmol, 1.0 eq.) in dry acetone (20 mL). After a 
few minutes, CH3I (2.25 mL, 36.0 mmol, 6.0 eq.) was added to the 
suspension. The reaction mixture was refluxed for 2.5 h, cooled, filtered 
and the remaining solid washed with hot acetone (~30 mL). After evaporating the solvent in 
vacuo, H2O (35 mL) was added and the resulting mixture was extracted with EtOAc (5 × 30 
mL). The combined organic layers were dried over MgSO4 and the solvent evaporated to 
afford the pure acetophenone 106 (1.07 g, 5.94 mmol, 99%) as a white solid.  
1
H NMR (300 MHz, CDCl3): δ = 12.84 (s, 1 H; 2’-OH), 7.65 (dd, J = 7.5, 1.8 Hz, 1 H), 6.45-
6.42 (m, 2 H), 3.83 (s, 3 H; OCH3), 2.95 (q, J = 7.3 Hz, 2 H; CH2), 1.22 (t, J = 7.3 Hz, 3 H; 
CH3) ppm. 
13
C NMR (75 MHz, CDCl3): δ= 205.4 (C=O), 165.9, 165.3, 131.4 (CH), 113.3, 107.5 (CH), 
100.9 (CH), 55.6 (OCH3), 31.2 (CH2), 8.5 (CH3) ppm. 
The 
1
H NMR spectral data is in accordance with the literature.
115
 
(E)-3-(3,4-Dimethoxyphenyl)-1-(2-hydroxy-4-methoxyphenyl)-2-methylprop-2-en-1-one 
(-Me-HC, 96).53  A solution of propiophenone 106 (300 mg, 
1.66 mmol, 1.0 eq.), 3,4-dimethoxybenzaldehyde (29) (276 
mg, 1.66 mmol, 1.0 eq.), piperidine (328 L, 3.32 mmol, 2 
eq.) and glacial AcOH (161 mL, 2.82 mmol, 1.7 eq.) in dry 
benzene (8 mL) was heated to reflux using a Dean Stark apparatus for 24 h. The reaction 
mixture was cooled to room temperature and diluted with EtOAc (60 mL). This mixture was 
washed with 1 M aq. HCl (15 mL), 1 M aq. NaOH (15 mL), 1 M aq. HCl (15 mL) and then 
brine (2 x 15 mL). The organic layer was dried over MgSO4, filtered and concentrated in 
vacuo then the product was purified on preparative TLC plates (SiO2, petroleum ether/EtOAc, 
7:3) to afford -Me-HC (96) (300 mg, 914 mmol, 55%) as a yellow solid; m.p. 82 °C. 
1
H NMR (400 MHz, CDCl3): δ = 12.58 (s, 1 H; 2’-OH), 7.69 (d, J = 8.9 Hz, 1 H), 7.04 (dd,   
J = 8.3, 1.9 Hz, 1 H), 6.94-6.90 (m, 2 H), 6.84 (d, J = 1.1 Hz, 1 H; -H), 6.48 (d, J = 2.5 Hz, 1 
H), 6.42 (dd, J = 8.9, 2.5 Hz, 1 H), 3.91 (s, 3 H; OCH3), 3.89 (s, 3 H; OCH3), 3.84 (s, 3 H; 
OCH3), 2.26 (d, J = 1.4 Hz, 3 H; CH3) ppm. 
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13
C NMR (101 MHz, CDCl3): δ = 202.6 (C=O), 166.1, 165.9, 149.2, 148.7, 137.4 (-CH), 
134.4(CH), 133.9, 128.5, 122.8 (CH), 112.7, 112.6 (CH), 110.9 (CH), 106.9 (CH), 101.1 
(CH), 55.9 (OCH3), 55.9 (OCH3), 55.5 (OCH3), 15.6 (CH3) ppm. 
IR (neat): 2937, 2837, 1616, 1579, 1511, 1440, 1338, 1240, 1109, 1023 cm
-1
. 
MS (EI): m/z (%): 329 [M+H]
+
 (100). 
HRMS (EI): calcd. for C19H21O5: 329.1384 [M+H]
+
; found 329.1391.  
6.2.12. General Procedure for the synthesis of -Br/Cl/CF3/p-NO2-C6H4-HCs (20-23) 
 
To a solution of -X-TMCs 73, 74, 77 or 78 (1.0 eq.) in dry CH2Cl2 was added at 78 °C 
dropwise a 1 M hexane or CH2Cl2 solution of BCl3 (3.0 eq.). Upon addition the yellow 
solution turned immediately deep-red. After 30 min at 78 °C the solution was allowed to 
warm to 0 °C and the solution was stirred for about 1 h. Then, 1.0 mL EtOH and 40 mL H2O 
were added to the reaction mixture and the resulting mixture was extracted with CH2Cl2 
(3×20 mL). The combined organic layers were dried over MgSO4, filtered and the solvent 
removed under reduced pressure. Purification on preparative TLC plates afforded the 2’-OH 
chalcones 97-100, respectively.  
(Z)-2-Bromo-3-(3,4-dimethoxyphenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one 
(-Br-HC, 97). The -bromochalcone 97 was prepared 
according to the general procedure (5.2.12) starting with a 
solution of -Br-TMC (73) (50.0 mg, 0.123 mmol, 1.0 eq.) in 
dry CH2Cl2 (2.5 mL) and a 1 M solution of BCl3 in hexane 
(0.368 mL, 0.368 mmol, 3.0 eq.). Purification on preparative 
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TLC plates (SiO2, EtOAc/petroleum ether 3:1) afforded -Br-HC (97) (39.0 mg, 0.0992 
mmol, 81 %) as a yellow solid; m.p. 80 °C. 
1
H NMR (400 MHz, CDCl3): δ = 12.06 (s, 1 H, 2’-OH), 7.71 (d, J = 9.0 Hz, 1 H), 7.59 (d, J = 
2.0 Hz, 1 H), 7.37 (dd, J = 8.6, 2.0 Hz, 1 H), 7.33 (s, 1 H; -CH), 6.92 (d, J = 8.4 Hz, 1 H), 
6.50 (d, J = 2.5 Hz, 1 H), 6.46 (dd, J = 9.0, 2.5 Hz, 1 H), 3.93 (s, 3 H; OCH3), 3.93 (s, 3 H; 
OCH3), 3.87 (s, 3 H, OCH3) ppm. 
13
C NMR (101 MHz, CDCl3): δ = 194.3 (C=O), 166.7, 166.4, 150.6, 148.6, 137.9 (-CH), 
134.3 (CH), 126.1, 124.4 (CH), 115.5, 112.2 (CH), 111.5, 110.7 (CH), 107.8 (CH), 101.2 
(CH), 55.9 (2 OCH3), 55.7 (OCH3) ppm.  
IR (neat): 3004, 2934, 2837, 1624, 1586, 1509, 1440, 1235, 1203, 1127, 1020, 959, 799 cm
-1
.  
MS (ESI
+
) m/z (%): 393 [M+H]
+
 (100). 
HRMS (ES-MS): calcd. for C18H18BrO5: 393.0332 [M+H]
+
; found 393.0336. 
(Z)-2-Chloro-3-(3,4-dimethoxyphenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one 
(-Cl-HC, 98). The -chlorochalcone 98 was prepared 
according to the general procedure (5.2.12) starting with a 
solution of -Cl-TMC (74) (50.0 mg, 0.138 mmol, 1.0 eq.) in 
dry CH2Cl2 (2.5 mL) and 1 M solution of BCl3 in hexane 
(0.413 mL, 0.413 mmol, 3.0 eq.). Purification on preparative 
TLC plates (SiO2, EtOAc/petroleum ether 3:1) afforded -Cl-HC (98) (44.0 mg, 0.126 mmol, 
91%) as a yellow solid; m.p. 89 °C. 
1
H NMR (300 MHz, CDCl3): δ = 12.00 (s, 1 H; 2’-OH), 7.73 (d, J = 8.9 Hz, 1 H), 7.53 (d, J = 
2.0 Hz, 1 H), 7.37 (dd, J = 8.5, 2.0 Hz, 1 H), 7.14 (s, 1 H; -CH), 6.92 (d, J = 8.5 Hz, 1 H), 
6.50 (d, J = 2.4 Hz, 1 H), 6.46 (dd, J = 8.9, 2.5 Hz, 1 H), 3.93 (s, 3 H; OCH3), 3.92 (s, 3 H; 
OCH3), 3.86 (s, 3 H; OCH3) ppm. 
13
C NMR (101 MHz, CDCl3): δ = 193.5 (C=O), 166.6, 166.2, 150.6, 148.7, 135.8 (-CH), 
134.0 (CH), 125.6, 125.0, 124.8 (CH), 112.6 (CH), 111.8, 110.8 (CH), 107.7 (CH), 101.2 
(CH), 55.9 (2 OCH3), 55.7 (OCH3) ppm. 
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IR (neat): 3005, 2935, 2838, 1620, 1586, 1509, 1440, 1336, 1236, 1128, 1067, 1020, 959,  
831 cm
-1
. 
MS (ESI
+
) m/z (%): 349 [M+H]
+
 (100).  
HRMS (ES-MS): calcd. for C18H18ClO5: 349.0837 [M+H]
+
; found 349.0835. 
(Z)-3-(3,4-Dimethoxyphenyl)-1-(2-hydroxy-4-methoxyphenyl)-2-(trifluoromethyl)prop-
2-en-1-one (-CF3-HC, 99). The -trifluoromethylchalcone 99 
was prepared according to the general procedure (5.2.12) starting 
with a solution of -CF3-TMC (77) (46.0 mg, 0.116 mmol, 1.0 
eq.) in dry CH2Cl2 (2 mL) and a 1 M solution of BCl3 in CH2Cl2 
(0.348 mL, 0.348 mmol, 3.0 eq.). Purification by preparative TLC 
plates (SiO2, EtOAc/petroleum ether 2:1) afforded -CF3-HC (99) 
(38.0 mg, 0.0994 mmol, 86 %) as a pale yellow solid; m.p. 97 °C. 
1
H NMR (400 MHz, CDCl3): δ = 12.34 (s, 1 H; 2’-OH), 7.42 (d, J = 9.0 Hz, 1 H), 7.32 (d, J = 
1.5 Hz, 1 H, -H), 6.92 (dd, J = 8.3, 2.1 Hz, 1 H), 6.77-6.73 (m, 2 H), 6.42 (d, J = 2.4 Hz, 1 
H), 6.29 (dd, J = 9.0, 2.5 Hz, 1 H), 3.83 (s, 3 H; OCH3), 3.81 (s, 3 H; OCH3), 3.64 (s, 3 H; 
OCH3) ppm. 
13
C NMR (101 MHz, CDCl3):  = 195.9 (C=O), 167.4, 166.2, 150.8, 148.8, 136.2 (q, J = 5.8 
Hz, -CH), 134.1 (CH), 124.7 (q, J = 30.5 Hz, -C), 124.5, 124.2 (CH), 122.4 (q, J = 274.1 
Hz, CF3), 113.6, 111.4 (CH), 110.8 (CH), 108.7 (CH), 100.8 (CH), 55.8 (OCH3), 55.7 
(OCH3), 55.5 (OCH3) ppm.  
19
F NMR (376 MHz, CDCl3):  = -62.4 (d, J = 1 Hz) ppm.  
IR (neat): 3013, 2937, 2842, 1622, 1596, 1515, 1442, 1393, 1238, 1144, 1109, 1023, 833,  
616 cm
-1
.  
MS (ESI
+
): m/z (%): 383 [M+H]
+
 (100).  
HRMS (ES-MS): calcd for C19H18F3O5: 383.1101 [M+H]
+
; found 383.1098. 
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(E)-3-(3,4-Dimethoxyphenyl)-1-(2-hydroxy-4-methoxyphenyl)-2-(4-nitrophenyl)prop-2-
en-1-one (-p-NO2-C6H4-HC, 100). The -aryl-HC 100 was 
prepared according to the general procedure (5.2.12) starting 
with a solution of -p-NO2-C6H4-TMC (78) (60.0 mg, 0.133 
mmol, 1.0 eq) in dry CH2Cl2 (3 mL) and a 1 M solution of 
BCl3 in CH2Cl2 (0.40 mL, 0.399 mmol, 3.0 eq). Purification by 
preparative TLC plates (SiO2, EtOAc/petroleum ether 2:1) 
afforded -p-NO2-C6H4-HC (100) (35.0 mg, 0.0804 mmol, 60 
%) as a yellow solid; m.p. 68 °C. 
1
H NMR (400 MHz, CDCl3):  = 12.41 (s, 1 H; 2’-OH), 8.30-8.15 (m, 2 H), 7.73 (d, J = 9.0 
Hz, 1 H), 7.60-7.52 (m, 2 H), 7.08 (s, 1 H; -H), 6.74 (d, J = 0.8 Hz, 2 H), 6.57-6.48 (m, 2 H), 
6.44 (dd, J = 9.0, 2.5 Hz, 1 H), 3.87 (s, 6 H; 2 OCH3), 3.55 (s, 3 H; OCH3) ppm. 
13
C NMR (101 MHz, CDCl3):  = 199.1 (C=O), 166.6, 166.5, 150.3, 148.6, 147.3, 144.1, 
138.7 (-CH), 135.4, 134.3 (CH), 130.9 (2 CH), 126.3, 124.1 (CH), 124.0 (2 CH), 112.9, 
112.5(CH), 110.9 (CH), 107.7 (CH), 101.3 (CH), 55.9 (OCH3), 55.7 (OCH3), 55.4 (OCH3) 
ppm. 
IR (neat): 2934, 2839, 1677, 1604, 1514, 1442, 1343, 1254, 1159, 1021, 808 cm
-1
. 
MS (ESI
+
): m/z (%): 436 [M+H]
+
 (100). 
HRMS (ES-MS): calcd for C24H22NO7: 436.1391 [M+H]
+
; found 436.1391. 
6.3. Kinetic thiol assay 
6.3.1. Standard assay (96-well-format) for compounds with middle to low reactivity 
The thiol assay was conducted in 96-well plates (ELISA Microplates, F-bottom, MICROLON 
200, Greiner Bio-one, Germany) and PCR foils (Viewseal transparent, 80×140 mm, Greiner 
Bio-one, USA) were applied to cover the plate during the measurements. As a solvent system 
100 mM TRIS-HCl buffer pH 7.4 with 2 mM EDTA/ethylene glycol (20:80) was used that 
was filtered and degassed prior to use. All measurements were done in a Thermo Scientific 
Multiskan Spectrum UV/Vis microplate and cuvette spectrophotometer (Thermo Fisher 
Scientific Inc., Finland) at 25 °C. To perform the assay 10 mM stock solutions of the chalcone 
in DMSO were diluted in the buffer/ethylene glycol mixture to give a concentration of 80 M 
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(160 M for chalcone 71 and 77). Stock solutions with a concentration of 40 mM of the 
respective thiol (cysteamine·HCl (107), 1,4-butanedithiol (109), -mercaptoethanol (111) or 
glutathione (GSH, 112)) were directly prepared in the buffer/ethylene glycol mixture and 
diluted accordingly to give 12-500 fold dilutions compared to the ,-unsaturated carbonyl 
compounds. Suitable wavelengths for the individual compounds were determined by 
photoscan experiments (λ = 290-600 nm) of the tested chalcones with the thiol together with 
LC-MS measurements to rule out an overlap of UV bands of the starting material with the 
products. Chalcone and thiol solutions were incubated separately in the instrument for 10 min 
at 25 °C just prior to the measurement. Then, equal amounts of both solutions were combined, 
mixed thoroughly, the wells were covered with foil, and the kinetic measurement was started 
immediately to be as close as possible to the starting concentration of 40 M (80 M in case 
of chalcone 71 and 77) for the chalcones. Figure 53 shows the detailed protocol of this assay. 
 
Figure 53: The kinetic thiol assay protocol. 
Measurements were done in duplicates. A set of 380 data points (absorbances At) was 
collected each time with varying time intervals (t). The raw data were corrected versus the 
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blank using an Excel data sheet that was programmed by Karl Amslinger to give individual 
curves for each measurement. These curves are fit to a first-order exponential decay function 
with the software OriginPro 8 (OriginLab Corporation, USA) to gain individual kobs values. 
The k2 values were calculated on an Excel data sheet by linear regression of the obtained kobs 
values versus their corresponding thiol concentrations. All compounds were measured with  
3-7 independent experiments. 
6.3.2. Stopped-flow assay for compounds with high reactivity 
The stopped-flow measurements were performed at 25 °C in the same solvent system utilized 
in the microtiter plate assay which is 100 mM TRIS-HCl buffer pH 7.4 with 2 mM 
EDTA/ethylene glycol (20:80), by using the SX20 stopped-flow instrument (Applied 
Photophysics, UK). The decrease in the absorbance at the suitable wavelength of each 
chalcone was recorded over time. Multiple turnover kinetics of a certain chalcone with a thiol 
were measured by mixing 80 M solutions of chalcones (160 M solutions of chalcone 71 
and 77) in buffer/ethylene glycol (20:80) and the corresponding solutions of thiol (in 
buffer/ethylene glycol (20:80), different concentrations, 12-500-fold) in a 1:1 volume ratio. 
The final concentration of chalcones was 40 M (80 M for chalcone 71 and 77). Three to 
five traces were recorded at each thiol concentration and averaged. These curves were fit to a 
first-order exponential decay function by using the software Pro-Data SX 2.0 (Applied 
Photophysics, UK) and the k2 values were calculated as in the standard assay. Three 
independent experiments were performed for each chalcone 
6.4. LC-MS study of the thiol assay samples 
Mass spectrometric investigations were carried out on an Agilent 1290 Infinity HPLC system 
coupled to Agilent Technologies 6540 UHD TOF/Q-TOF mass spectrometer (USA). For 
chromatographic separation, Agilent Zorbax Eclipse Plus C18, 1.8 u, 50×2.1 mm column was 
used at 40 °C and detection wavelength range was 190-640 nm. Using 0.1% formic acid/water 
(eluent A) and 0.1% formic acid/MeCN (eluent B), the following gradient at a constant flow 
rate of 0.60 mL/min was applied: 0-4 min, 95% A, 5% B; 4–5.1 min, 2% A, 98% B; 5.1-6 
min, 95% A, 5% B. The following parameters for MS data acquisition were applied: operation 
mode: positive; capillary voltage: 3500 V; dry gas flow (N2): 8 L/min; nebulizer pressure: 35 
psi and capillary temperature: 320 °C. Mass spectra were recorded between m/z 80 and 1400. 
The software used to control the LC-MS system and process data was a MassHunter 
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Workstation (Agilent, USA). Compounds were identified according to their HR-MS, specific 
fragmentation pattern, UV spectra and retention times. 
6.5. Biological tests 
Tests were performed on murine macrophages (RAW264.7 cells) that were cultured in RPMI 
1640 medium supplemented with 10% (v/v) heat inactivated fetal calf serum (FCS) and 2 mM 
glutamine (Biochrom AG, Germany) at 37 °C in humidified air containing 5% CO2. 
6.5.1. In vitro cell viability assay 
The cell viability was evaluated by MTT assay. In brief, RAW264.7 cells were seeded in 96-
well plates at a density of 5×10
3
 per well, cultured for 24 h, and then incubated for 20 h with 
medium supplemented with compounds (for compound preparation see iNOS inhibition test 
below) in presence and absence of 10 ng mL
-1
 LPS (Sigma, Germany). Controls received only 
culture medium with or without solvent, both in presence and absence of LPS. The total assay 
volume was 100 L and the final concentration of the solvent (DMSO) was ≤ 0.025%. After 
the 20 h of incubation, 10 L of MTT solution (4 mg mL-1 in phosphate-buffered saline 
(PBS)) was added to each well, and the cells were incubated for another 4 h at 37 °C. 
Subsequently, the culture medium was removed from the wells, then 100 L of sodium 
dodecyl sulfate (SDS) solution (10% in water) was added, and the formed formazan dye was 
allowed to dissolve overnight. The absorbance was determined at λ = 560 nm with a 
Multiskan Spectrum spectrophotometer (Thermo Fisher Scientific Inc., Finland) at 25 °C. 
Figure 54 represents a summary of this protocol. The data represent the mean standard 
deviation (± SD) of at least three independent experiments carried out in quadruplicates. 
  
Figure 54: MTT assay protocol with relevant reaction of the yellow MTT to give the purple formazan dye. 
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6.5.2. iNOS inhibition test (Griess assay) 
The produced NO, which is accumulated as nitrite in the culture medium, was quantified 
using the Griess reaction. RAW264.7 macrophages (8×10
4
 cells per well) were plated in 96-
well plates and allowed to attach for 24 h. Stock solutions of the compounds were prepared in 
DMSO (100 mM) and stored at -20 °C. Test concentrations were freshly prepared by diluting 
the stock solution in culture medium in presence and absence of 10 ng mL
-1
 LPS and then 
incubated with the cells for 24 h. The final concentration of DMSO was ≤ 0.025% and the 
total assay volume was 100 L. An amount of 50 L of the culture medium was mixed with 
50 L of the Griess reagent (0.1% NED (N-1-naphtylethylenediamine dihydrochloride), 1% 
sulfanilamide, 0.35% phosphoric acid in water) and incubated for 15 min at room 
temperature. During this time the formed air bubbles upon pipetting are removed using 
nitrogen stream. The absorbance was measured at λ = 560 nm with a Multiskan Spectrum 
Photometer (Thermo Fisher Scientific Inc., Finland) at 25 °C.  The assay protocol is depicted 
in Figure 55. The data represent the mean ± SD of at least three independent experiments 
carried out in quadruplicates.  
  
Figure 55: The Griess assay protocol. 
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7. APPENDIX 
7.1. Table of the synthesized compounds 
# Assigned structure # Assigned structure 
3 
 
66 
 
60 
 
67 
 
61 
 
68 
 
62 
 
69 
 
63 
 
70 
 
64 
 
71 
 
65 
 
72 
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# Assigned structure # Assigned structure 
73 
 
80 
 
74 
 
81 
 
75 
 
82 
 
76 
 
94 
 
77 
 
95 
 
78 
 
96 
 
79 
 
97 
 
APPENDIX 
131 
# Assigned structure # Assigned structure 
98 
 
103 
 
99 
 
104 
 
100 
 
105 
 
102 
 
106 
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7.2.X-Ray data 
7.2.1. (E)-3-(3,4-Dimethoxyphenyl)-1-(2-hydroxy-4-methoxy-phenyl)prop-2-en-1-one   
(-H-HC, 61) 
CCDC no.: 909409.  
The dihedral angle between the two aromatic rings is: 11.38°. 
Crystal data 
C18H18O5 zV = 1499.16 (9) Å
3
 
Mr = 314.32 Z = 4 
Monoclinic, P21/c Cu Kα radiation 
a = 17.9253 (7) Å µ = 0.84 mm
−1
 
b = 5.36599 (19) Å T = 123 K 
c = 15.7715 (5) Å 
0.29 × 0.14 × 0.04  
mm 
β = 98.798 (3)° 
 
Data collection 
SuperNova, Single source at offset), Atlas diffractometer  
2974 independent 
reflections 
Absorption correction: analytical  
CrysAlis PRO, Oxford Diffraction Ltd., Version 1.171.33.55 
(release 05-01-2010 CrysAlis171 .NET) Analytical numeric 
absorption correction using a multifaceted crystal model based on 
expressions derived by R.C. Clark & J.S. Reid. (Clark, R. C. & 
Reid, J. S. (1995). Acta Cryst. A51, 887-897) 
2642 reflections with I 
> 2σ(I) 
Tmin = 0.832, Tmax = 0.965 Rint = 0.024 
11609 measured reflections θmax = 73.6° 
Refinement 
R[F
2
 > 2σ(F2)] = 0.036 0 restraints 
wR(F
2
) = 0.096 H-atom parameters constrained  
S = 1.03 Δρmax = 0.20 e Å
−3
 
2974 reflections Δρmin = −0.29 e Å
−3
 
208 parameters 
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7.2.2. (Z)-2-(2,4-Dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)-2-fluoroprop-2-en-1-one  
(-F-TMC, 68) 
CCDC no.: 9111005.  
The dihedral angle between the two aromatic rings is: 54.33°. 
Crystal data 
C19H19FO5 V = 810.16 (10) Å
3
 
Mr = 346.34 Z = 2 
Monoclinic, P21 Cu Kα radiation 
a = 4.1742 (3) Å µ = 0.92 mm
−1
 
b = 16.3559 (12) Å T = 123 K 
c = 11.9009 (7) Å 
0.18 × 0.07 × 0.02 
mm 
β = 94.353 (6)° 
 
Data collection 
SuperNova, Single source at offset, Atlas diffractometer  
2381 independent 
reflections 
Absorption correction: analytical CrysAlisPro, Oxford Diffraction 
Ltd., Version 1.171.33.55 (release 05-01-2010 CrysAlis171 .NET) 
Analytical numeric absorption correction using a multifaceted 
crystal model based on expressions derived by R.C. Clark & J.S. 
Reid. (R. C. Clark, J. S. Reid, Acta Crystallogr., Sect. A 1995, 51, 
887-897) 
2098 reflections with I 
> 2σ(I) 
Tmin = 0.907, Tmax = 0.979 Rint = 0.046 
3620 measured reflections θmax = 72.9° 
Refinement 
R[F
2
 > 2σ(F2)] = 0.052 H-atom parameters constrained  
wR(F
2
) = 0.140 Δρmax = 0.23 e Å
−3
 
S = 1.04 Δρmin = −0.26 e Å
−3
 
2381 reflections 
Absolute structure: H. Flack, Acta Crystallogr., Sect. A 1983, 
39, 876-881. 
226 parameters Flack parameter: −0.1 (2) 
1 restraint 
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7.2.3. (E)-2-Cyano-1-(2,4-dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one 
(-CN-TMC, 69) 
CCDC no.: 910997 
The dihedral angle between the two aromatic rings is: 73.81°. 
Crystal data 
C20H19NO5 γ = 80.585 (5)° 
Mr = 353.36 V = 861.54 (9) Å
3
 
Triclinic, P  Z = 2 
a = 8.7545 (6) Å Cu Kα radiation 
b = 8.7992 (5) Å µ = 0.81 mm
−1
 
c = 11.5752 (7) Å T = 123 K 
α = 86.825 (5)° 
0.38 × 0.31 × 0.10 
mm 
β = 78.429 (5)° 
 
Data collection 
SuperNova, Single source at offset), Atlas diffractometer  3192 independent reflections 
Absorption correction: analytical  
CrysAlisPro, Oxford Diffraction Ltd., Version 1.171.33.55 
(release 05-01-2010 CrysAlis171 .NET) Analytical numeric 
absorption correction using a multifaceted crystal model 
based on expressions derived by R.C. Clark & J.S. Reid. (R. 
C. Clark, J. S. Reid, Acta Crystallogr., Sect. A 1995, 51, 887-
897) 
2967 reflections with I > 
2σ(I) 
Tmin = 0.838, Tmax = 0.931 Rint = 0.012 
6077 measured reflections θmax = 73.7° 
Refinement 
R[F
2
 > 2σ(F2)] = 0.033 0 restraints 
wR(F
2
) = 0.088 H-atom parameters constrained  
S = 1.06 Δρmax = 0.21 e Å
−3
 
3192 reflections Δρmin = −0.19 e Å
−3
 
235 parameters 
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7.2.4. (Z)-2-Bromo-1-(2,4-dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one 
(-Br-TMC, 73) 
CCDC no.: 910973 
The dihedral angle between the two aromatic rings is: 61.37°. 
Crystal data 
C19H19BrO5  V = 1791.9 (4) Å
3
 
Mr = 407.24 Z = 4 
Orthorhombic, 
Pca21 
Mo Kα radiation 
a = 15.281 (3) Å µ = 2.32 mm
−1
 
b = 13.5346 (17) Å T = 123 K 
c = 8.6638 (5) Å 0.84 × 0.08 × 0.06 mm 
Data collection 
Xcalibur, Ruby, Gemini Ultra diffractometer  5088 independent reflections 
Absorption correction: gaussian  
CrysAlisPro, Agilent Technologies, Version 
1.171.35.21 (release 20-01-2012 CrysAlis171 
.NET) (compiled Jan 23 2012,18:06:46) Numerical 
absorption correction based on gaussian integration 
over a multifaceted crystal model 
4563 reflections with > 2σ(i) 
Tmin = 0.440, Tmax = 2.163 Rint = 0.056 
20133 measured reflections θmax = 30.8° 
Refinement 
R[F
2
 > 2σ(F2)] = 0.041 H-atom parameters constrained  
wR(F
2
) = 0.101 Δρmax = 0.99 e Å
−3
 
S = 1.04 Δρmin = −0.68 e Å
−3
 
5088 reflections 
Absolute structure: H. Flack, Acta Crystallogr., Sect. A 
1983, 39, 876-881. 
230 parameters Flack parameter: −0.018 (9) 
1 restraint 
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7.2.5. (Z)-2-Chloro-1-(2,4-dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one 
(-Cl-TMC, 74) 
CCDC no.: 911020 
The dihedral angle between the two aromatic rings is: 61.26°. 
Crystal data 
C19H19ClO5 V = 1752.73 (4) Å
3
 
Mr = 362.79 Z = 4 
Orthorhombic, 
Pca21 
Cu Kα radiation 
a = 15.1477 (2) Å µ = 2.16 mm
−1
 
b = 13.4641 (2) Å T = 123 K 
c = 8.5939 (1) Å 
0.77 × 0.07 × 0.04 
mm 
Data collection 
SuperNova,Single source at offset, Atlas diffractometer  2614 independent reflections 
Absorption correction: gaussian  
CrysAlisPro, Agilent Technologies, Version 1.171.35.21 
(release 20-01-2012 CrysAlis171 .NET) (compiled Jan 23 
2012,18:06:46) Numerical absorption correction based on 
gaussian integration over a multifaceted crystal model 
2544 reflections with > 2σ(i) 
Tmin = 0.523, Tmax = 1.382 Rint = 0.047 
9295 measured reflections θmax = 70.8° 
Refinement 
R[F
2
 > 2σ(F2)] = 0.030 H-atom parameters constrained  
wR(F
2
) = 0.076 Δρmax = 0.17 e Å
−3
 
S = 1.12 Δρmin = −0.23 e Å
−3
 
2614 reflections 
Absolute structure: H. Flack, Acta Crystallogr., Sect. A 
1983, 39, 876-881. 
230 parameters Flack parameter: 0.020 (16) 
1 restraint 
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7.2.6. (Z)-1-(2,4-Dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)-2-iodoprop-2-en-1-one     
(-I-TMC, 75) 
CCDC no.: 911012 
The dihedral angle between the two aromatic rings is: 78.63°. 
Crystal data 
C19H19IO5  V = 1803.12 (7) Å
3
 
Mr = 454.24 Z = 4 
Monoclinic, P21/c Mo Kα radiation 
a = 9.4013 (2) Å µ = 1.80 mm
−1
 
b = 23.4507 (4) Å T = 123 K 
c = 8.5471 (2) Å 0.34 × 0.29 × 0.12 mm 
β = 106.885 (2)° 
 
Data collection 
Xcalibur, Ruby, Gemini Ultra diffractometer  9277 independent reflections 
Absorption correction: multi-scan  
CrysAlisPro, Agilent Technologies, Version 
1.171.35.21 (release 20-01-2012 CrysAlis171 .NET) 
(compiled Jan 23 2012,18:06:46) Empirical absorption 
correction using spherical harmonics, implemented in 
SCALE3 ABSPACK scaling algorithm. 
8406 reflections with > 2σ(i) 
Tmin = 0.784, Tmax = 1.000 Rint = 0.025 
47651 measured reflections θmax = 37.7° 
Refinement 
R[F
2
 > 2σ(F2)] = 0.022 0 restraints 
wR(F
2
) = 0.059 H-atom parameters constrained  
S = 1.06 Δρmax = 0.81 e Å
−3
 
9277 reflections Δρmin = −1.03 e Å
−3
 
230 parameters 
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7.2.7. (E)-3-(3,4-Dimethoxyphenyl)-1-(2-hydroxy-4-methoxyphenyl)-2-methylprop-2-en-
1-one (-Me-HC, 96) 
The dihedral angle between the two aromatic rings is: 63.61°. 
Crystal data 
C19H20O5 γ = 82.771 (4)° 
Mr = 328.35 V = 801.83 (7) Å3 
Triclinic, P  Z = 2 
a = 5.5747 (3) Å Cu Kα radiation 
b = 11.0856 (5) Å µ = 0.81 mm−1 
c = 13.7020 (7) Å T = 123 K 
α = 73.158 (4)° 
0.19 × 0.10 × 0.03 
mm 
β = 83.900 (4)° 
 
Data collection 
SuperNova, Single source at offset), Atlas diffractometer  3090 independent reflections 
Absorption correction: analytical  
CrysAlisPro, Oxford Diffraction Ltd., Version 
1.171.33.55 (release 05-01-2010 CrysAlis171 .NET) 
Analytical numeric absorption correction using a 
multifaceted crystal model based on expressions derived 
by R.C. Clark & J.S. Reid. (R. C. Clark, J. S. Reid, Acta 
Crystallogr., Sect. A 1995, 51, 887-897) 
2572 reflections with I > 2σ(I) 
Tmin = 0.911, Tmax = 0.979 Rint = 0.034 
6642 measured reflections θmax = 73.7° 
Refinement 
R[F
2
 > 2σ(F2)] = 0.050 0 restraints 
wR(F
2
) = 0.144 
H atoms treated by a mixture of independent and 
constrained refinement  
S = 1.06 Δρmax = 0.56 e Å
−3
 
3090 reflections Δρmin = −0.56 e Å
−3
 
220 parameters 
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7.2.8. (Z)-3-(3,4-Dimethoxyphenyl)-2-fluoro-1-(2-isopropoxy-4-methoxyphenyl)prop-2-
en-1-one (-F-pHC, 104) 
The dihedral angle between the two aromatic rings is: 64.46° 
 
  
Crystal data 
C21H23FO5 V = 1882.26 (10) Å
3
 
Mr = 374.39 Z = 4 
Monoclinic, P21/c Cu Kα radiation 
a = 11.8439 (4) Å µ = 0.83 mm
−1
 
b = 8.6028 (2) Å T = 123 K 
c = 18.9320 (6) Å 
0.10 × 0.08 × 0.05 
mm 
β = 102.638 (3)° 
 
Data collection 
SuperNova, Single source at offset), Atlas diffractometer  2928 independent reflections 
Absorption correction: analytical  
CrysAlis PRO, Oxford Diffraction Ltd., Version 
1.171.33.55 (release 05-01-2010 CrysAlis171 .NET) 
Analytical numeric absorption correction using a 
multifaceted crystal model based on expressions derived by 
R.C. Clark & J.S. Reid. ( R. C. Clark, J. S. Reid, Acta 
Crystallogr., Sect. A 1995, 51, 887-897) 
2448 reflections with I > 2σ(I) 
Tmin = 0.956, Tmax = 0.978 Rint = 0.028 
7936 measured reflections θmax = 63.2° 
Refinement 
R[F
2
 > 2σ(F2)] = 0.036 0 restraints 
wR(F
2
) = 0.091 H-atom parameters constrained  
S = 1.05 Δρmax = 0.15 e Å
−3
 
2928 reflections Δρmin = −0.19 e Å
−3
 
244 parameters 
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7.3. NMR Spectra 
(E)-1-(2-Hydroxy-4,6-dimethoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one 
(Flavokawain A) (3) 
1
H NMR 
 
13
C NMR 
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(E)-1-(2,4-Dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one (-H-TMC, 60) 
1
H NMR 
 
13
C NMR 
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(E)-3-(3,4-Dimethoxyphenyl)-1-(2-hydroxy-4-methoxy-phenyl)prop-2-en-1-one             
(-H-HC, 61) 
1
H NMR 
 
13
C NMR 
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(E)-1-(2-Hydroxyphenyl)-3-phenylprop-2-en-1-one (62)  
1
H NMR 
 
13
C NMR 
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1-(2,4-Dimethoxyphenyl)-2-fluoroethanone (63)  
1
H NMR 
 
13
C NMR 
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19
F NMR 
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3-(2,4-Dimethoxyphenyl)-3-oxopropanenitrile (64)  
1
H NMR 
 
13
C NMR 
 
  
H2O 
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1-(2,4-Dimethoxyphenyl)propan-1-one (65)  
1
H NMR 
 
13
C NMR 
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1-(2,4-Dimethoxyphenyl)-2-nitroethanone (66)  
1
H NMR 
 
13
C NMR 
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Ethyl 3-(2,4-dimethoxyphenyl)-3-oxopropanoate (67)  
1
H NMR 
 
13
C NMR 
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(Z/E)-1-(2,4-Dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)-2-fluoroprop-2-en-1-one        
(-F-TMC, 68)  
1
H NMR 
 
13
C NMR 
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19
F NMR 
 
  
* 
** 
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(E)-2-Cyano-1-(2,4-dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one           
(-CN-TMC, 69)  
1
H NMR 
 
13
C NMR 
 
  
H2O 
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(E)-1-(2,4-Dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)-2-methylprop-2-en-1-one          
(-Me-TMC, 70)  
1
H NMR 
 
13
C NMR 
 
  
APPENDIX 
154 
(E)-1-(2,4-Dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)-2-nitroprop-2-en-1-one             
(-NO2-TMC, 71)  
1
H NMR 
 
13
C NMR 
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(E)-2-Ethoxycarbonyl-1-(2,4-dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)propen-1-one 
(-COOEt-TMC, 72)  
1
H NMR 
 
13
C NMR 
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(Z)-2-Bromo-1-(2,4-dimethoxyphenyl)-3-(3,4-dimethoxy-phenyl)prop-2-en-1-one          
(-Br-TMC, 73)  
1
H NMR 
 
13
C NMR 
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(Z)-2-Chloro-1-(2,4-dimethoxyphenyl)-3-(3,4-dimethoxy-phenyl)prop-2-en-1-one         
(-Cl-TMC, 74)  
1
H NMR 
 
13
C NMR 
 
  
H2O 
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(Z/E)-1-(2,4-Dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)-2-iodoprop-2-en-1-one           
(-I-TMC, 75)  
1
H NMR 
 
13
C NMR 
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(E)-2-(2,4-Dimethoxybenzoyl)-3-(3,4-dimethoxyphenyl)propenoic acid (-COOH-TMC, 
76)  
1
H NMR 
 
13
C NMR 
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(E)-1-(2,4-Dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)-2-(trifluoromethyl)prop-2-en-1-
one (-CF3-TMC, 77)  
1
H NMR 
 
13
C NMR 
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19
F NMR 
 
§ Traces of the other isomer 
 
  
§  
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(E)-1-(2,4-Dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)-2-(4-nitrophenyl)prop-2-en-1-one 
(78)  
1
H NMR 
 
13
C NMR 
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(E)-1-(2,4-Dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)-2-phenylprop-2-en-1-one (79)  
1
H NMR 
 
13
C NMR 
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E)-1-(2,4-Dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)-2-(4-methoxyphenyl)prop-2-en-1-
one (80)  
1
H NMR 
 
13
C NMR 
 
  
H2O 
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2-Bromo-1-(2,4-dimethoxyphenyl)ethanone (81)  
1
H NMR 
 
13
C NMR 
 
  
H2O 
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2-Chloro-1-(2,4-dimethoxyphenyl)ethanone (82)  
1
H NMR 
 
13
C NMR 
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(Z)-3-(3,4-Dimethoxyphenyl)-2-fluoro-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one 
(-F-HC, 94)  
1
H NMR 
 
13
C NMR 
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19
F NMR 
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(E)-2-Cyano-1-(3,4-dimethoxyphenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one 
(-CN-HC, 95)  
1
H NMR 
 
13
C NMR 
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(E)-3-(3,4-Dimethoxyphenyl)-1-(2-hydroxy-4-methoxyphenyl)-2-methylprop-2-en-1-one 
(-Me-HC, 96)  
1
H NMR 
 
13
C NMR 
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(Z)-2-Bromo-3-(3,4-dimethoxyphenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one 
(-Br-HC, 97)  
1
H NMR 
 
13
C NMR 
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(Z)-2-Chloro-3-(3,4-dimethoxyphenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one 
(-Cl-HC, 98)  
1
H NMR 
 
13
C NMR 
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(Z)-3-(3,4-Dimethoxyphenyl)-1-(2-hydroxy-4-methoxyphenyl)-2-(trifluoromethyl)prop-
2-en-1-one (-CF3-HC, 99)  
1
H NMR 
 
13
C NMR 
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19
F NMR 
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(E)-3-(3,4-Dimethoxyphenyl)-1-(2-hydroxy-4-methoxyphenyl)-2-(4-nitrophenyl)prop-2-
en-1-one (-p-NO2-C6H4-HC, 100)  
1
H NMR 
 
13
C NMR 
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2-Fluoro-1-(2-isopropoxy-4-methoxyphenyl)ethanone (102)  
1
H NMR 
 
13
C NMR 
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19
F NMR 
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3-(2-Isopropoxy-4-methoxyphenyl)-3-oxopropanenitrile (103)  
1
H NMR 
 
13
C NMR 
 
x: impurity 
  
x x 
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(Z)-3-(3,4-Dimethoxyphenyl)-2-fluoro-1-(2-isopropoxy-4-methoxyphenyl)prop-2-en-1-
one (-F-pHC, 104)  
1
H NMR 
 
13
C NMR 
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19
F NMR 
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(E)-2-Cyano-3-(3,4-dimethoxyphenyl)-1-(2-isopropoxy-4-methoxyphenyl)prop-2-en-1-
one (-CN-pHC, 105)  
1
H NMR 
 
13
C NMR 
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1-(2-Hydroxy-4-methoxyphenyl)propan-1-one (106)  
1
H NMR 
 
13
C NMR 
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7.4. Kinetic measurements 
7.4.1. Representativek2 value determinations for -H-chalcones with cysteamine 
Chalcone (1)  
 
 
 
 
 
 
 
 
 
 
Butein (2) 
 
 
 
 
 
 
 
 
 
 
Isoliquiritigenin (4)  
 
 
 
 
 
 
 
  
Entry 
Thiol 
[M] 
(fold) 
Individual 
kobs [s
-1
] 
kobs [s
-1
] 
Mean 
Abs3 0.00480 
(12) 
2.71 x 10
-3
 
2.72 x 10
-3
 
Abs4 2.73 x 10
-3
 
Abs5 0.00960 
(24) 
4.20 x 10
-3
 
4.20 x 10
-3
 
Abs6 4.19 x 10
-3
 
Abs7 0.0144 
(36) 
5.64 x 10
-3
 
5.64 x 10
-3
 
Abs8 --- 
Abs9 0.0192 
(48) 
7.00 x 10
-3
 
7.02 x 10
-3
 
Abs10 7.05 x 10
-3
 
Abs11 0.0240 
(60) 
8.41 x 10
-3
 
8.39 x 10
-3
 
Abs12 8.37 x 10
-3
 
k2 = 2.95 M
-1
 s
-1
 
Entry 
Thiol 
[M] 
(fold) 
Individual 
kobs [s
-1
] 
kobs [s
-1
] 
Mean 
Abs3 0.00240 
(60) 
--- 
--- 
Abs4 --- 
Abs5 0.00288 
(72) 
1.45 x 10
-3
 
1.40 x 10
-3
 
Abs6 1.34 x 10
-3
 
Abs7 0.00336 
(84) 
1.56 x 10
-3
 
1.52 x 10
-3
 
Abs8 1.49 x 10
-3
 
Abs9 0.00384 
(96) 
1.66 x 10
-3
 
1.65 x 10
-3
 
Abs10 1.64 x 10
-3
 
Abs11 0.00432 
(108) 
1.81 x 10
-3
 
1.80 x 10
-3
 
Abs12 1.78 x 10
-3
 
k2 = 0.277 M
-1
 s
-1
 
Entry 
Thiol 
[M] 
(fold) 
Individual 
kobs [s
-1
] 
kobs [s
-1
] 
Mean  
Abs3 0.00240 
(60) 
1.24 x 10
-3
 
1.25 x 10
-3
 
Abs4 1.26 x 10
-3
 
Abs5 0.00288 
(72) 
1.38 x 10
-3
 
1.38 x 10
-3
 
Abs6 1.37 x 10
-3
 
Abs7 0.00336 
(84) 
1.50 x 10
-3
 
1.50 x 10
-3
 
Abs8 1.50 x 10
-3
 
Abs9 0.00384 
(96) 
1.61 x 10
-3
 
1.61 x 10
-3
 
Abs10 1.62 x 10
-3
 
Abs11 0.00432 
(108) 
1.73 x 10
-3
 
1.73 x 10
-3
 
Abs12 1.74 x 10
-3
 
k2 = 0.248 M
-1
 s
-1
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Xanthohumol (5) 
 
 
 
 
 
 
 
 
 
 
(E)-3-(3,4-Dimethoxyphenyl)-1-(2-hydroxy-4-methoxy-phenyl)prop-2-en-1-one (-H-HC, 61) 
 
 
 
 
 
 
 
 
 
 
(E)-1-(2-Hydroxyphenyl)-3-phenylprop-2-en-1-one (62)  
 
 
 
 
 
 
 
 
 
  
Entry 
Thiol 
[M] 
(fold) 
Individual 
kobs [s
-1
] 
kobs [s
-1
] 
Mean  
Abs3 0.00240 
(60) 
5.76 x 10
-4
 
5.71 x 10
-4
 
Abs4 5.67 x 10
-4
 
Abs5 0.00288 
(72) 
6.35 x 10
-4
 
6.29 x 10
-4
 
Abs6 6.23 x 10
-4
 
Abs7 0.00336 
(84) 
7.05 x 10
-4
 
6.96 x 10
-4
 
Abs8 6.87 x 10
-4
 
Abs9 0.00384 
(96) 
7.70 x 10
-4
 
7.66 x 10
-4
 
Abs10 7.61 x 10
-4
 
Abs11 0.00432 
(108) 
8.21 x 10
-4
 
8.13 x 10
-4
 
Abs12 8.05 x 10
-4
 
k2 = 0.129 M
-1
 s
-1
 
Entry 
Thiol 
[M] 
(fold) 
Individual 
kobs [s
-1
] 
kobs [s
-1
] 
Mean  
Abs3 0.00240 
(60) 
3.08 x 10
-3
 
3.10 x 10
-3
 
Abs4 3.11 x 10
-3
 
Abs5 0.00288 
(72) 
3.61 x 10
-3
 
3.60 x 10
-3
 
Abs6 3.60 x 10
-3
 
Abs7 0.00336 
(84) 
3.94 x 10
-3
 
3.95 x 10
-3
 
Abs8 3.96 x 10
-3
 
Abs9 0.00384 
(96) 
4.26 x 10
-3
 
4.24 x 10
-3
 
Abs10 4.22 x 10
-3
 
Abs11 0.00432 
(108) 
4.47 x 10
-3
 
4.47 x 10
-3
 
Abs12 4.48 x 10
-3
 
k2 = 0.706 M
-1
 s
-1
 
Entry 
Thiol 
[M] 
(fold) 
kobs [s
-1
] 
Mean of 
replicates 
1 0.00400 
(100) 
0.0331 
 
2 0.00800 
(200) 
0.0600 
 
3 0.0120 
(300) 
0.0815 
 
4 0.0160 
(400) 
0.100 
 
5 0.0200 
(500) 
0.114 
 
k2 = 5.07 M
-1
 s
-1
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Calythropsin (116) 
 
 
 
 
 
 
 
 
 
 
4-Methoxy-2’,3,4’-trihydroxychalcone (118)  
 
 
 
 
 
 
 
 
 
 
2’,4’-Dihydroxy-3,4-dimethoxychalcone (119)  
 
 
 
 
 
 
 
 
 
 
The other -H-chalcones shown in Table 5 in Results and Discussion part were tested by Katrin 
Winter.
116  
Entry 
Thiol 
[M] 
(fold) 
Individual 
kobs [s
-1
] 
kobs [s
-1
] 
Mean  
Abs3 0.00400 
(100) 
3.09 x 10
-3
 
3.06 x 10
-3
 
Abs4 3.04 x 10
-3
 
Abs5 0.00600 
(150) 
3.90 x 10
-3
 
3.87 x 10
-3
 
Abs6 3.84 x 10
-3
 
Abs7 0.00800 
(200) 
4.63 x 10
-3
 
4.60 x 10
-3
 
Abs8 4.56 x 10
-3
 
Abs9 0.0100 
(250) 
5.06 x 10
-3
 
5.05 x 10
-3
 
Abs10 5.05 x 10
-3
 
Abs11 0.0120 
(300) 
5.65 x 10
-3
 
5.64 x 10
-3
 
Abs12 5.63 x 10
-3
 
k2 = 0.317 M
-1
 s
-1
 
Entry 
Thiol 
[M] 
(fold) 
Individual 
kobs [s
-1
] 
kobs [s
-1
] 
Mean  
Abs3 0.00240 
(60) 
1.65 x 10
-3
 
1.65 x 10
-3
 
Abs4 1.64 x 10
-3
 
Abs5 0.00288 
(72) 
1.87 x 10
-3
 
1.86 x 10
-3
 
Abs6 1.86 x 10
-3
 
Abs7 0.00336 
(84) 
2.06 x 10
-3
 
2.07 x 10
-3
 
Abs8 2.07 x 10
-3
 
Abs9 0.00384 
(96) 
2.24 x 10
-3
 
2.24 x 10
-3
 
Abs10 2.24 x 10
-3
 
Abs11 0.00432 
(108) 
2.47 x 10
-3
 
2.45 x 10
-3
 
Abs12 2.44 x 10
-3
 
k2 = 0.415 M
-1
 s
-1
 
Entry 
Thiol 
[M] 
(fold) 
Individual 
kobs [s
-1
] 
kobs [s
-1
] 
Mean  
Abs3 0.00240 
(60) 
1.92 x 10
-3
 
1.94 x 10
-3
 
Abs4 1.95 x 10
-3
 
Abs5 0.00288 
(72) 
2.21 x 10
-3
 
2.21 x 10
-3
 
Abs6 2.21 x 10
-3
 
Abs7 0.00336 
(84) 
2.39 x 10
-3
 
2.42 x 10
-3
 
Abs8 2.44 x 10
-3
 
Abs9 0.00384 
(96) 
2.70 x 10
-3
 
2.68 x 10
-3
 
Abs10 2.66 x 10
-3
 
Abs11 0.00432 
(108) 
2.88 x 10
-3
 
2.85 x 10
-3
 
Abs12 2.82 x 10
-3
 
k2 = 0.479 M
-1
 s
-1
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7.4.2. Representativek2 value determinations for -X-TMCs with cysteamine 
-F-TMC (68) 
 
 
-CN-TMC (69) 
 
 
 
 
 
 
 
 
 
-Me-TMC (70) 
 
 
 
 
 
 
 
 
 
  
Entry 
Thiol 
[M] 
(fold) 
Individual 
kobs [s
-1
] 
kobs [s
-1
] 
Mean  
Abs3 0.00400 
(100) 
1.63 x 10
-4
 
1.63 x 10
-4
 
Abs4 1.63 x 10
-4
 
Abs5 0.00800 
(200) 
2.67 x 10
-4
 
2.59 x 10
-4
 
Abs6 2.52 x 10
-4
 
Abs7 0.0120 
(300) 
3.34 x 10
-4
 
3.32 x 10
-4
 
Abs8 3.31 x 10
-4
 
Abs9 0.0160 
(400) 
3.89 x 10
-4
 
3.92 x 10
-4
 
Abs10 3.94 x 10
-4
 
Abs11 0.0200 
(500) 
4.39 x 10
-4
 
4.41 x 10
-4
 
Abs12 4.43 x 10
-4
 
k2 = 0.0172 M
-1
 s
-1
 
Entry 
Thiol 
[M] 
(fold) 
kobs [s
-1
] 
Mean of 
replicates 
1 0.00480 
(12) 
6.39 
 
2 0.00960 
(24) 
9.08 
 
3 0.0144 
(36) 
12.0 
 
4 0.0192 
(48) 
14.7 
 
5 0.0240 
(60) 
17.4 
 
k2 = 5770 M
-1
 s
-1
 
Entry 
Thiol 
[M] 
(fold) 
Individual 
kobs [s
-1
] 
kobs [s
-1
] 
Mean  
Abs3 0.00800 
(200) 
1.12 x 10
-4
 
1.11 x 10
-4
 
Abs4 1.10 x 10
-4
 
Abs5 0.0120 
(300) 
1.44 x 10
-4
 
1.44 x 10
-4
 
Abs6 1.44 x 10
-4
 
Abs7 0.0160 
(400) 
1.74 x 10
-4
 
1.73 x 10
-4
 
Abs8 1.72 x 10
-4
 
Abs9 0.0180 
(450) 
1.89 x 10
-4
 
1.89 x 10
-4
 
Abs10 --- 
Abs11 0.0200 
(500) 
--- 
--- 
Abs12 --- 
k2 = 0.00776 M
-1
 s
-1
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-NO2-TMC (71)  
 
 
 
 
 
 
 
 
 
 
-COOEt-TMC (72) 
 
 
 
 
 
 
 
 
 

-Br-TMC (73)  
 
 
 
 
 
 
 
 
 
  
Entry 
Thiol 
[M] 
(fold) 
kobs [s
-1
] 
Mean of 
replicates 
1 0.00480 
(60) 
4.12 
 
2 0.00576 
(72) 
4.92 
 
3 0.00672 
(84) 
5.85 
 
4 0.00768 
(96) 
6.27 
 
5 0.00864 
(108) 
7.03 
 
k2 = 747 M
-1
 s
-1
 
Entry 
Thiol 
[M] 
(fold) 
Individual 
kobs [s
-1
] 
kobs [s
-1
] 
Mean  
Abs3 0.00240 
(60) 
1.37 x 10
-3
 
1.38 x 10
-3
 
Abs4 1.38 x 10
-3
 
Abs5 0.00288 
(72) 
1.52 x 10
-3
 
1.52 x 10
-3
 
Abs6 1.51 x 10
-3
 
Abs7 0.00336 
(84) 
1.67 x 10
-3
 
1.67 x 10
-3
 
Abs8 1.66 x 10
-3
 
Abs9 0.00384 
(96) 
1.78 x 10
-3
 
1.80 x 10
-3
 
Abs10 1.82 x 10
-3
 
Abs11 0.00432 
(108) 
1.93 x 10
-3
 
1.98 x 10
-3
 
Abs12 2.02 x 10
-3
 
k2 = 0.308 M
-1
 s
-1
 
Entry 
Thiol 
[M] 
(fold) 
kobs [s
-1
] 
Mean of 
replicates 
1 0.00400 
(100) 
0.0207 
 
2 0.00800  
(200) 
0.0354 
 
3 0.0120 
(300) 
0.0480 
 
4 0.0160 
(400) 
0.0583 
 
5 0.0200 
(500) 
0.0672 
 
k2 = 2.90 M
-1
 s
-1
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-Cl-TMC (74) 
 







 
 
-I-TMC (75) 
 
 
 
 
 
 
 
 
 
 
-COOH-TMC (76) 
 
 
 
 
 
 
 
 
 
  
Entry 
Thiol 
[M] 
(fold) 
Individual 
kobs [s
-1
] 
kobs [s
-1
] 
Mean  
Abs3 0.00480 
(12) 
1.23 x 10
-3
 
1.24 x 10
-3
 
Abs4 1.25 x 10
-3
 
Abs5 0.00960 
(24) 
2.17 x 10
-3
 
2.21 x 10
-3
 
Abs6 2.25 x 10
-3
 
Abs7 0.0144 
(36) 
3.12 x 10
-3
 
3.02 x 10
-3
 
Abs8 2.91 x 10
-3
 
Abs9 0.0192 
(48) 
3.87 x 10
-3
 
3.80 x 10
-3
 
Abs10 3.74 x 10
-3
 
Abs11 0.0240 
(60) 
4.44 x 10
-3
 
4.47 x 10
-3
 
Abs12 4.50 x 10
-3
 
k2 = 1.68 M
-1
 s
-1
 
Entry 
Thiol 
[M] 
(fold) 
Individual 
kobs [s
-1
] 
kobs [s
-1
] 
Mean  
Abs3 0.00240 
(60) 
1.15 x 10
-3
 
1.16 x 10
-3
 
Abs4 1.16 x 10
-3
 
Abs5 0.00288 
(72) 
1.29 x 10
-3
 
1.29 x 10
-3
 
Abs6 1.29 x 10
-3
 
Abs7 0.00336 
(84) 
1.45 x 10
-3
 
1.44 x 10
-3
 
Abs8 1.44 x 10
-3
 
Abs9 0.00384 
(96) 
1.56 x 10
-3
 
1.57 x 10
-3
 
Abs10 1.57 x 10
-3
 
Abs11 0.00432 
(108) 
1.69 x 10
-3
 
1.71 x 10
-3
 
Abs12 1.72 x 10
-3
 
k2 = 0.287 M
-1
 s
-1
 
Entry 
Thiol 
[M] 
(fold) 
Individual 
kobs [s
-1
] 
kobs [s
-1
] 
Mean  
Abs3 0.00800 
(200) 
3.83 x 10
-5
 
3.84 x 10
-5
 
Abs4 3.84 x 10
-5
 
Abs5 0.0100 
(250) 
4.70 x 10
-5
 
4.63 x 10
-5
 
Abs6 4.55 x 10
-5
 
Abs7 0.0120 
(300) 
5.36 x 10
-5
 
5.35 x 10
-5
 
Abs8 5.33 x 10
-5
 
Abs9 0.0140 
(350) 
6.09 x 10
-5
 
6.12 x 10
-5
 
Abs10 6.14 x 10
-5
 
Abs11 0.160 
(400) 
--- 
--- 
Abs12 --- 
k2 = 0.00378 M
-1
 s
-1
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-CF3-TMC (77)  
 
 
 
 
 
 




-p-NO2-C6H4-TMC (78) 
 
 
 
 
 
 
 
 
 
 
-Ph-TMC (79) 
 
 
 
 
 
 
 
 
 
 
Entry 
Thiol 
[M] 
(fold) 
kobs [s
-1
] 
Mean of 
replicates 
1 0.00480 
(60) 
0.103 
 
2 0.00576 
(72) 
0.131 
 
3 0.00672 
(84) 
0.140 
 
4 0.00768 
(96) 
0.166 
 
5 0.00864 
(108) 
0.174 
 
k2 = 18.5 M
-1
 s
-1
 
Entry 
Thiol 
[M] 
(fold) 
Individual 
kobs [s
-1
] 
kobs [s
-1
] 
Mean  
Abs3 0.00240 
(60) 
1.39 x 10
-3
 
1.39 x 10
-3
 
Abs4 1.39 x 10
-3
 
Abs5 0.00288 
(72) 
1.56 x 10
-3
 
1.55 x 10
-3
 
Abs6 1.54 x 10
-3
 
Abs7 0.00336 
(84) 
1.70 x 10
-3
 
1.70 x 10
-3
 
Abs8 1.69 x 10
-3
 
Abs9 0.00384 
(96) 
1.84 x 10
-3
 
1.83 x 10
-3
 
Abs10 1.83 x 10
-3
 
Abs11 0.00432 
(108) 
1.97 x 10
-3
 
1.97 x 10
-3
 
Abs12 1.97 x 10
-3
 
k2 = 0.302 M
-1
 s
-1
 
Entry 
Thiol 
[M] 
(fold) 
Individual 
kobs [s
-1
] 
kobs [s
-1
] 
Mean  
Abs3 0.00800 
(200) 
1.19 x 10
-4
 
1.14 x 10
-4
 
Abs4 1.10 x 10
-4
 
Abs5 0.0100 
(250) 
1.22 x 10
-4
 
1.21 x 10
-4
 
Abs6 1.21 x 10
-4
 
Abs7 0.0120 
(300) 
1.35 x 10
-4
 
1.39 x 10
-4
 
Abs8 1.42 x 10
-4
 
Abs9 0.0160 
(400) 
1.69 x 10
-4
 
1.70 x 10
-4
 
Abs10 1.71 x 10
-4
 
Abs11 0.0200 
(500) 
1.88 x 10
-4
 
1.88 x 10
-4
 
Abs12 --- 
k2 = 0.00652 M
-1
 s
-1
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-p-OMe-C6H4-TMC (80) 
 
 
 
 
 
 
 
 
 
 
7.4.3. Representativek2 value determinations for selectred -X-TMCs with other thiols 
-CN-TMC (69) with 2-mercaptoethanol  
 
 
 
 
 
 
 
 
 
 
-NO2-TMC (71) with 2-mercaptoethanol  
 
 
 
 
 
 
 
 
 
 
Entry 
Thiol 
[M] 
(fold) 
Individual 
kobs [s
-1
] 
kobs [s
-1
] 
Mean s 
Abs3 0.00240 
(60) 
5.65 x 10
-5
 
5.53 x 10
-5
 
Abs4 5.42 x 10
-5
 
Abs5 0.00288 
(72) 
5.94 x 10
-5
 
5.79 x 10
-5
 
Abs6 5.65 x 10
-5
 
Abs7 0.00336 
(84) 
6.49 x 10
-5
 
6.44 x 10
-5
 
Abs8 6.39 x 10
-5
 
Abs9 0.00384 
(96) 
6.73 x 10
-5
 
6.65 x 10
-5
 
Abs10 6.57 x 10
-5
 
Abs11 0.00432 
(108) 
7.18 x 10
-5
 
7.09 x 10
-5
 
Abs12 7.00 x 10
-5
 
k2 = 0.00827 M
-1
 s
-1
 
Entry 
Thiol 
[M] 
(fold) 
kobs [s
-1
] 
Mean of 
replicates 
1 0.00240 
(60) 
1.20 
 
2 0.00288 
(72) 
1.37 
 
3 0.00336 
(84) 
1.60 
 
4 0.00384 
(96) 
1.76 
 
5 0.00432 
(108) 
1.93 
 
k2 = 384 M
-1
 s
-1
 
Entry 
Thiol 
[M] 
(fold) 
kobs [s
-1
] 
Mean of 
replicates 
1 0.00480 
(60) 
0.149 
 
2 0.00576 
(72) 
0.182 
 
3 0.00672 
(84) 
0.218 
 
4 0.00768 
(96) 
0.247 
 
5 0.00864 
(108) 
0.280 
 
k2 = 34.0 M
-1
 s
-1
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-Br-TMC (73) with 2-mercaptoethanol 
 
 
 
 
 
 
 
 
 
 
-CF3-TMC (77) with 2-mercaptoethanol 
 
 
 
 
 
 
 
 
 
 
-Br-TMC (73) with 1,4-butanedithiol 
 
 
 
 
 
 
 
 
 
  
Entry 
Thiol 
[M] 
(fold) 
Individual 
kobs [s
-1
] 
kobs [s
-1
] 
Mean  
Abs3 0.00240 
(60) 
--- 
3.09 x 10
-4
 
Abs4 3.09 x 10
-4
 
Abs5 0.00288 
(72) 
3.74 x 10
-4
 
3.74 x 10
-4
 
Abs6 3.74 x 10
-4
 
Abs7 0.00336 
(84) 
4.35 x 10
-4
 
4.35 x 10
-4
 
Abs8 4.36 x 10
-4
 
Abs9 0.00384 
(96) 
5.04 x 10
-4
 
5.10 x 10
-4
 
Abs10 5.17 x 10
-4
 
Abs11 0.00432 
(108) 
5.77 x 10
-4
 
5.71 x 10
-4
 
Abs12 5.65 x 10
-4
 
k2 = 0.137 M
-1
 s
-1
 
Entry 
Thiol 
[M] 
(fold) 
Individual 
kobs [s
-1
] 
kobs [s
-1
] 
Mean  
Abs3 0.00160 
(20) 
2.51 x 10
-3
 
2.57 x 10
-3
 
Abs4 2.63 x 10
-3
 
Abs5 0.00200 
(25) 
3.17 x 10
-3
 
3.20 x 10
-3
 
Abs6 3.23 x 10
-3
 
Abs7 0.00240 
(30) 
4.08 x 10
-3
 
3.90 x 10
-3
 
Abs8 3.73 x 10
-3
 
Abs9 0.00280 
(35) 
4.39 x 10
-3
 
4.32 x 10
-3
 
Abs10 4.25 x 10
-3
 
Abs11 0.00320 
(40) 
4.92 x 10
-3
 
4.99 x 10
-3
 
Abs12 5.05 x 10
-3
 
k2 = 1.49 M
-1
 s
-1
 
Entry 
Thiol 
[M] 
(fold) 
Individual 
kobs [s
-1
] 
kobs [s
-1
] 
Mean  
Abs3 0.00240 
(60) 
2.94 x 10
-4
 
2.97 x 10
-4
 
Abs4 3.01 x 10
-4
 
Abs5 0.00288 
(72) 
3.63 x 10
-4
 
3.58 x 10
-4
 
Abs6 3.54 x 10
-4
 
Abs7 0.00336 
(84) 
4.31 x 10
-4
 
4.38 x 10
-4
 
Abs8 4.44 x 10
-4
 
Abs9 0.00384 
(96) 
5.05 x 10
-4
 
5.19 x 10
-4
 
Abs10 5.32 x 10
-4
 
Abs11 0.00432 
(108) 
5.64 x 10
-4
 
5.86 x 10
-4
 
Abs12 6.08 x 10
-4
 
k2 = 0.154 M
-1
 s
-1
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-Br-TMC (73) with glutathione 
 
 
 
 
 
 
 
 
 
 
7.4.4. Representativek2 value determination for -CN-pHC (95) with cysteamine 
 
 
 
 
 
 
 
 
 
  
Entry 
Thiol [M] 
(fold) 
Individual 
kobs [s
-1
] 
kobs [s
-1
] 
Mean of 
duplicates 
Abs3 0.000480 
(12) 
--- 
3.38 x 10
-5
 
Abs4 3.38 x 10
-5
 
Abs5 0.000600 
(15) 
4.06 x 10
-5
 
4.04 x 10
-5
 
Abs6 4.02 x 10
-5
 
Abs7 0.000720 
(18) 
4.58 x 10
-5
 
4.53 x 10
-5
 
Abs8 4.48 x 10
-5
 
Abs9 0.000840 
(21) 
4.93 x 10
-5
 
4.93 x 10
-5
 
Abs10 4.94 x 10
-5
 
Abs11 0.000960 
(24) 
5.31 x 10
-5
 
5.32 x 10
-5
 
Abs12 5.34 x 10
-5
 
k2 = 0.0398 M
-1
 s
-1
 
Entry 
Thiol 
[M] 
(fold) 
kobs [s
-1
] 
Mean of 
replicates 
1 0.00480 
(12) 
4.41 
 
2 0.00960 
(24) 
5.80 
 
3 0.0144 
(36) 
7.49 
 
4 0.0192 
(48) 
8.66 
 
5 0.0240 
(60) 
10.2 
 
k2 = 3020 M
-1
 s
-1
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7.5. LC-MS analysis of chalcones in buffer-ethylene glycol solution 
7.5.1.-H-Chalcones in presence of cysteamine 
Chalcone (1) with 12 fold cysteamine 
 
 
Butein (2) with 60 fold cysteamine 
 
  
APPENDIX 
194 
Isoliquiritigenin (4) with 60 fold cysteamine  
 
  
APPENDIX 
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Xanthohumol (5) with 60 fold cysteamine 
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(E)-3-(3,4-Dimethoxyphenyl)-1-(2-hydroxy-4-methoxy-phenyl)prop-2-en-1-one -H-HC, 
61) without thiol 
 
(E)-3-(3,4-Dimethoxyphenyl)-1-(2-hydroxy-4-methoxy-phenyl)prop-2-en-1-one (-H-HC 
(61)) with 60 fold cysteamine  
APPENDIX 
197 
(E)-1-(2-Hydroxyphenyl)-3-phenylprop-2-en-1-one (62) with 12 fold cysteamine  
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Calythropsin (116) with 100 fold cysteamine  
 
  
APPENDIX 
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4-Methoxy-2’,3,4’-trihydroxychalcone (118) with 60 fold cysteamine  
 
  
APPENDIX 
200 
2’,4’-Dihydroxy-3,4-dimethoxychalcone (119) with 60 fold cysteamine  
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7.5.2.-X-TMCs in presence of thiols 
-F-TMC (68) with 200 fold cysteamine 
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-CN-TMC (69) with cysteamine  
 
 
APPENDIX 
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-CN-TMC (69) with 2-mercaptoethanol 
 
  
[M+Na]+: 454.1294 
APPENDIX 
204 
-Me-TMC (70) with 200 fold cysteamine   
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-NO2-TMC (71) without thiol  
 
 
-NO2-TMC (71) with 60 fold cysteamine 
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-NO2-TMC (71) with 2-mercaptoethanol  
 
 
[M+Na]+: 474.1193 
[M+NH4
++CH3CN]:510.1904 
APPENDIX 
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-COOEt-TMC (72) with 60 fold cysteamine   
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-Br-TMC (73) with 60 fold cysteamine  
  

 
This measurement was done ~15 min after mixing the chalcone solution 
with the thiol solution. The measurement that was done directly after 
mixing showed the presence of the direct thiol adduct. 
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-Br-TMC (73) with 60 fold 1,4-butanedithiol  
 
 
[M+Na]+: 533.1636 
[M+Na]+:  
489.1376 
[M+Na]+: 533.1636 
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-Br-TMC (73) with 60 fold 2-mercaptoethanol 
 
  
[M+Na]+: 489.1552 
[M+Na]+: 445.1289 
? 
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-Br-TMC (73) with 60 fold glutathione 
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-Cl-TMC (74) with 12 fold cysteamine  
 
This measurement was done directly after mixing the chalcone solution with 
the thiol solution. When the measurement was repeated after about 24 h of 
incubation the major product was the thiazepine shown on the right (which 
was also detected in the case of -Br-TMC (73) with cysteamine). 
  
APPENDIX 
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-I-TMC (75) without thiol 

 
APPENDIX 
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-I-TMC (75) with 12 fold cysteamine  
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-COOH-TMC (76) without thiol  
 
 
APPENDIX 
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-COOH-TMC (76) with 200 fold cysteamine 
 
 
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-CF3-TMC (77) with cysteamine 
 
 
APPENDIX 
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-CF3-TMC (77) with 2-mercaptoethanol 
 
 
Impurity (the starting 
-Br-TMC) 
[M+Na]+: 497.1216 
[M+TRIS+H]+: 596.2137 
 
Impurity (the starting 
-Br-TMC) 
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-p-NO2-C6H4-TMC (78) with 60 fold cysteamine 
 
-Ph-TMC (79) with 200 fold cysteamine 
 
  
APPENDIX 
220 
-p-OMe-C6H4-TMC (80) with 100 fold cysteamine 
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7.5.3.-X-HCs in absence and presence of cysteamine 
-F-HC (94) without thiol 
 
-F-HC (94) with 60 fold cysteamine  
 
  
Impurity 
Impurity 
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-CN-HC (95) without thiol 
 
-CN-HC (95) with 60 fold cysteamine  
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-Me-HC (96) without thiol 
 
-Me-HC (96) with 60 fold cysteamine  
  
APPENDIX 
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-Br-HC (97) without thiol 
 
 
APPENDIX 
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-Br-HC (97) with 60 fold cysteamine 
 
  
APPENDIX 
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-CF3-HC (99) without thiol 
 
-CF3-HC (99) with 60 fold cysteamine  
  
? 
 ? 
? 
? 
? 
? 
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-p-NO2-C6H4-HC (100) without thiol 
 
-p-NO2-C6H4-HC (100) with 60 fold cysteamine  
  
APPENDIX 
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7.5.4.-X-pHCs in presence of cysteamine 
-F-pHC (104) with cysteamine  
 
  
APPENDIX 
229 
-CN-pHC (105) with cysteamine 
 
This measurement was done like all the others with an HPLC run at 40 °C. 
When it was repeated at 25 °C the expected addition product shown on the 
right side was detected. 
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